| (+)-alpha-tocopherol | multiple interactions | ISO | RGD:70373 | 6480464 | alpha-Tocopherol affects the reaction [Lipopolysaccharides results in increased expression of BAX protein] | CTD | PMID:11805214 |
| (+)-catechin | multiple interactions | EXP | | 6480464 | Catechin inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA]; more ... | CTD | PMID:18611398 |
| (+)-catechin | multiple interactions | ISO | RGD:70373 | 6480464 | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BAX mRNA] | CTD | PMID:21882252 |
| (+)-pilocarpine | decreases expression | EXP | | 6480464 | Pilocarpine results in decreased expression of BAX mRNA | CTD | PMID:17971868 |
| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of BAX protein | CTD | PMID:14754538 PMID:19429016 |
| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of BAX mRNA | CTD | PMID:17971868 |
| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of BAX protein | CTD | PMID:19429016 PMID:14754538 |
| (-)-citrinin | increases expression | ISO | RGD:10226 | 6480464 | Citrinin results in increased expression of BAX protein | CTD | PMID:21622943 |
| (-)-citrinin | affects expression | ISO | RGD:10226 | 6480464 | Citrinin affects the expression of BAX protein | CTD | PMID:22771370 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:70373 | 6480464 | [decitabine co-treated with epigallocatechin gallate] affects the expression of BAX mRNA | CTD | PMID:18250043 |
| (-)-epigallocatechin 3-gallate | affects localization | ISO | RGD:70373 | 6480464 | epigallocatechin gallate analog affects the localization of BAX protein | CTD | PMID:16115949 |
| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:70373 | 6480464 | epigallocatechin gallate results in increased expression of BAX protein | CTD | PMID:15657356 more ... |
| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:70373 | 6480464 | epigallocatechin gallate results in increased expression of BAX protein | CTD | PMID:15764647 more ... |
| (-)-epigallocatechin 3-gallate | increases activity | ISO | RGD:70373 | 6480464 | epigallocatechin gallate results in increased activity of BAX protein | CTD | PMID:15705601 |
| (-)-epigallocatechin 3-gallate | decreases expression | ISO | RGD:70373 | 6480464 | epigallocatechin gallate results in decreased expression of BAX mRNA | CTD | PMID:18851785 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:70373 | 6480464 | epigallocatechin gallate promotes the reaction [BAX protein binds to BAX protein] | CTD | PMID:15705601 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:70373 | 6480464 | epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein] | CTD | PMID:12672908 |
| (-)-epigallocatechin 3-gallate | affects expression | ISO | RGD:70373 | 6480464 | epigallocatechin gallate affects the expression of BAX protein | CTD | PMID:15975156 |
| (-)-epigallocatechin 3-gallate | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to epigallocatechin gallate | CTD | PMID:15764647 |
| (-)-perillyl alcohol | multiple interactions | ISO | RGD:10226 | 6480464 | perilla alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of BAX protein] | CTD | PMID:19161993 |
| (-)-selegiline | multiple interactions | ISO | RGD:10226 | 6480464 | Selegiline inhibits the reaction [3-morpholino-sydnonimine results in increased expression of BAX protein]; more ... | CTD | PMID:12880480 |
| (R)-lipoic acid | multiple interactions | ISO | RGD:70373 | 6480464 | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased localization of BAX protein] | CTD | PMID:15735709 |
| (R)-noradrenaline | multiple interactions | EXP | | 6480464 | N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea inhibits the reaction [Norepinephrine results in increased expression of BAX protein] | CTD | PMID:20374255 |
| (R)-noradrenaline | increases expression | EXP | | 6480464 | Norepinephrine results in increased expression of BAX mRNA | CTD | PMID:18675472 |
| (R)-noradrenaline | increases expression | EXP | | 6480464 | Norepinephrine results in increased expression of BAX protein | CTD | PMID:20374255 |
| (S)-colchicine | increases expression | ISO | RGD:70373 | 6480464 | Colchicine results in increased expression of BAX protein | CTD | PMID:22342440 |
| (S)-nicotine | multiple interactions | ISO | RGD:70373 | 6480464 | L 663536 inhibits the reaction [Nicotine results in decreased expression of BAX protein] | CTD | PMID:20061081 |
| (S)-nicotine | decreases expression | ISO | RGD:70373 | 6480464 | Nicotine results in decreased expression of BAX protein | CTD | PMID:20106947 PMID:20061081 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of BAX mRNA | CTD | PMID:20339300 |
| (S)-nicotine | affects localization | EXP | | 6480464 | Nicotine affects the localization of BAX protein | CTD | PMID:18203686 |
| (S)-nicotine | increases expression | ISO | RGD:10226 | 6480464 | Nicotine results in increased expression of BAX mRNA | CTD | PMID:15831280 |
| (S)-nicotine | multiple interactions | ISO | RGD:70373 | 6480464 | PRKCZ protein affects the reaction [Nicotine results in increased phosphorylation of BAX protein] | CTD | PMID:17525161 |
| (S)-nicotine | decreases expression | ISO | RGD:10226 | 6480464 | Nicotine results in decreased expression of BAX mRNA; more ... | CTD | PMID:17135361 |
| (S)-nicotine | increases phosphorylation | ISO | RGD:70373 | 6480464 | Nicotine results in increased phosphorylation of BAX protein | CTD | PMID:17525161 |
| (S)-nicotine | decreases expression | ISO | RGD:70373 | 6480464 | Nicotine results in decreased expression of BAX protein | CTD | PMID:20061081 PMID:20106947 |
| (S)-nicotine | multiple interactions | ISO | RGD:70373 | 6480464 | Nicotine inhibits the reaction [[Cisplatin co-treated with Etoposide] affects the localization of BAX protein] | CTD | PMID:18676776 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | decreases expression | ISO | RGD:10226 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in decreased expression of BAX protein | CTD | PMID:15525693 |
| 1,3-dinitrobenzene | increases expression | EXP | | 6480464 | 3-dinitrobenzene results in increased expression of BAX mRNA | CTD | PMID:16025311 |
| 1,3-dinitrobenzene | increases expression | ISO | RGD:10226 | 6480464 | 3-dinitrobenzene results in increased expression of BAX protein; more ... | CTD | PMID:19477251 |
| 1,3-thiazolidine-2,4-dione | increases expression | ISO | RGD:70373 | 6480464 | 2,4-thiazolidinedione results in increased expression of BAX protein | CTD | PMID:15916743 |
| 1,4-benzoquinone | increases expression | ISO | RGD:70373 | 6480464 | benzoquinone results in increased expression of BAX protein | CTD | PMID:20499891 |
| 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:10226 | 6480464 | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of BAX mRNA] | CTD | PMID:15913567 |
| 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of BAX mRNA | CTD | PMID:12883083 PMID:20551477 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:10226 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of BAX mRNA | CTD | PMID:15913567 |
| 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of BAX mRNA | CTD | PMID:12883083 |
| 11-deoxycorticosterone | multiple interactions | EXP | | 6480464 | A 127722 inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of BAX protein]; more ... | CTD | PMID:22431579 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:10226 | 6480464 | Ethinyl Estradiol affects the expression of BAX mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Gossypol co-treated with Methyltestosterone co-treated with Ethinyl Estradiol] results in increased expression of BAX mRNA | CTD | PMID:15451339 |
| 17beta-estradiol | decreases expression | ISO | RGD:70373 | 6480464 | Estradiol results in decreased expression of BAX protein | CTD | PMID:15870704 |
| 17beta-estradiol | decreases expression | ISO | RGD:70373 | 6480464 | Estradiol results in decreased expression of BAX protein | CTD | PMID:15870704 PMID:18174961 |
| 17beta-estradiol | multiple interactions | ISO | RGD:70373 | 6480464 | Estradiol inhibits the reaction [Lindane results in decreased expression of BAX protein]; more ... | CTD | PMID:18174961 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of BAX protein | CTD | PMID:15964511 |
| 17beta-estradiol | multiple interactions | ISO | RGD:70373 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in decreased expression of BAX protein] | CTD | PMID:15870704 |
| 17beta-estradiol | increases expression | ISO | RGD:70373 | 6480464 | Estradiol results in increased expression of BAX mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | affects expression | ISO | RGD:70373 | 6480464 | Estradiol affects the expression of BAX mRNA | CTD | PMID:11896290 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | EXP | | 6480464 | Dihydrotestosterone inhibits the reaction [Testosterone deficiency results in increased expression of BAX mRNA]; more ... | CTD | PMID:20850791 |
| 1H-pyrazole | increases expression | ISO | RGD:10226 | 6480464 | pyrazole results in increased expression of BAX mRNA | CTD | PMID:17945193 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | RGD:10226 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of BAX protein | CTD | PMID:21291966 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | RGD:70373 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of BAX protein | CTD | PMID:20638727 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10226 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAX mRNA | CTD | PMID:14718643 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10226 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BAX mRNA | CTD | PMID:17586704 PMID:22889882 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAX mRNA | CTD | PMID:19520675 PMID:20959002 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10226 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAX protein | CTD | PMID:15972635 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10226 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAX mRNA | CTD | PMID:14718643 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10226 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAX mRNA | CTD | PMID:12167310 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10226 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAX mRNA | CTD | PMID:12167310 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10226 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAX protein | CTD | PMID:19085997 PMID:15972635 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10226 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAX mRNA | CTD | PMID:14718646 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAX mRNA | CTD | PMID:19520675 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BAX mRNA; more ... | CTD | PMID:15965093 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10226 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BAX protein | CTD | PMID:15972635 PMID:19085997 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:70373 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BAX mRNA | CTD | PMID:16039398 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10226 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BAX mRNA | CTD | PMID:17586704 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | Losartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAX mRNA] | CTD | PMID:15502641 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:10226 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of BAX protein | CTD | PMID:22427801 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:10226 | 6480464 | D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of BAX protein] | CTD | PMID:22427801 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of BAX mRNA | CTD | PMID:15502641 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of BAX mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of BAX mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of BAX mRNA | CTD | PMID:19167416 PMID:17070881 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of BAX mRNA | CTD | PMID:17070881 more ... |
| 2-acetamidofluorene | increases expression | ISO | RGD:10226 | 6480464 | 2-Acetylaminofluorene results in increased expression of BAX mRNA | CTD | PMID:17317680 PMID:21607683 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of BAX mRNA | CTD | PMID:17070881 PMID:19167416 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BAX protein] | CTD | PMID:11915028 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of BAX mRNA | CTD | PMID:17070881 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:10226 | 6480464 | TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of BAX mRNA] | CTD | PMID:17317680 |
| 2-acetamidofluorene | increases expression | ISO | RGD:10226 | 6480464 | 2-Acetylaminofluorene results in increased expression of BAX mRNA | CTD | PMID:17317680 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | RGD:10226 | 6480464 | baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of BAX protein modified form]; more ... | CTD | PMID:20850421 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | EXP | | 6480464 | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of BAX mRNA | CTD | PMID:21401295 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | RGD:10226 | 6480464 | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of BAX protein] | CTD | PMID:20558151 |
| 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of BAX mRNA | CTD | PMID:14600272 PMID:15890375 |
| 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of BAX mRNA | CTD | PMID:14600272 more ... |
| 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of BAX mRNA | CTD | PMID:14600272 more ... |
| 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of BAX mRNA | CTD | PMID:15890375 PMID:14600272 |
| 2-nitropropane | increases expression | EXP | | 6480464 | 2-nitropropane results in increased expression of BAX mRNA | CTD | PMID:17070881 |
| 3',4',7-trihydroxyisoflavone | multiple interactions | ISO | RGD:70373 | 6480464 | 3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of BAX mRNA]; more ... | CTD | PMID:22914566 |
| 3',4',7-trihydroxyisoflavone | increases expression | ISO | RGD:70373 | 6480464 | 3',4',7-trihydroxyisoflavone results in increased expression of BAX mRNA | CTD | PMID:22914566 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | ISO | RGD:10226 | 6480464 | Puromycin Aminonucleoside results in increased expression of BAX protein | CTD | PMID:15987750 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of BAX protein | CTD | PMID:16152783 more ... |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of BAX protein | CTD | PMID:16152783 more ... |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of BAX protein | CTD | PMID:16396944 more ... |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of BAX protein | CTD | PMID:15113391 more ... |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | EXP | | 6480464 | Dinoprostone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of BAX protein] | CTD | PMID:16396944 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | ISO | RGD:10226 | 6480464 | Dexamethasone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of BAX protein] | CTD | PMID:15987750 |
| 3,3',4,4',5-pentachlorobiphenyl | affects expression | ISO | RGD:70373 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl affects the expression of BAX mRNA | CTD | PMID:21703328 |
| 3,3',4,4'-tetrachlorobiphenyl | increases expression | ISO | RGD:70373 | 6480464 | 3,4,3',4'-tetrachlorobiphenyl results in increased expression of BAX protein | CTD | PMID:20638727 |
| 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | RGD:10226 | 6480464 | tetrabromobisphenol A results in increased expression of BAX mRNA | CTD | PMID:22677475 |
| 3,3',5-triiodo-L-thyronine | decreases expression | ISO | RGD:70373 | 6480464 | Triiodothyronine results in decreased expression of BAX protein | CTD | PMID:16021636 |
| 3,3',5-triiodo-L-thyronine | decreases expression | EXP | | 6480464 | Triiodothyronine results in decreased expression of BAX protein | CTD | PMID:16021636 |
| 3,3'-diindolylmethane | increases expression | ISO | RGD:70373 | 6480464 | 3,3'-diindolylmethane results in increased expression of BAX protein | CTD | PMID:22290291 |
| 3-nitropropanoic acid | multiple interactions | EXP | | 6480464 | tauroursodeoxycholic acid inhibits the reaction [3-nitropropionic acid affects the localization of BAX protein] | CTD | PMID:11080188 |
| 3-nitropropanoic acid | multiple interactions | EXP | | 6480464 | Ginkgo biloba extract 761 inhibits the reaction [3-nitropropionic acid results in increased expression of BAX mRNA] | CTD | PMID:21827809 |
| 3-nitropropanoic acid | increases expression | EXP | | 6480464 | 3-nitropropionic acid results in increased expression of BAX mRNA | CTD | PMID:21827809 |
| 3-nitropropanoic acid | affects localization | EXP | | 6480464 | 3-nitropropionic acid affects the localization of BAX protein | CTD | PMID:11080188 |
| 3-nitropropanoic acid | multiple interactions | EXP | | 6480464 | [Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BAX protein | CTD | PMID:15571979 |
| 4'-epidoxorubicin | increases expression | ISO | RGD:70373 | 6480464 | Epirubicin results in increased expression of BAX mRNA | CTD | PMID:22914566 |
| 4'-epidoxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | 3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of BAX mRNA]; more ... | CTD | PMID:22914566 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BAX mRNA | CTD | PMID:14600272 PMID:15890375 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BAX mRNA | CTD | PMID:14600272 more ... |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BAX mRNA | CTD | PMID:14600272 more ... |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | RGD:70373 | 6480464 | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BAX mRNA] | CTD | PMID:21882252 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BAX mRNA | CTD | PMID:15890375 PMID:14600272 |
| 4-amino-1,8-naphthalimide | multiple interactions | ISO | RGD:70373 | 6480464 | 4-amino-1,8-naphthalimide promotes the reaction [Doxorubicin affects the localization of BAX protein] | CTD | PMID:15456408 |
| 4-hydroperoxycyclophosphamide | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [perfosfamide affects the folding of BAX protein]; more ... | CTD | PMID:18034189 |
| 4-hydroperoxycyclophosphamide | affects folding | ISO | RGD:70373 | 6480464 | perfosfamide affects the folding of BAX protein | CTD | PMID:18034189 |
| 4-hydroperoxycyclophosphamide | increases expression | ISO | RGD:10226 | 6480464 | perfosfamide results in increased expression of BAX protein | CTD | PMID:16488414 |
| 4-hydroperoxycyclophosphamide | increases expression | ISO | RGD:70373 | 6480464 | perfosfamide results in increased expression of BAX | CTD | PMID:18034189 |
| 4-hydroxynon-2-enal | increases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased expression of BAX protein | CTD | PMID:21187080 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:70373 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of BAX mRNA | CTD | PMID:12419474 |
| 4-hydroxynon-2-enal | increases expression | ISO | RGD:70373 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of BAX protein | CTD | PMID:15607904 |
| 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:70373 | 6480464 | Fenretinide results in increased expression of and affects the localization of BAX protein | CTD | PMID:16675469 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:70373 | 6480464 | Fenretinide results in increased expression of BAX protein | CTD | PMID:17159502 |
| 4-nitro-1,2-phenylenediamine | increases expression | EXP | | 6480464 | 1,2-diamino-4-nitrobenzene results in increased expression of BAX mRNA | CTD | PMID:17070881 |
| 4-nonylphenol | decreases expression | ISO | RGD:70373 | 6480464 | 4-nonylphenol results in decreased expression of BAX mRNA | CTD | PMID:15461258 |
| 5-aminolevulinic acid | increases expression | ISO | RGD:70373 | 6480464 | Aminolevulinic Acid analog results in increased expression of BAX mRNA | CTD | PMID:20676910 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70373 | 6480464 | [decitabine affects the methylation of BAX gene] affects the reaction [TP53 protein results in increased expression of BAX mRNA] | CTD | PMID:18608210 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [Paraquat co-treated with decitabine] results in increased expression of BAX protein | CTD | PMID:22796470 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70373 | 6480464 | [Valproic Acid co-treated with decitabine co-treated with TNFSF10 protein] results in increased activity of BAX protein | CTD | PMID:21771726 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70373 | 6480464 | [decitabine affects the methylation of BAX gene] affects the reaction [TP53 protein results in increased expression of BAX mRNA] | CTD | PMID:18608210 PMID:18608210 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70373 | 6480464 | decitabine results in increased expression of BAX protein | CTD | PMID:18636160 PMID:19372550 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:70373 | 6480464 | decitabine results in increased expression of BAX protein | CTD | PMID:19372550 PMID:18636160 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:70373 | 6480464 | [decitabine co-treated with epigallocatechin gallate] affects the expression of BAX mRNA | CTD | PMID:18250043 |
| 5-azacytidine | decreases expression | ISO | RGD:70373 | 6480464 | Azacitidine results in decreased expression of BAX protein | CTD | PMID:15547111 |
| 5-azacytidine | multiple interactions | ISO | RGD:70373 | 6480464 | pifithrin promotes the reaction [Azacitidine results in decreased expression of BAX protein] | CTD | PMID:15547111 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70373 | 6480464 | Aspirin promotes the reaction [Fluorouracil results in increased expression of BAX protein]; more ... | CTD | PMID:15986848 |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX mRNA | CTD | PMID:15641988 more ... |
| 5-fluorouracil | multiple interactions | ISO | RGD:70373 | 6480464 | [wogonin co-treated with Fluorouracil] results in increased expression of BAX protein | CTD | PMID:20570612 |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX protein | CTD | PMID:15641988 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX | CTD | PMID:11750847 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX protein | CTD | PMID:15641988 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX mRNA | CTD | PMID:15641988 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX protein | CTD | PMID:19116755 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:10226 | 6480464 | Fluorouracil results in increased expression of BAX protein | CTD | PMID:19116755 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX mRNA | CTD | PMID:15641988 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX | CTD | PMID:12442003 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX protein | CTD | PMID:17589894 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:10226 | 6480464 | Fluorouracil results in increased expression of BAX protein | CTD | PMID:20844880 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX mRNA | CTD | PMID:17589894 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX | CTD | PMID:9388485 more ... |
| 5-fluorouracil | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to Fluorouracil | CTD | PMID:16686938 PMID:11062132 |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX mRNA | CTD | PMID:17589894 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX protein | CTD | PMID:19116755 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX | CTD | PMID:12442003 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:10226 | 6480464 | Fluorouracil results in increased expression of BAX protein | CTD | PMID:18567086 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX | CTD | PMID:9388485 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX protein | CTD | PMID:19116755 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:10226 | 6480464 | Fluorouracil results in increased expression of BAX protein | CTD | PMID:20844880 more ... |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of BAX mRNA | CTD | PMID:16888818 |
| 5-fluorouracil | multiple interactions | ISO | RGD:10226 | 6480464 | IL1RN protein affects the reaction [Fluorouracil results in increased expression of BAX protein] | CTD | PMID:20844880 |
| 5-fluorouracil | multiple interactions | ISO | RGD:10226 | 6480464 | [Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in increased expression of BAX protein | CTD | PMID:18567086 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70373 | 6480464 | IFNA1 protein promotes the reaction [Fluorouracil results in increased expression of BAX mRNA] | CTD | PMID:17045692 |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX | CTD | PMID:9792140 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX mRNA | CTD | PMID:17045692 more ... |
| 5-fluorouracil | increases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in increased expression of BAX protein | CTD | PMID:15641988 more ... |
| 5-fluorouracil | decreases expression | ISO | RGD:70373 | 6480464 | Fluorouracil results in decreased expression of BAX protein | CTD | PMID:11062132 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70373 | 6480464 | Fluorouracil promotes the reaction [Plant Extracts results in increased expression of BAX protein] | CTD | PMID:18834353 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70373 | 6480464 | Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased expression of BAX protein] | CTD | PMID:16168113 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70373 | 6480464 | Fluorouracil promotes the reaction [andrographolide affects the folding of BAX protein] | CTD | PMID:19097688 |
| 5-fluorouracil | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to Fluorouracil | CTD | PMID:11062132 PMID:16686938 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70373 | 6480464 | [Fluorouracil co-treated with irinotecan co-treated with vorinostat] results in increased expression of BAX protein | CTD | PMID:15754201 |
| 5-fluorouracil | multiple interactions | ISO | RGD:70373 | 6480464 | [Docosahexaenoic Acids co-treated with Fluorouracil] results in increased expression of BAX mRNA | CTD | PMID:19015929 |
| 6-propyl-2-thiouracil | multiple interactions | EXP | | 6480464 | Propylthiouracil results in increased expression of and affects the localization of BAX protein | CTD | PMID:16059974 |
| 6alpha-methylprednisolone | multiple interactions | EXP | | 6480464 | Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BAX mRNA]; more ... | CTD | PMID:17570061 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:70373 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BAX mRNA; more ... | CTD | PMID:20562217 |
| 7,12-dimethyltetraphene | decreases expression | ISO | RGD:10226 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein | CTD | PMID:18791811 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:10226 | 6480464 | resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein] | CTD | PMID:18791811 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:70373 | 6480464 | alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BAX mRNA] | CTD | PMID:20562217 |
| 8'-apo-beta,psi-caroten-8'-al | decreases expression | ISO | RGD:70373 | 6480464 | apocarotenal results in decreased expression of BAX mRNA | CTD | PMID:17034753 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:70373 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BAX | CTD | PMID:11802967 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:70373 | 6480464 | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BAX protein | CTD | PMID:16709600 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | alitretinoin results in increased expression of BAX | CTD | PMID:16909596 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | alitretinoin results in increased expression of BAX protein | CTD | PMID:12189556 more ... |
| 9-cis-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | alitretinoin results in increased expression of BAX protein | CTD | PMID:16340750 more ... |
| 9-cis-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | alitretinoin results in increased expression of BAX protein | CTD | PMID:16109544 more ... |
| 9-cis-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | alitretinoin results in increased expression of BAX protein | CTD | PMID:16340750 more ... |
| 9-cis-retinoic acid | multiple interactions | ISO | RGD:70373 | 6480464 | seocalcitol inhibits the reaction [alitretinoin results in increased expression of BAX protein] | CTD | PMID:16340750 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | alitretinoin results in increased expression of BAX protein | CTD | PMID:16109544 more ... |
| acetaldehyde | increases expression | ISO | RGD:70373 | 6480464 | Acetaldehyde results in increased expression of BAX mRNA | CTD | PMID:16814256 |
| acetaldehyde | multiple interactions | ISO | RGD:70373 | 6480464 | ADIPOQ protein inhibits the reaction [Acetaldehyde results in increased expression of BAX mRNA] | CTD | PMID:16814256 |
| acetylsalicylic acid | increases expression | ISO | RGD:70373 | 6480464 | Aspirin results in increased expression of BAX protein | CTD | PMID:11532860 more ... |
| acetylsalicylic acid | increases expression | ISO | RGD:70373 | 6480464 | Aspirin results in increased expression of BAX protein | CTD | PMID:11532860 more ... |
| acetylsalicylic acid | increases expression | ISO | RGD:70373 | 6480464 | Aspirin results in increased expression of BAX protein | CTD | PMID:19212664 more ... |
| acetylsalicylic acid | increases localization | ISO | RGD:70373 | 6480464 | Aspirin results in increased localization of BAX protein | CTD | PMID:15976387 PMID:11228543 |
| acetylsalicylic acid | increases expression | ISO | RGD:70373 | 6480464 | Aspirin results in increased expression of BAX protein | CTD | PMID:15986848 more ... |
| acetylsalicylic acid | decreases expression | ISO | RGD:70373 | 6480464 | Aspirin results in decreased expression of BAX mRNA | CTD | PMID:20457246 |
| acetylsalicylic acid | increases expression | ISO | RGD:10226 | 6480464 | Aspirin results in increased expression of BAX protein | CTD | PMID:16880202 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:70373 | 6480464 | CASP8 affects the reaction [Aspirin results in increased localization of BAX protein] | CTD | PMID:15976387 |
| acetylsalicylic acid | increases localization | ISO | RGD:70373 | 6480464 | Aspirin results in increased localization of BAX protein | CTD | PMID:11228543 PMID:15976387 |
| acetylsalicylic acid | increases expression | ISO | RGD:70373 | 6480464 | Aspirin results in increased expression of BAX protein | CTD | PMID:19212664 more ... |
| acetylsalicylic acid | decreases expression | ISO | RGD:70373 | 6480464 | Aspirin results in decreased expression of BAX protein | CTD | PMID:18636671 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:70373 | 6480464 | Aspirin promotes the reaction [Fluorouracil results in increased expression of BAX protein]; more ... | CTD | PMID:15986848 |
| acridine orange | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to Acridine Orange | CTD | PMID:16177561 |
| acrolein | affects localization | ISO | RGD:70373 | 6480464 | Acrolein affects the localization of BAX protein | CTD | PMID:19596284 |
| acrylonitrile | increases expression | ISO | RGD:70373 | 6480464 | Acrylonitrile results in increased expression of BAX protein | CTD | PMID:16173056 |
| actinomycin D | increases expression | ISO | RGD:70373 | 6480464 | Dactinomycin results in increased expression of BAX mRNA | CTD | PMID:21527772 |
| actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAX mRNA] | CTD | PMID:21281706 |
| actinomycin D | increases expression | ISO | RGD:70373 | 6480464 | Dactinomycin results in increased expression of BAX protein | CTD | PMID:12927789 PMID:10760829 |
| actinomycin D | multiple interactions | ISO | RGD:70373 | 6480464 | Naloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in increased expression of BAX protein]] | CTD | PMID:12927789 |
| actinomycin D | increases expression | ISO | RGD:70373 | 6480464 | Dactinomycin results in increased expression of BAX protein | CTD | PMID:10760829 PMID:12927789 |
| adenosine | increases localization | ISO | RGD:70373 | 6480464 | Adenosine results in increased localization of BAX protein | CTD | PMID:11570579 |
| adenosine | multiple interactions | ISO | RGD:70373 | 6480464 | Thymidine inhibits the reaction [Adenosine results in increased localization of BAX protein] | CTD | PMID:11570579 |
| aflatoxin B1 | affects expression | ISO | RGD:70373 | 6480464 | Aflatoxin B1 affects the expression of BAX protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of BAX mRNA | CTD | PMID:14600272 more ... |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of BAX mRNA | CTD | PMID:14600272 more ... |
| aflatoxin B1 | increases expression | ISO | RGD:70373 | 6480464 | Aflatoxin B1 results in increased expression of BAX protein | CTD | PMID:22743290 |
| aflatoxin B1 | decreases phosphorylation | ISO | RGD:70373 | 6480464 | Aflatoxin B1 results in decreased phosphorylation of BAX protein | CTD | PMID:22743290 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of BAX mRNA | CTD | PMID:15890375 PMID:14600272 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of BAX mRNA | CTD | PMID:14600272 PMID:15890375 |
| alachlor | increases expression | EXP | | 6480464 | alachlor results in increased expression of BAX mRNA | CTD | PMID:12419858 |
| alantolactone | decreases expression | ISO | RGD:70373 | 6480464 | alantolactone results in decreased expression of BAX protein | CTD | PMID:22721982 |
| albuterol | increases expression | ISO | RGD:70373 | 6480464 | Albuterol results in increased expression of BAX | CTD | PMID:11802967 |
| all-trans-acitretin | increases expression | ISO | RGD:70373 | 6480464 | Acitretin results in increased expression of BAX protein | CTD | PMID:16109552 PMID:16196285 |
| all-trans-acitretin | increases expression | ISO | RGD:70373 | 6480464 | Acitretin results in increased expression of BAX protein | CTD | PMID:16196285 PMID:16109552 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:70373 | 6480464 | leptomycin B inhibits the reaction [Tretinoin results in increased expression of BAX protein] | CTD | PMID:14592536 |
| all-trans-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | Tretinoin results in increased expression of BAX protein | CTD | PMID:14592536 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | Tretinoin results in increased expression of BAX protein | CTD | PMID:9342185 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | Tretinoin results in increased expression of BAX protein | CTD | PMID:15254726 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | Tretinoin results in increased expression of BAX protein | CTD | PMID:9342185 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | Tretinoin results in increased expression of BAX protein | CTD | PMID:21159206 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | Tretinoin results in increased expression of BAX protein | CTD | PMID:16109552 more ... |
| all-trans-retinoic acid | affects localization | ISO | RGD:10226 | 6480464 | Tretinoin affects the localization of BAX protein | CTD | PMID:16712891 |
| all-trans-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | Tretinoin results in increased expression of BAX protein | CTD | PMID:16109544 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | Tretinoin results in increased expression of BAX mRNA | CTD | PMID:14646600 |
| all-trans-retinoic acid | increases expression | ISO | RGD:70373 | 6480464 | Tretinoin results in increased expression of BAX | CTD | PMID:16909596 |
| all-trans-retinoic acid | increases cleavage | ISO | RGD:70373 | 6480464 | Tretinoin results in increased cleavage of BAX protein | CTD | PMID:16242776 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:70373 | 6480464 | [Tretinoin co-treated with Melatonin] results in increased expression of BAX protein | CTD | PMID:9649124 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:70373 | 6480464 | [Melatonin co-treated with Tretinoin] results in increased expression of BAX protein | CTD | PMID:10965999 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:70373 | 6480464 | [Tretinoin co-treated with zoledronic acid] results in increased expression of BAX protein | CTD | PMID:20349282 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:70373 | 6480464 | [Tretinoin co-treated with IFNG protein] results in increased expression of BAX protein | CTD | PMID:17960384 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:70373 | 6480464 | leupeptin inhibits the reaction [Tretinoin results in increased cleavage of BAX protein]; more ... | CTD | PMID:16242776 |
| all-trans-retinol | increases expression | EXP | | 6480464 | Vitamin A results in increased expression of BAX protein | CTD | PMID:16216918 |
| aluminium atom | affects response to substance | EXP | | 6480464 | BAX protein affects the susceptibility to Aluminum | CTD | PMID:20385067 |
| aluminium trichloride | increases expression | EXP | | 6480464 | aluminum chloride results in increased expression of BAX mRNA | CTD | PMID:17096939 PMID:23065425 |
| aluminium trichloride | decreases expression | EXP | | 6480464 | aluminum chloride results in decreased expression of BAX mRNA | CTD | PMID:16535832 |
| aluminium trichloride | increases expression | EXP | | 6480464 | aluminum chloride results in increased expression of BAX mRNA; more ... | CTD | PMID:17096939 |
| aluminium(0) | affects response to substance | EXP | | 6480464 | BAX protein affects the susceptibility to Aluminum | CTD | PMID:20385067 |
| amidotrizoic acid | multiple interactions | ISO | RGD:70373 | 6480464 | [Diatrizoate co-treated with Iodine] results in increased expression of BAX protein | CTD | PMID:17173243 |
| amifostine | multiple interactions | ISO | RGD:70373 | 6480464 | [Amifostine co-treated with Doxorubicin] results in increased expression of BAX mRNA | CTD | PMID:15985719 |
| aminoguanidine | decreases expression | ISO | RGD:70373 | 6480464 | pimagedine results in decreased expression of BAX protein | CTD | PMID:19266598 |
| amiodarone | increases expression | ISO | RGD:70373 | 6480464 | Amiodarone results in increased expression of BAX mRNA | CTD | PMID:12084619 |
| amitriptyline | multiple interactions | EXP | | 6480464 | Amitriptyline inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein] | CTD | PMID:19135049 |
| amlodipine | multiple interactions | ISO | RGD:70373 | 6480464 | Amlodipine inhibits the reaction [AGT results in increased expression of BAX mRNA]; more ... | CTD | PMID:21376258 |
| amlodipine | multiple interactions | EXP | | 6480464 | Amlodipine inhibits the reaction [Gentamicins results in increased expression of BAX protein] | CTD | PMID:19698708 |
| amlodipine | multiple interactions | EXP | | 6480464 | Amlodipine inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:17234320 |
| ammonium chloride | increases expression | EXP | | 6480464 | Ammonium Chloride results in increased expression of BAX mRNA | CTD | PMID:12420312 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of BAX mRNA | CTD | PMID:16483693 |
| amosite asbestos | multiple interactions | ISO | RGD:70373 | 6480464 | pifithrin inhibits the reaction [Asbestos, Amosite affects the localization of BAX protein] | CTD | PMID:16357363 |
| amosite asbestos | affects localization | ISO | RGD:70373 | 6480464 | Asbestos, Amosite affects the localization of BAX protein | CTD | PMID:16357363 |
| amphetamine | increases expression | ISO | RGD:10226 | 6480464 | Amphetamine results in increased expression of BAX mRNA; more ... | CTD | PMID:15731293 |
| amphetamine | increases response to substance | ISO | RGD:10226 | 6480464 | BAX protein results in increased susceptibility to Amphetamine | CTD | PMID:15731293 |
| ampicillin | increases response to substance | ISO | RGD:10226 | 6480464 | BAX results in increased susceptibility to Ampicillin | CTD | PMID:15731293 |
| amsacrine | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to Amsacrine | CTD | PMID:16177561 |
| andrographolide | affects folding | ISO | RGD:70373 | 6480464 | andrographolide affects the folding of BAX protein | CTD | PMID:19097688 |
| andrographolide | multiple interactions | ISO | RGD:70373 | 6480464 | Fluorouracil promotes the reaction [andrographolide affects the folding of BAX protein] | CTD | PMID:19097688 |
| apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of BAX protein] | CTD | PMID:22431579 |
| arachidonic acid | multiple interactions | ISO | RGD:70373 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Arachidonic Acid affects the localization of BAX protein]; more ... | CTD | PMID:19540902 |
| arachidonic acid | affects localization | ISO | RGD:70373 | 6480464 | Arachidonic Acid affects the localization of BAX protein | CTD | PMID:19540902 PMID:19720122 |
| arachidonic acid | affects localization | ISO | RGD:70373 | 6480464 | Arachidonic Acid affects the localization of BAX protein | CTD | PMID:19540902 |
| Aroclor 1254 | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of BAX protein] | CTD | PMID:23281070 |
| Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of BAX mRNA; more ... | CTD | PMID:23281070 |
| Aroclor 1254 | increases expression | ISO | RGD:10226 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of BAX protein | CTD | PMID:22406624 |
| arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of BAX protein | CTD | PMID:11756236 |
| arsenite(3-) | increases expression | ISO | RGD:70373 | 6480464 | arsenite results in increased expression of BAX mRNA; more ... | CTD | PMID:20083129 |
| arsenite(3-) | multiple interactions | ISO | RGD:10226 | 6480464 | TRP53 protein affects the reaction [arsenite results in decreased expression of BAX mRNA] | CTD | PMID:18929588 |
| arsenite(3-) | decreases expression | ISO | RGD:10226 | 6480464 | arsenite results in decreased expression of BAX mRNA | CTD | PMID:18929588 |
| arsenite(3-) | increases activity | ISO | RGD:70373 | 6480464 | arsenite results in increased activity of BAX protein | CTD | PMID:17553788 |
| asbestos | increases expression | ISO | RGD:70373 | 6480464 | Asbestos results in increased expression of BAX mRNA | CTD | PMID:22398240 |
| atrazine | multiple interactions | ISO | RGD:70373 | 6480464 | kolaviron promotes the reaction [Atrazine results in decreased expression of BAX mRNA]; more ... | CTD | PMID:21333729 |
| atrazine | multiple interactions | EXP | | 6480464 | kolaviron inhibits the reaction [Atrazine affects the expression of BAX] | CTD | PMID:21726175 |
| atrazine | affects expression | EXP | | 6480464 | Atrazine affects the expression of BAX | CTD | PMID:21726175 |
| atrazine | decreases expression | ISO | RGD:10226 | 6480464 | Atrazine results in decreased expression of BAX protein | CTD | PMID:22515965 |
| atrazine | multiple interactions | ISO | RGD:10226 | 6480464 | [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in decreased expression of BAX protein | CTD | PMID:22515965 |
| atrazine | decreases expression | ISO | RGD:70373 | 6480464 | Atrazine results in decreased expression of BAX protein; more ... | CTD | PMID:21333729 |
| atropine | multiple interactions | EXP | | 6480464 | [HI 6 co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman affects the expression of BAX mRNA]; more ... | CTD | PMID:21971501 |
| auranofin | multiple interactions | ISO | RGD:10226 | 6480464 | [BAX co-treated with BAK1] results in increased susceptibility to Auranofin | CTD | PMID:21172426 |
| auranofin | increases response to substance | ISO | RGD:10226 | 6480464 | BAX results in increased susceptibility to Auranofin | CTD | PMID:18789312 |
| auranofin | multiple interactions | ISO | RGD:10226 | 6480464 | BAX mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] | CTD | PMID:18789312 |
| azadirachtin A | increases expression | ISO | RGD:70373 | 6480464 | azadirachtin results in increased expression of BAX mRNA | CTD | PMID:20429769 |
| baicalein | multiple interactions | ISO | RGD:10226 | 6480464 | baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of BAX protein modified form] | CTD | PMID:20850421 |
| baicalein | increases expression | ISO | RGD:70373 | 6480464 | baicalein results in increased expression of BAX protein | CTD | PMID:21457722 |
| baicalin | increases expression | ISO | RGD:70373 | 6480464 | baicalin results in increased expression of BAX protein | CTD | PMID:21457722 |
| benazepril | decreases expression | EXP | | 6480464 | benazepril results in decreased expression of BAX protein | CTD | PMID:20026869 |
| benomyl | multiple interactions | ISO | RGD:70373 | 6480464 | Benomyl inhibits the reaction [BCL2 protein binds to BAX protein] | CTD | PMID:16903866 |
| benzene | increases expression | ISO | RGD:10226 | 6480464 | Benzene results in increased expression of BAX mRNA | CTD | PMID:15122651 more ... |
| benzene | increases expression | ISO | RGD:10226 | 6480464 | Benzene results in increased expression of BAX mRNA | CTD | PMID:11896287 more ... |
| benzene | increases expression | ISO | RGD:10226 | 6480464 | Benzene results in increased expression of BAX mRNA | CTD | PMID:15050406 more ... |
| benzene | increases expression | ISO | RGD:10226 | 6480464 | Benzene results in increased expression of BAX mRNA | CTD | PMID:15120971 more ... |
| benzene | increases expression | ISO | RGD:10226 | 6480464 | Benzene results in increased expression of BAX mRNA | CTD | PMID:15935812 more ... |
| benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of BAX protein | CTD | PMID:18093815 |
| benzene | increases expression | ISO | RGD:10226 | 6480464 | Benzene results in increased expression of BAX mRNA | CTD | PMID:15050406 more ... |
| benzene | multiple interactions | ISO | RGD:10226 | 6480464 | TRP53 protein affects the reaction [Benzene results in increased expression of BAX mRNA] | CTD | PMID:11896287 |
| benzene | decreases expression | ISO | RGD:70373 | 6480464 | Benzene results in decreased expression of BAX mRNA | CTD | PMID:18724895 |
| benzene | increases expression | ISO | RGD:10226 | 6480464 | Benzene results in increased expression of BAX mRNA | CTD | PMID:15122651 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:70373 | 6480464 | Benzo(a)pyrene results in increased expression of BAX mRNA | CTD | PMID:15735009 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:70373 | 6480464 | Benzo(a)pyrene results in increased expression of BAX protein | CTD | PMID:16041517 PMID:16120219 |
| benzo[a]pyrene | increases expression | ISO | RGD:70373 | 6480464 | Benzo(a)pyrene results in increased expression of BAX mRNA | CTD | PMID:10837373 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10226 | 6480464 | Benzo(a)pyrene results in increased expression of BAX mRNA | CTD | PMID:21569818 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70373 | 6480464 | [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BAX mRNA; more ... | CTD | PMID:21882252 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70373 | 6480464 | [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of BAX mRNA | CTD | PMID:17690111 |
| benzo[a]pyrene | increases expression | ISO | RGD:70373 | 6480464 | Benzo(a)pyrene results in increased expression of BAX mRNA | CTD | PMID:10837373 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10226 | 6480464 | Benzo(a)pyrene results in increased expression of BAX mRNA | CTD | PMID:21569818 PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:70373 | 6480464 | Benzo(a)pyrene results in increased expression of BAX mRNA | CTD | PMID:10837373 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:70373 | 6480464 | Benzo(a)pyrene results in increased expression of BAX mRNA | CTD | PMID:15735009 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70373 | 6480464 | TP53 affects the reaction [Benzo(a)pyrene results in increased expression of BAX mRNA] | CTD | PMID:10837373 |
| benzo[a]pyrene | increases expression | ISO | RGD:70373 | 6480464 | Benzo(a)pyrene results in increased expression of BAX mRNA | CTD | PMID:10837373 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:70373 | 6480464 | Benzo(a)pyrene results in increased expression of BAX mRNA | CTD | PMID:11782367 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:70373 | 6480464 | Benzo(a)pyrene results in increased expression of BAX mRNA | CTD | PMID:15735009 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70373 | 6480464 | Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased expression of BAX protein] | CTD | PMID:16041517 |
| benzo[a]pyrene | increases expression | ISO | RGD:70373 | 6480464 | Benzo(a)pyrene results in increased expression of BAX protein | CTD | PMID:16041517 |
| benzo[a]pyrene | increases expression | ISO | RGD:10226 | 6480464 | Benzo(a)pyrene results in increased expression of BAX mRNA | CTD | PMID:21569818 |
| benzo[b]fluoranthene | increases expression | ISO | RGD:10226 | 6480464 | benzo(b)fluoranthene results in increased expression of BAX protein | CTD | PMID:21392559 |
| berberine | increases expression | ISO | RGD:70373 | 6480464 | Berberine results in increased expression of BAX protein | CTD | PMID:16505103 |
| berberine | increases expression | ISO | RGD:70373 | 6480464 | Berberine results in increased expression of BAX mRNA | CTD | PMID:20656010 |
| berberine | increases expression | ISO | RGD:70373 | 6480464 | Berberine results in increased expression of BAX protein | CTD | PMID:16505103 PMID:20656010 |
| beta-carotene | decreases expression | ISO | RGD:70373 | 6480464 | beta Carotene results in decreased expression of BAX mRNA | CTD | PMID:17034753 |
| beta-carotene | increases expression | ISO | RGD:70373 | 6480464 | beta Carotene results in increased expression of BAX protein; more ... | CTD | PMID:15949688 |
| betulinic acid | multiple interactions | ISO | RGD:70373 | 6480464 | [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine co-treated with betulinic acid analog] results in increased activity of BAX protein; more ... | CTD | PMID:23000516 |
| bicalutamide | decreases expression | ISO | RGD:70373 | 6480464 | bicalutamide results in decreased expression of BAX | CTD | PMID:11845989 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:10226 | 6480464 | Mustard Gas results in increased expression of BAX mRNA | CTD | PMID:18955075 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:10226 | 6480464 | Mustard Gas results in increased expression of BAX protein | CTD | PMID:19560481 |
| bis(2-chloroethyl) sulfide | affects expression | EXP | | 6480464 | Mustard Gas affects the expression of BAX mRNA | CTD | PMID:15651846 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:70373 | 6480464 | Diethylhexyl Phthalate results in increased expression of BAX mRNA | CTD | PMID:22155658 |
| bisphenol A | decreases expression | ISO | RGD:70373 | 6480464 | bisphenol A results in decreased expression of BAX protein | CTD | PMID:21277958 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of BAX protein | CTD | PMID:23328667 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of BAX mRNA | CTD | PMID:23146694 |
| bisphenol A | decreases expression | ISO | RGD:70373 | 6480464 | bisphenol A results in decreased expression of BAX protein | CTD | PMID:21277958 PMID:23222814 |
| bisphenol A | multiple interactions | ISO | RGD:70373 | 6480464 | Curcumin inhibits the reaction [bisphenol A results in decreased expression of BAX protein] | CTD | PMID:23222814 |
| bisphenol A | decreases expression | ISO | RGD:70373 | 6480464 | bisphenol A results in decreased expression of BAX mRNA | CTD | PMID:15461258 |
| bisphenol A | increases expression | ISO | RGD:10226 | 6480464 | bisphenol A results in increased expression of BAX mRNA; more ... | CTD | PMID:11906184 |
| bosentan | multiple interactions | ISO | RGD:10226 | 6480464 | bosentan inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:17974986 |
| bromocriptine | increases expression | EXP | | 6480464 | Bromocriptine results in increased expression of BAX protein | CTD | PMID:15046398 |
| bromocriptine | multiple interactions | EXP | | 6480464 | [Bromocriptine co-treated with Octreotide] results in increased expression of BAX protein | CTD | PMID:15046398 |
| bucladesine | multiple interactions | ISO | RGD:70373 | 6480464 | adenosine-3',5'-cyclic phosphorothioate inhibits the reaction [Bucladesine inhibits the reaction [Lipopolysaccharides results in increased expression of BAX protein]] | CTD | PMID:16822680 |
| butyric acid | multiple interactions | EXP | | 6480464 | Butyric Acid analog inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA] | CTD | PMID:17473824 |
| butyric acid | increases expression | ISO | RGD:70373 | 6480464 | Butyric Acid results in increased expression of BAX protein | CTD | PMID:11964082 |
| cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of BAX protein | CTD | PMID:20455018 |
| cadmium atom | increases expression | ISO | RGD:70373 | 6480464 | Cadmium results in increased expression of BAX mRNA | CTD | PMID:15016657 |
| cadmium atom | multiple interactions | ISO | RGD:70373 | 6480464 | NR4A1 mutant form inhibits the reaction [Cadmium results in increased expression of BAX mRNA] | CTD | PMID:15016657 |
| cadmium atom | multiple interactions | EXP | | 6480464 | Lithium inhibits the reaction [Cadmium results in increased expression of BAX protein] | CTD | PMID:20455018 |
| cadmium dichloride | affects localization | EXP | | 6480464 | Cadmium Chloride affects the localization of BAX protein | CTD | PMID:19523979 |
| cadmium dichloride | increases expression | ISO | RGD:70373 | 6480464 | Cadmium Chloride results in increased expression of BAX mRNA | CTD | PMID:12160620 PMID:22961094 |
| cadmium dichloride | increases expression | ISO | RGD:70373 | 6480464 | Cadmium Chloride results in increased expression of BAX mRNA; more ... | CTD | PMID:12160620 |
| cadmium dichloride | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Buthionine Sulfoximine] results in decreased expression of BAX protein] | CTD | PMID:11341981 |
| caffeine | increases expression | ISO | RGD:70373 | 6480464 | Caffeine results in increased expression of BAX protein | CTD | PMID:12811820 |
| caffeine | increases expression | ISO | RGD:10226 | 6480464 | Caffeine results in increased expression of BAX protein | CTD | PMID:12907610 |
| calcitriol | decreases expression | ISO | RGD:70373 | 6480464 | Calcitriol results in decreased expression of BAX mRNA | CTD | PMID:21592394 |
| calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of BAX protein | CTD | PMID:17570329 |
| calcitriol | multiple interactions | ISO | RGD:70373 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of BAX mRNA | CTD | PMID:21592394 |
| calcitriol | increases expression | ISO | RGD:70373 | 6480464 | Calcitriol results in increased expression of BAX mRNA | CTD | PMID:15955619 |
| calcitriol | multiple interactions | ISO | RGD:70373 | 6480464 | [Calcitriol co-treated with Genistein] results in increased expression of BAX mRNA | CTD | PMID:15955619 |
| camptothecin | multiple interactions | ISO | RGD:70373 | 6480464 | Camptothecin affects the cleavage of and results in decreased expression of BAX protein; more ... | CTD | PMID:19481069 |
| camptothecin | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [Camptothecin results in increased expression of BAX protein] | CTD | PMID:11279278 |
| camptothecin | increases expression | EXP | | 6480464 | Camptothecin results in increased expression of BAX protein | CTD | PMID:11279278 |
| camptothecin | increases expression | ISO | RGD:70373 | 6480464 | Camptothecin results in increased expression of BAX protein | CTD | PMID:17555331 |
| camptothecin | increases activity | ISO | RGD:70373 | 6480464 | Camptothecin results in increased activity of BAX protein | CTD | PMID:15665116 |
| candesartan | increases expression | EXP | | 6480464 | candesartan results in increased expression of BAX mRNA; more ... | CTD | PMID:11409658 |
| cantharidin | increases expression | ISO | RGD:70373 | 6480464 | Cantharidin results in increased expression of BAX protein | CTD | PMID:16117893 |
| capsaicin | increases expression | ISO | RGD:70373 | 6480464 | Capsaicin results in increased expression of BAX protein | CTD | PMID:17292493 more ... |
| capsaicin | increases expression | ISO | RGD:70373 | 6480464 | Capsaicin results in increased expression of BAX protein | CTD | PMID:16540674 more ... |
| capsaicin | increases expression | ISO | RGD:70373 | 6480464 | Capsaicin results in increased expression of BAX protein | CTD | PMID:16540674 more ... |
| capsaicin | increases expression | ISO | RGD:10226 | 6480464 | Capsaicin results in increased expression of BAX | CTD | PMID:20069556 |
| capsaicin | increases activity | ISO | RGD:10226 | 6480464 | Capsaicin results in increased activity of BAX protein | CTD | PMID:17295509 |
| capsaicin | multiple interactions | ISO | RGD:70373 | 6480464 | TP53 protein promotes the reaction [Capsaicin results in increased expression of BAX protein]; more ... | CTD | PMID:17292493 |
| capsaicin | increases expression | ISO | RGD:70373 | 6480464 | Capsaicin results in increased expression of BAX protein | CTD | PMID:19002586 PMID:17292493 |
| capsaicin | increases expression | ISO | RGD:70373 | 6480464 | Capsaicin results in increased expression of BAX mRNA | CTD | PMID:17292493 |
| capsaicin | increases expression | ISO | RGD:70373 | 6480464 | Capsaicin results in increased expression of BAX | CTD | PMID:19002586 |
| capsaicin | affects localization | ISO | RGD:70373 | 6480464 | Capsaicin affects the localization of BAX protein | CTD | PMID:19331147 |
| carbachol | multiple interactions | ISO | RGD:10226 | 6480464 | Carbachol inhibits the reaction [APP protein modified form results in increased expression of BAX protein] | CTD | PMID:10758335 |
| carbachol | multiple interactions | ISO | RGD:10226 | 6480464 | Carbachol inhibits the reaction [domoic acid results in increased localization of BAX protein] | CTD | PMID:19200344 |
| carboplatin | decreases expression | ISO | RGD:70373 | 6480464 | Carboplatin results in decreased expression of BAX mRNA | CTD | PMID:15576332 |
| carboplatin | multiple interactions | ISO | RGD:70373 | 6480464 | Carboplatin results in increased cleavage of and results in increased expression of BAX protein | CTD | PMID:15131059 |
| carmustine | increases expression | ISO | RGD:70373 | 6480464 | Carmustine results in increased expression of BAX protein | CTD | PMID:20920327 |
| carvedilol | multiple interactions | EXP | | 6480464 | carvedilol inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA] | CTD | PMID:15380674 |
| carvedilol | increases expression | EXP | | 6480464 | carvedilol results in increased expression of BAX protein | CTD | PMID:20079142 |
| carvedilol | decreases expression | EXP | | 6480464 | carvedilol results in decreased expression of BAX | CTD | PMID:12973927 |
| cefalotin | increases expression | ISO | RGD:70373 | 6480464 | Cephalothin results in increased expression of BAX protein | CTD | PMID:15012731 |
| cefotaxime | increases expression | ISO | RGD:70373 | 6480464 | Cefotaxime results in increased expression of BAX protein | CTD | PMID:15012731 |
| celastrol | increases expression | ISO | RGD:70373 | 6480464 | tripterine results in increased expression of BAX protein | CTD | PMID:21466843 |
| celecoxib | multiple interactions | ISO | RGD:70373 | 6480464 | BBC3 mutant form inhibits the reaction [celecoxib results in increased activity of and results in increased localization of BAX protein] | CTD | PMID:17368424 |
| celecoxib | decreases expression | ISO | RGD:70373 | 6480464 | celecoxib results in decreased expression of BAX mRNA | CTD | PMID:17342322 |
| celecoxib | increases expression | ISO | RGD:70373 | 6480464 | celecoxib results in increased expression of BAX protein | CTD | PMID:15688368 |
| celecoxib | multiple interactions | ISO | RGD:70373 | 6480464 | [docetaxel co-treated with celecoxib] results in increased expression of BAX protein; more ... | CTD | PMID:15688368 |
| celecoxib | increases activity | ISO | RGD:70373 | 6480464 | celecoxib results in increased activity of BAX protein | CTD | PMID:17952603 |
| cetrorelix | increases expression | ISO | RGD:10226 | 6480464 | cetrorelix results in increased expression of BAX protein; more ... | CTD | PMID:17268770 |
| cetrorelix | increases expression | EXP | | 6480464 | cetrorelix results in increased expression of BAX mRNA; more ... | CTD | PMID:17268770 |
| chenodeoxycholic acid | increases expression | EXP | | 6480464 | Chenodeoxycholic Acid results in increased expression of BAX mRNA | CTD | PMID:17881359 |
| chitosan | multiple interactions | ISO | RGD:10226 | 6480464 | [Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in increased expression of BAX protein | CTD | PMID:18567086 |
| chlorambucil | increases expression | ISO | RGD:70373 | 6480464 | Chlorambucil results in increased expression of BAX protein | CTD | PMID:11699414 |
| chloroacetic acid | multiple interactions | ISO | RGD:10226 | 6480464 | SB 203580 inhibits the reaction [chloroacetic acid results in increased expression of BAX mRNA] | CTD | PMID:23103613 |
| chloroacetic acid | increases expression | ISO | RGD:10226 | 6480464 | chloroacetic acid results in increased expression of BAX mRNA | CTD | PMID:23103613 |
| chloroquine | multiple interactions | ISO | RGD:10226 | 6480464 | BAX mutant form inhibits the reaction [Chloroquine results in increased activity of CASP3 protein] | CTD | PMID:11589424 |
| chlorpyrifos | multiple interactions | ISO | RGD:10226 | 6480464 | [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in decreased expression of BAX protein | CTD | PMID:22515965 |
| chlorpyrifos | decreases expression | ISO | RGD:10226 | 6480464 | Chlorpyrifos results in decreased expression of BAX protein | CTD | PMID:22515965 |
| cholesterol | decreases expression | EXP | | 6480464 | Cholesterol analog results in decreased expression of BAX mRNA | CTD | PMID:19477266 |
| chrysazin | increases expression | ISO | RGD:70373 | 6480464 | danthron results in increased expression of BAX protein | CTD | PMID:21126053 |
| cidofovir anhydrous | increases expression | ISO | RGD:70373 | 6480464 | cidofovir results in increased expression of BAX | CTD | PMID:12700662 |
| ciglitazone | multiple interactions | ISO | RGD:70373 | 6480464 | DDIT3 mutant form inhibits the reaction [[Niflumic Acid co-treated with ciglitazone] results in increased activity of BAX protein] | CTD | PMID:21067863 |
| ciglitazone | affects response to substance | EXP | | 6480464 | BAX mRNA affects the susceptibility to ciglitazone | CTD | PMID:12065618 |
| ciglitazone | increases expression | EXP | | 6480464 | ciglitazone results in increased expression of BAX protein | CTD | PMID:12065618 |
| ciglitazone | increases expression | ISO | RGD:70373 | 6480464 | ciglitazone results in increased expression of BAX protein | CTD | PMID:15492468 |
| cilostazol | increases expression | ISO | RGD:70373 | 6480464 | cilostazol results in increased expression of BAX protein | CTD | PMID:20131233 |
| cilostazol | affects expression | EXP | | 6480464 | cilostazol affects the expression of BAX protein | CTD | PMID:15978173 |
| cilostazol | multiple interactions | ISO | RGD:70373 | 6480464 | cilostazol inhibits the reaction [Lipopolysaccharides results in increased expression of BAX protein] | CTD | PMID:16822680 |
| cimetidine | increases expression | ISO | RGD:70373 | 6480464 | Cimetidine results in increased expression of BAX protein | CTD | PMID:20127008 |
| ciprofloxacin | multiple interactions | ISO | RGD:70373 | 6480464 | BCL2 protein inhibits the reaction [Ciprofloxacin results in increased localization of BAX protein] | CTD | PMID:11832715 |
| ciprofloxacin | increases localization | ISO | RGD:70373 | 6480464 | Ciprofloxacin results in increased localization of BAX protein | CTD | PMID:11832715 PMID:12632069 |
| ciprofloxacin | increases expression | ISO | RGD:70373 | 6480464 | Ciprofloxacin results in increased expression of BAX protein | CTD | PMID:10741713 PMID:11875713 |
| ciprofloxacin | increases expression | ISO | RGD:70373 | 6480464 | Ciprofloxacin results in increased expression of BAX protein | CTD | PMID:11875713 PMID:10741713 |
| ciprofloxacin | increases localization | ISO | RGD:70373 | 6480464 | Ciprofloxacin results in increased localization of BAX protein | CTD | PMID:12632069 PMID:11832715 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of and results in increased activity of BAX protein] | CTD | PMID:17574045 |
| cisplatin | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Cisplatin results in increased expression of BAX protein]; more ... | CTD | PMID:19428505 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:12690470 more ... |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:12690470 more ... |
| cisplatin | increases expression | ISO | RGD:70373 | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:14512787 more ... |
| cisplatin | increases expression | ISO | RGD:70373 | 6480464 | Cisplatin results in increased expression of BAX mRNA | CTD | PMID:15641988 more ... |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:18992762 more ... |
| cisplatin | multiple interactions | EXP | | 6480464 | 1,3-dimethylthiourea inhibits the reaction [Cisplatin results in increased expression of BAX protein] | CTD | PMID:18992762 |
| cisplatin | increases expression | ISO | RGD:10226 | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:20566416 more ... |
| cisplatin | increases expression | ISO | RGD:70373 | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:21420390 more ... |
| cisplatin | multiple interactions | EXP | | 6480464 | sildenafil inhibits the reaction [Cisplatin results in increased expression of BAX protein] | CTD | PMID:19152827 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:19152827 more ... |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | Cisplatin promotes the reaction [BAX protein binds to BAX protein]; more ... | CTD | PMID:20145152 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | [Cisplatin co-treated with TP73 protein] results in increased expression of BAX protein | CTD | PMID:20100536 |
| cisplatin | increases expression | ISO | RGD:10226 | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:19833167 more ... |
| cisplatin | increases expression | ISO | RGD:10226 | 6480464 | Cisplatin results in increased expression of BAX mRNA | CTD | PMID:19833167 |
| cisplatin | increases expression | ISO | RGD:70373 | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:21420390 more ... |
| cisplatin | increases expression | ISO | RGD:70373 | 6480464 | Cisplatin results in increased expression of BAX mRNA | CTD | PMID:20655883 more ... |
| cisplatin | multiple interactions | ISO | RGD:10226 | 6480464 | IL6 gene mutant form affects the reaction [Cisplatin results in increased expression of BAX mRNA]; more ... | CTD | PMID:19833167 |
| cisplatin | affects localization | ISO | RGD:10226 | 6480464 | Cisplatin affects the localization of BAX protein | CTD | PMID:21593185 PMID:21633170 |
| cisplatin | increases expression | ISO | RGD:70373 | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:20674069 more ... |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:12690470 more ... |
| cisplatin | increases expression | ISO | RGD:10226 | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:20566416 more ... |
| cisplatin | increases expression | ISO | RGD:70373 | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:15641988 more ... |
| cisplatin | increases expression | ISO | RGD:70373 | 6480464 | Cisplatin results in increased expression of BAX mRNA | CTD | PMID:20309937 more ... |
| cisplatin | increases expression | ISO | RGD:70373 | 6480464 | Cisplatin results in increased expression of BAX mRNA | CTD | PMID:20655883 more ... |
| cisplatin | multiple interactions | EXP | | 6480464 | SB 203580 promotes the reaction [Cisplatin results in increased expression of BAX protein] | CTD | PMID:19578154 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:20817559 more ... |
| cisplatin | increases expression | ISO | RGD:10226 | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:21526214 more ... |
| cisplatin | increases expression | ISO | RGD:70373 | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:21660965 more ... |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:20817559 PMID:12690470 |
| cisplatin | multiple interactions | EXP | | 6480464 | picolinic acid inhibits the reaction [Cisplatin results in increased expression of BAX protein] | CTD | PMID:20817559 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BAX | CTD | PMID:21795690 |
| cisplatin | multiple interactions | ISO | RGD:10226 | 6480464 | rosemarinic acid inhibits the reaction [Cisplatin results in increased expression of BAX protein] | CTD | PMID:21526214 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin results in increased expression of and affects the localization of BAX; more ... | CTD | PMID:21795690 |
| cisplatin | multiple interactions | EXP | | 6480464 | chelerythrine inhibits the reaction [sodium arsenite inhibits the reaction [Cisplatin results in increased expression of BAX protein]]; more ... | CTD | PMID:12690470 |
| cisplatin | multiple interactions | ISO | RGD:10226 | 6480464 | rottlerin inhibits the reaction [Cisplatin affects the localization of BAX protein] | CTD | PMID:21633170 |
| cisplatin | increases expression | ISO | RGD:10226 | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:21526214 PMID:21616140 |
| cisplatin | multiple interactions | ISO | RGD:10226 | 6480464 | Cisplatin promotes the reaction [TRP53 protein results in increased expression of BAX] | CTD | PMID:21552291 |
| cisplatin | multiple interactions | ISO | RGD:10226 | 6480464 | MFN1 protein inhibits the reaction [Cisplatin results in increased activity of BAX protein]; more ... | CTD | PMID:21160028 |
| cisplatin | increases activity | ISO | RGD:10226 | 6480464 | Cisplatin results in increased activity of BAX protein | CTD | PMID:21160028 |
| cisplatin | affects localization | ISO | RGD:10226 | 6480464 | Cisplatin affects the localization of BAX protein | CTD | PMID:21633170 PMID:21593185 |
| cisplatin | multiple interactions | ISO | RGD:10226 | 6480464 | [BAX co-treated with BAK1] results in increased susceptibility to Cisplatin | CTD | PMID:21172426 |
| cisplatin | multiple interactions | ISO | RGD:10226 | 6480464 | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [resveratrol inhibits the reaction [Cisplatin affects the localization of BAX protein]] | CTD | PMID:21593185 |
| cisplatin | multiple interactions | ISO | RGD:10226 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of BAX protein]; more ... | CTD | PMID:21616140 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | [tubeimoside I co-treated with Cisplatin] results in increased expression of BAX protein | CTD | PMID:21687949 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | [Quercetin results in increased susceptibility to Cisplatin] which results in increased expression of BAX protein | CTD | PMID:16619537 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | PLK1 protein inhibits the reaction [Cisplatin results in increased expression of BAX mRNA] | CTD | PMID:20655883 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | Noscapine promotes the reaction [Cisplatin results in increased expression of BAX protein] | CTD | PMID:20674069 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | ING4 protein promotes the reaction [Cisplatin results in increased expression of BAX protein] | CTD | PMID:21052098 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | CITED2 mutant form promotes the reaction [Cisplatin results in increased expression of BAX protein]; more ... | CTD | PMID:21660965 |
| cisplatin | increases localization | ISO | RGD:70373 | 6480464 | Cisplatin results in increased localization of BAX protein | CTD | PMID:20654585 |
| cisplatin | increases expression | ISO | RGD:70373 | 6480464 | Cisplatin results in increased expression of BAX protein | CTD | PMID:20674069 more ... |
| cisplatin | increases expression | ISO | RGD:70373 | 6480464 | Cisplatin results in increased expression of BAX mRNA | CTD | PMID:20655883 PMID:15641988 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | [Cisplatin results in decreased susceptibility to Cisplatin] which results in decreased expression of BAX protein | CTD | PMID:21130731 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | Cisplatin promotes the reaction [TP53 protein results in increased expression of BAX] | CTD | PMID:21552291 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | Cisplatin promotes the reaction [Metformin results in increased expression of BAX protein] | CTD | PMID:21388661 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | Cisplatin promotes the reaction [2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one results in increased expression of BAX mRNA]; more ... | CTD | PMID:21109480 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | [Cisplatin co-treated with Etoposide] affects the localization of BAX protein; more ... | CTD | PMID:18676776 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of BAX mRNA; more ... | CTD | PMID:21214929 |
| cisplatin | affects localization | ISO | RGD:70373 | 6480464 | Cisplatin affects the localization of BAX protein | CTD | PMID:16009487 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | BCL2 protein inhibits the reaction [Cisplatin affects the localization of BAX protein] | CTD | PMID:16009487 |
| cisplatin | decreases response to substance | ISO | RGD:70373 | 6480464 | BAX results in decreased susceptibility to Cisplatin | CTD | PMID:21849418 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | beta-solamarine promotes the reaction [Cisplatin results in increased expression of BAX protein] | CTD | PMID:17619073 |
| cisplatin | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of BAX protein] | CTD | PMID:15496615 |
| citric acid | multiple interactions | ISO | RGD:70373 | 6480464 | [Citric Acid co-treated with zinc chloride] results in increased expression of BAX protein | CTD | PMID:16624386 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of BAX mRNA | CTD | PMID:12883083 |
| clonazepam | increases expression | EXP | | 6480464 | Clonazepam results in increased expression of BAX protein | CTD | PMID:17456340 |
| clozapine | increases expression | ISO | RGD:70373 | 6480464 | Clozapine results in increased expression of BAX mRNA; more ... | CTD | PMID:16160616 |
| clozapine | multiple interactions | ISO | RGD:70373 | 6480464 | CSF3 protein inhibits the reaction [Clozapine results in increased expression of BAX mRNA] | CTD | PMID:16160616 |
| clozapine | decreases expression | EXP | | 6480464 | Clozapine results in decreased expression of BAX protein | CTD | PMID:17069804 |
| cobalt atom | multiple interactions | ISO | RGD:70373 | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of BAX mRNA | CTD | PMID:18078969 |
| cobalt atom | increases expression | ISO | RGD:70373 | 6480464 | Cobalt results in increased expression of BAX mRNA | CTD | PMID:18078969 |
| cobalt dichloride | multiple interactions | ISO | RGD:70373 | 6480464 | cobaltous chloride inhibits the reaction [[Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of BAX mRNA] | CTD | PMID:19714248 |
| cobalt dichloride | increases expression | ISO | RGD:70373 | 6480464 | cobaltous chloride results in increased expression of BAX mRNA | CTD | PMID:18078969 |
| cocaine | increases expression | ISO | RGD:70373 | 6480464 | Cocaine results in increased expression of BAX mRNA | CTD | PMID:20948987 |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of BAX protein | CTD | PMID:11392460 more ... |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of BAX protein | CTD | PMID:17635674 more ... |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of BAX protein | CTD | PMID:18974856 more ... |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of BAX protein | CTD | PMID:15685203 more ... |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of BAX protein | CTD | PMID:18974856 more ... |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of BAX protein | CTD | PMID:18974856 more ... |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of BAX protein | CTD | PMID:18974856 more ... |
| cocaine | increases activity | EXP | | 6480464 | Cocaine results in increased activity of BAX protein | CTD | PMID:17635674 |
| cocaine | affects expression | ISO | RGD:10226 | 6480464 | Cocaine affects the expression of BAX mRNA | CTD | PMID:15681117 |
| codeinone | increases expression | ISO | RGD:70373 | 6480464 | 6-codeinone results in increased expression of BAX protein | CTD | PMID:12894543 |
| copper atom | increases expression | ISO | RGD:70373 | 6480464 | Copper results in increased expression of BAX protein; more ... | CTD | PMID:16962711 |
| copper atom | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAX mRNA]; more ... | CTD | PMID:22085843 |
| copper atom | increases expression | ISO | RGD:70373 | 6480464 | Copper results in increased expression of BAX protein | CTD | PMID:15880691 PMID:16962711 |
| copper atom | increases expression | ISO | RGD:10226 | 6480464 | Copper analog results in increased expression of BAX protein | CTD | PMID:22000994 |
| copper(0) | increases expression | ISO | RGD:70373 | 6480464 | Copper results in increased expression of BAX protein; more ... | CTD | PMID:16962711 |
| copper(0) | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAX mRNA]; more ... | CTD | PMID:22085843 |
| copper(0) | increases expression | ISO | RGD:70373 | 6480464 | Copper results in increased expression of BAX protein | CTD | PMID:15880691 PMID:16962711 |
| copper(0) | increases expression | ISO | RGD:10226 | 6480464 | Copper analog results in increased expression of BAX protein | CTD | PMID:22000994 |
| copper(II) chloride | increases expression | ISO | RGD:10226 | 6480464 | cupric chloride results in increased expression of BAX protein | CTD | PMID:22239859 |
| cordycepin | affects localization | ISO | RGD:70373 | 6480464 | cordycepin affects the localization of BAX protein | CTD | PMID:21933677 |
| cordycepin | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [cordycepin results in increased expression of BAX protein] | CTD | PMID:21310227 |
| cordycepin | increases expression | ISO | RGD:70373 | 6480464 | cordycepin results in increased expression of BAX protein | CTD | PMID:21310227 |
| coumarin | increases expression | ISO | RGD:70373 | 6480464 | coumarin results in increased expression of BAX protein | CTD | PMID:15964220 |
| crocidolite asbestos | affects expression | ISO | RGD:70373 | 6480464 | Asbestos, Crocidolite affects the expression of BAX mRNA | CTD | PMID:17331233 |
| crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of BAX mRNA | CTD | PMID:12909582 |
| curcumin | affects localization | ISO | RGD:70373 | 6480464 | Curcumin affects the localization of BAX protein | CTD | PMID:17332930 |
| curcumin | increases expression | ISO | RGD:70373 | 6480464 | Curcumin results in increased expression of BAX protein | CTD | PMID:17096185 more ... |
| curcumin | multiple interactions | ISO | RGD:70373 | 6480464 | Curcumin inhibits the reaction [bisphenol A results in decreased expression of BAX protein] | CTD | PMID:23222814 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Streptozocin results in increased expression of BAX mRNA] | CTD | PMID:23267840 |
| curcumin | multiple interactions | ISO | RGD:70373 | 6480464 | arsenic trioxide promotes the reaction [Curcumin affects the localization of BAX protein]; more ... | CTD | PMID:20605902 |
| curcumin | affects localization | ISO | RGD:70373 | 6480464 | Curcumin affects the localization of BAX protein | CTD | PMID:17332930 PMID:20605902 |
| curcumin | increases expression | ISO | RGD:70373 | 6480464 | Curcumin results in increased expression of BAX protein | CTD | PMID:17096185 more ... |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Peroxynitrous Acid results in increased expression of BAX mRNA]; more ... | CTD | PMID:20869986 |
| curcumin | increases expression | ISO | RGD:70373 | 6480464 | Curcumin results in increased expression of BAX protein | CTD | PMID:17096185 more ... |
| curcumin | increases expression | ISO | RGD:70373 | 6480464 | Curcumin results in increased expression of BAX mRNA | CTD | PMID:17332930 more ... |
| curcumin | increases expression | ISO | RGD:70373 | 6480464 | Curcumin results in increased expression of BAX protein | CTD | PMID:17671742 more ... |
| curcumin | increases expression | ISO | RGD:70373 | 6480464 | Curcumin results in increased expression of BAX mRNA | CTD | PMID:17332930 more ... |
| curcumin | increases expression | ISO | RGD:70373 | 6480464 | Curcumin results in increased expression of BAX protein | CTD | PMID:21594647 more ... |
| curcumin | increases expression | ISO | RGD:70373 | 6480464 | Curcumin results in increased expression of BAX mRNA | CTD | PMID:19235267 more ... |
| curcumin | increases expression | ISO | RGD:70373 | 6480464 | Curcumin results in increased expression of BAX protein | CTD | PMID:17671742 more ... |
| curcumin | increases expression | ISO | RGD:70373 | 6480464 | Curcumin results in increased expression of BAX mRNA | CTD | PMID:17671742 more ... |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of BAX mRNA; more ... | CTD | PMID:17531121 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein] | CTD | PMID:15569404 |
| curcumin | multiple interactions | EXP | | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased expression of BAX mRNA]; more ... | CTD | PMID:17531121 |
| curcumin | increases response to substance | ISO | RGD:10226 | 6480464 | BAX protein results in increased susceptibility to Curcumin | CTD | PMID:17277231 |
| curcumin | multiple interactions | ISO | RGD:10226 | 6480464 | Curcumin affects the localization of and results in increased expression of and results in increased activity of BAX protein | CTD | PMID:17277231 |
| curcumin | multiple interactions | ISO | RGD:70373 | 6480464 | TNFSF10 protein promotes the reaction [Curcumin results in increased expression of BAX protein] | CTD | PMID:18226269 |
| curcumin | increases expression | ISO | RGD:70373 | 6480464 | Curcumin results in increased expression of BAX protein | CTD | PMID:17332930 more ... |
| curcumin | increases expression | ISO | RGD:70373 | 6480464 | Curcumin results in increased expression of BAX mRNA | CTD | PMID:19235267 more ... |
| curcumin | multiple interactions | ISO | RGD:70373 | 6480464 | [Curcumin co-treated with Sirolimus] results in increased expression of BAX | CTD | PMID:19373661 |
| cyanamide | increases expression | EXP | | 6480464 | Cyanamide results in increased expression of BAX mRNA | CTD | PMID:12003908 |
| cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [TGFB1 protein results in increased expression of BAX protein] | CTD | PMID:9790906 |
| cyclosporin A | multiple interactions | ISO | RGD:10226 | 6480464 | Cyclosporine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BAX protein] | CTD | PMID:10205001 |
| cyclosporin A | increases expression | ISO | RGD:70373 | 6480464 | Cyclosporine results in increased expression of BAX mRNA | CTD | PMID:20106945 |
| cypermethrin | increases expression | EXP | | 6480464 | cypermethrin results in increased expression of BAX protein | CTD | PMID:22048644 |
| cypermethrin | multiple interactions | EXP | | 6480464 | HBEGF protein inhibits the reaction [cypermethrin results in increased expression of BAX protein] | CTD | PMID:22048644 |
| cytarabine | increases expression | ISO | RGD:70373 | 6480464 | Cytarabine results in increased expression of BAX protein | CTD | PMID:16129037 more ... |
| cytarabine | increases expression | ISO | RGD:70373 | 6480464 | Cytarabine results in increased expression of BAX protein | CTD | PMID:10200513 more ... |
| cytarabine | increases expression | ISO | RGD:70373 | 6480464 | Cytarabine results in increased expression of BAX protein | CTD | PMID:10200513 more ... |
| cytarabine | increases expression | EXP | | 6480464 | Cytarabine results in increased expression of BAX mRNA | CTD | PMID:15203180 |
| cytarabine | increases expression | ISO | RGD:70373 | 6480464 | [Cytarabine results in increased expression of TP53 protein] which results in increased expression of BAX protein | CTD | PMID:10200513 |
| dasatinib (anhydrous) | multiple interactions | ISO | RGD:70373 | 6480464 | AKT1 protein inhibits the reaction [[dasatinib co-treated with NVP-AEW541] promotes the reaction [BAX protein binds to BAX protein]]; more ... | CTD | PMID:20664932 |
| daunorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | [bromotetrandrine co-treated with Daunorubicin] results in increased expression of BAX mRNA; more ... | CTD | PMID:19421372 |
| daunorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | [Daunorubicin co-treated with Magnetite Nanoparticles] results in increased expression of BAX mRNA | CTD | PMID:19918366 |
| daunorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | [Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in increased expression of BAX mRNA; more ... | CTD | PMID:21720514 |
| DDE | increases expression | ISO | RGD:70373 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of BAX mRNA; more ... | CTD | PMID:19545618 |
| DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of BAX mRNA | CTD | PMID:21281706 PMID:21384494 |
| DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of BAX mRNA | CTD | PMID:21281706 |
| DDE | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAX mRNA] | CTD | PMID:21281706 |
| delphinidin | increases expression | ISO | RGD:70373 | 6480464 | delphinidin results in increased expression of BAX protein | CTD | PMID:15740068 |
| delphinidin | decreases expression | ISO | RGD:70373 | 6480464 | delphinidin results in decreased expression of BAX protein | CTD | PMID:19818742 |
| Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:70373 | 6480464 | Tetrahydrocannabinol results in decreased expression of BAX mRNA | CTD | PMID:16039398 |
| deoxycholic acid | increases expression | EXP | | 6480464 | Deoxycholic Acid results in increased expression of BAX mRNA | CTD | PMID:17881359 PMID:20137712 |
| deoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of BAX protein] | CTD | PMID:10510466 more ... |
| deoxycholic acid | increases expression | EXP | | 6480464 | Deoxycholic Acid results in increased expression of BAX protein | CTD | PMID:10510466 more ... |
| deoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of BAX protein] | CTD | PMID:9562975 more ... |
| deoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of BAX protein] | CTD | PMID:9562975 more ... |
| deoxycholic acid | increases expression | EXP | | 6480464 | Deoxycholic Acid results in increased expression of BAX protein | CTD | PMID:9562975 more ... |
| deoxycholic acid | increases expression | EXP | | 6480464 | Deoxycholic Acid results in increased expression of BAX protein | CTD | PMID:20137712 more ... |
| deoxycholic acid | increases expression | EXP | | 6480464 | Deoxycholic Acid results in increased expression of BAX mRNA | CTD | PMID:20137712 PMID:17881359 |
| deoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of BAX protein] | CTD | PMID:10510466 more ... |
| deoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of BAX mRNA] | CTD | PMID:20137712 |
| deoxycholic acid | multiple interactions | EXP | | 6480464 | TP53 protein affects the reaction [[Deoxycholic Acid results in increased expression of CCND1 protein] which affects the localization of BAX protein] | CTD | PMID:17431217 |
| deoxycholic acid | increases expression | EXP | | 6480464 | Deoxycholic Acid results in increased expression of BAX protein | CTD | PMID:10510466 more ... |
| desferrioxamine B | increases expression | ISO | RGD:70373 | 6480464 | Deferoxamine results in increased expression of BAX mRNA | CTD | PMID:16800926 |
| desferrioxamine B | multiple interactions | ISO | RGD:70373 | 6480464 | Deferoxamine inhibits the reaction [Hydrogen Peroxide affects the localization of BAX protein] | CTD | PMID:21742779 |
| dexamethasone | multiple interactions | ISO | RGD:10226 | 6480464 | Dexamethasone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of BAX protein] | CTD | PMID:15987750 |
| dexamethasone | multiple interactions | ISO | RGD:10226 | 6480464 | [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with [Dexamethasone co-treated with INS protein co-treated with PRL protein]] results in decreased expression of BAX protein | CTD | PMID:11751460 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of BAX mRNA; more ... | CTD | PMID:19080409 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [TGFB1 protein results in increased expression of BAX protein] | CTD | PMID:9790906 |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX protein | CTD | PMID:19364129 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | TNF protein promotes the reaction [arsenic trioxide affects the localization of BAX protein] | CTD | PMID:17673311 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide affects the localization of BAX protein]; more ... | CTD | PMID:18412143 |
| diarsenic trioxide | affects localization | ISO | RGD:70373 | 6480464 | arsenic trioxide affects the localization of BAX protein | CTD | PMID:17673311 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:10226 | 6480464 | arsenic trioxide results in decreased expression of BAX protein | CTD | PMID:10712780 |
| diarsenic trioxide | affects localization | ISO | RGD:70373 | 6480464 | arsenic trioxide affects the localization of BAX protein | CTD | PMID:20408844 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | [Docosahexaenoic Acids co-treated with arsenic trioxide] results in increased expression of BAX protein | CTD | PMID:12609832 |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX protein | CTD | PMID:11135700 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased cleavage of and results in increased expression of BAX protein; more ... | CTD | PMID:15131059 |
| diarsenic trioxide | increases activity | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased activity of BAX protein | CTD | PMID:15665116 PMID:18359480 |
| diarsenic trioxide | decreases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in decreased expression of BAX mRNA | CTD | PMID:11940349 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | arsenic trioxide promotes the reaction [Quercetin results in increased activity of BAX protein]; more ... | CTD | PMID:18359480 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | arsenic trioxide promotes the reaction [Genistein results in increased expression of BAX protein]; more ... | CTD | PMID:20219070 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | arsenic trioxide promotes the reaction [Curcumin affects the localization of BAX protein]; more ... | CTD | PMID:20605902 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | arsenic trioxide promotes the reaction [BAX protein binds to BAX protein] | CTD | PMID:15735709 PMID:17374990 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | arsenic trioxide inhibits the reaction [BCL2 protein binds to BAX protein binds to VDAC1 protein] | CTD | PMID:17374990 |
| diarsenic trioxide | increases response to substance | ISO | RGD:70373 | 6480464 | BAX results in increased susceptibility to arsenic trioxide | CTD | PMID:18412143 |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX protein | CTD | PMID:11135700 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX mRNA | CTD | PMID:17258074 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in decreased expression of BAX protein | CTD | PMID:16882451 PMID:18349030 |
| diarsenic trioxide | increases expression | ISO | RGD:10226 | 6480464 | arsenic trioxide results in increased expression of BAX protein | CTD | PMID:21565247 |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX protein | CTD | PMID:19208092 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX mRNA | CTD | PMID:19769630 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX protein | CTD | PMID:19208092 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX mRNA | CTD | PMID:20458559 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX protein | CTD | PMID:20200477 more ... |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of BAX protein | CTD | PMID:19260322 |
| diarsenic trioxide | affects expression | EXP | | 6480464 | arsenic trioxide affects the expression of BAX protein | CTD | PMID:12725324 |
| diarsenic trioxide | increases expression | ISO | RGD:10226 | 6480464 | arsenic trioxide results in increased expression of BAX mRNA | CTD | PMID:21533816 |
| diarsenic trioxide | affects response to substance | ISO | RGD:10226 | 6480464 | BAX protein affects the susceptibility to arsenic trioxide | CTD | PMID:15979664 |
| diarsenic trioxide | multiple interactions | ISO | RGD:10226 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of BAX mRNA] | CTD | PMID:21533816 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | [bortezomib co-treated with arsenic trioxide] affects the expression of BAX protein | CTD | PMID:18718063 |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX protein | CTD | PMID:20200477 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX mRNA | CTD | PMID:17258074 more ... |
| diarsenic trioxide | increases cleavage | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased cleavage of BAX protein | CTD | PMID:16020671 |
| diarsenic trioxide | decreases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in decreased expression of BAX protein | CTD | PMID:18349030 PMID:16882451 |
| diarsenic trioxide | increases activity | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased activity of BAX protein | CTD | PMID:15665116 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | [arsenic trioxide co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased activity of BAX protein | CTD | PMID:15665116 |
| diarsenic trioxide | affects localization | ISO | RGD:70373 | 6480464 | arsenic trioxide affects the localization of BAX protein | CTD | PMID:20408844 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [arsenic trioxide results in increased activity of and results in increased localization of BAX protein]; more ... | CTD | PMID:16972261 |
| diarsenic trioxide | affects expression | ISO | RGD:70373 | 6480464 | arsenic trioxide affects the expression of BAX | CTD | PMID:11775218 |
| diarsenic trioxide | affects expression | ISO | RGD:70373 | 6480464 | arsenic trioxide affects the expression of BAX protein | CTD | PMID:16010437 PMID:16867262 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased localization of BAX protein]; more ... | CTD | PMID:17237268 |
| diarsenic trioxide | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased localization of BAX protein]; more ... | CTD | PMID:15735709 |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX protein | CTD | PMID:19489279 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:70373 | 6480464 | arsenic trioxide results in increased expression of BAX mRNA | CTD | PMID:20458559 more ... |
| diazepam | multiple interactions | EXP | | 6480464 | [HI 6 co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman affects the expression of BAX mRNA]; more ... | CTD | PMID:21971501 |
| diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of BAX mRNA | CTD | PMID:17452286 |
| diazinon | multiple interactions | ISO | RGD:10226 | 6480464 | [TLR4 protein mutant form results in increased susceptibility to Diazinon] which results in increased expression of BAX mRNA | CTD | PMID:22428454 |
| diazoxide | multiple interactions | EXP | | 6480464 | Diazoxide inhibits the reaction [Streptozocin results in increased expression of BAX protein] | CTD | PMID:20650802 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of BAX protein | CTD | PMID:17961425 PMID:16116328 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of BAX protein | CTD | PMID:16116328 PMID:17961425 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of BAX mRNA | CTD | PMID:16116328 |
| diazoxide | increases expression | ISO | RGD:10226 | 6480464 | Isoproterenol results in increased expression of BAX protein | CTD | PMID:15052282 |
| dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of BAX mRNA | CTD | PMID:18636392 |
| dichlorvos | increases expression | EXP | | 6480464 | Dichlorvos results in increased expression of BAX protein | CTD | PMID:22817663 |
| diclofenac | increases activity | ISO | RGD:70373 | 6480464 | Diclofenac results in increased activity of BAX protein | CTD | PMID:18191430 |
| diclofenac | affects localization | ISO | RGD:70373 | 6480464 | Diclofenac affects the localization of BAX protein | CTD | PMID:18191430 |
| diepoxybutane | increases expression | ISO | RGD:70373 | 6480464 | erythritol anhydride results in increased expression of BAX | CTD | PMID:17693053 |
| diethanolamine | decreases expression | EXP | | 6480464 | diethanolamine results in decreased expression of BAX mRNA | CTD | PMID:16014740 |
| diethanolamine | decreases expression | ISO | RGD:10226 | 6480464 | diethanolamine results in decreased expression of BAX mRNA | CTD | PMID:16014740 |
| diethylstilbestrol | increases expression | ISO | RGD:10226 | 6480464 | Diethylstilbestrol results in increased expression of BAX mRNA | CTD | PMID:15545218 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of BAX protein | CTD | PMID:17009535 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of BAX mRNA | CTD | PMID:15890375 |
| diiodine | multiple interactions | ISO | RGD:70373 | 6480464 | [Diatrizoate co-treated with Iodine] results in increased expression of BAX protein | CTD | PMID:17173243 |
| dimethyl sulfoxide | increases expression | ISO | RGD:70373 | 6480464 | Dimethyl Sulfoxide results in increased expression of BAX mRNA | CTD | PMID:17652743 |
| dimethyl sulfoxide | multiple interactions | ISO | RGD:70373 | 6480464 | Quercetin inhibits the reaction [Dimethyl Sulfoxide results in increased expression of BAX mRNA] | CTD | PMID:17652743 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of BAX mRNA | CTD | PMID:16122865 |
| dioxygen | multiple interactions | ISO | RGD:70373 | 6480464 | [Oxygen deficiency results in increased expression of HIF1A protein] which affects the expression of BAX protein | CTD | PMID:20206160 |
| disodium selenite | increases expression | ISO | RGD:70373 | 6480464 | Sodium Selenite results in increased expression of BAX mRNA | CTD | PMID:16705456 |
| disodium selenite | multiple interactions | EXP | | 6480464 | Sodium Selenite inhibits the reaction [2-cresol results in increased expression of BAX mRNA] | CTD | PMID:21705299 |
| disodium selenite | decreases expression | EXP | | 6480464 | Sodium Selenite results in decreased expression of BAX protein | CTD | PMID:18209489 |
| disodium selenite | increases expression | ISO | RGD:10226 | 6480464 | Sodium Selenite results in increased expression of BAX mRNA | CTD | PMID:16542727 |
| disulfiram | increases expression | ISO | RGD:70373 | 6480464 | Disulfiram results in increased expression of BAX protein | CTD | PMID:17079463 |
| dobutamine | increases expression | ISO | RGD:10226 | 6480464 | Dobutamine results in increased expression of BAX protein | CTD | PMID:15052282 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:70373 | 6480464 | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel affects the folding of and results in increased activity of BAX protein]; more ... | CTD | PMID:17308071 |
| docetaxel anhydrous | increases expression | ISO | RGD:70373 | 6480464 | docetaxel results in increased expression of BAX protein | CTD | PMID:15641988 more ... |
| docetaxel anhydrous | increases expression | ISO | RGD:70373 | 6480464 | docetaxel results in increased expression of BAX protein | CTD | PMID:15641988 more ... |
| docetaxel anhydrous | increases expression | ISO | RGD:70373 | 6480464 | docetaxel results in increased expression of BAX protein | CTD | PMID:15688368 more ... |
| docetaxel anhydrous | increases expression | ISO | RGD:70373 | 6480464 | docetaxel results in increased expression of BAX protein | CTD | PMID:14506750 more ... |
| docetaxel anhydrous | multiple interactions | ISO | RGD:10226 | 6480464 | [docetaxel results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein] | CTD | PMID:10606283 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:70373 | 6480464 | PD 98059 promotes the reaction [docetaxel results in increased expression of BAX protein] | CTD | PMID:14506750 |
| docetaxel anhydrous | increases expression | ISO | RGD:70373 | 6480464 | docetaxel results in increased expression of BAX mRNA | CTD | PMID:15641988 |
| docetaxel anhydrous | increases expression | ISO | RGD:70373 | 6480464 | docetaxel results in increased expression of BAX protein | CTD | PMID:14506750 more ... |
| docetaxel anhydrous | increases activity | ISO | RGD:70373 | 6480464 | docetaxel results in increased activity of BAX protein | CTD | PMID:17317842 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:70373 | 6480464 | [docetaxel co-treated with celecoxib] results in increased expression of BAX protein | CTD | PMID:15688368 |
| docetaxel anhydrous | affects localization | ISO | RGD:70373 | 6480464 | docetaxel affects the localization of BAX protein | CTD | PMID:17308071 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:70373 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [docetaxel results in increased activity of BAX protein]; more ... | CTD | PMID:17317842 |
| dopamine | decreases expression | ISO | RGD:70373 | 6480464 | Dopamine results in decreased expression of BAX protein | CTD | PMID:19410601 |
| doxazosin | increases expression | ISO | RGD:70373 | 6480464 | Doxazosin results in increased expression of BAX protein | CTD | PMID:16007219 |
| doxazosin | multiple interactions | ISO | RGD:70373 | 6480464 | SERPINB5 protein promotes the reaction [Doxazosin results in increased expression of BAX protein] | CTD | PMID:16007219 |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | [Doxorubicin co-treated with PI103] results in increased activity of BAX protein | CTD | PMID:23300809 |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | Doxorubicin results in increased cleavage of and results in increased expression of BAX protein | CTD | PMID:15131059 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX mRNA | CTD | PMID:12505058 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin promotes the reaction [TP53 protein binds to BAX promoter]; more ... | CTD | PMID:22155320 |
| doxorubicin | increases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in increased expression of BAX mRNA | CTD | PMID:14766674 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | Propofol inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:22015447 |
| doxorubicin | increases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:12714334 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX mRNA | CTD | PMID:12505058 more ... |
| doxorubicin | increases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in increased expression of BAX mRNA | CTD | PMID:14766674 more ... |
| doxorubicin | increases expression | ISO | RGD:70373 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:17339365 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:11291592 more ... |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | cobaltous chloride inhibits the reaction [[Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of BAX mRNA] | CTD | PMID:19714248 |
| doxorubicin | multiple interactions | ISO | RGD:10226 | 6480464 | zinc chloride promotes the reaction [Doxorubicin results in increased expression of BAX mRNA] | CTD | PMID:19714248 |
| doxorubicin | increases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:17673183 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:17924179 more ... |
| doxorubicin | increases expression | ISO | RGD:70373 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:17542780 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX mRNA | CTD | PMID:15380674 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:19890356 more ... |
| doxorubicin | increases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in increased expression of BAX mRNA | CTD | PMID:15505089 more ... |
| doxorubicin | increases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:18321777 more ... |
| doxorubicin | increases expression | ISO | RGD:70373 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:17542780 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:18632596 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX mRNA | CTD | PMID:15380674 more ... |
| doxorubicin | increases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:18627295 more ... |
| doxorubicin | increases expression | ISO | RGD:70373 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:17542780 more ... |
| doxorubicin | decreases expression | ISO | RGD:70373 | 6480464 | Doxorubicin results in decreased expression of BAX mRNA | CTD | PMID:16001973 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:18775851 more ... |
| doxorubicin | increases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:18321777 more ... |
| doxorubicin | increases expression | ISO | RGD:70373 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:17922852 more ... |
| doxorubicin | decreases expression | ISO | RGD:70373 | 6480464 | Doxorubicin results in decreased expression of BAX mRNA | CTD | PMID:19757172 more ... |
| doxorubicin | affects localization | ISO | RGD:70373 | 6480464 | Doxorubicin affects the localization of BAX protein | CTD | PMID:21865289 PMID:15456408 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:11291592 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX mRNA | CTD | PMID:15380674 more ... |
| doxorubicin | increases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:12714334 more ... |
| doxorubicin | increases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in increased expression of BAX mRNA | CTD | PMID:15505089 more ... |
| doxorubicin | increases expression | ISO | RGD:70373 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:17542780 more ... |
| doxorubicin | decreases expression | ISO | RGD:70373 | 6480464 | Doxorubicin results in decreased expression of BAX mRNA | CTD | PMID:19757172 more ... |
| doxorubicin | affects localization | ISO | RGD:70373 | 6480464 | Doxorubicin affects the localization of BAX protein | CTD | PMID:15456408 PMID:21865289 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Probucol inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:11291592 |
| doxorubicin | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [Doxorubicin results in increased expression of BAX protein]; more ... | CTD | PMID:18775851 |
| doxorubicin | multiple interactions | EXP | | 6480464 | NOL3 protein inhibits the reaction [Doxorubicin results in increased localization of BAX protein] | CTD | PMID:19139834 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Ginkgo biloba extract 761 inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:18632596 |
| doxorubicin | increases localization | EXP | | 6480464 | Doxorubicin results in increased localization of BAX protein | CTD | PMID:19139834 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:18632596 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BAX mRNA | CTD | PMID:12505058 more ... |
| doxorubicin | affects localization | EXP | | 6480464 | Doxorubicin affects the localization of BAX protein | CTD | PMID:19184017 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Catechin inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA]; more ... | CTD | PMID:18611398 |
| doxorubicin | multiple interactions | EXP | | 6480464 | carvedilol inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA] | CTD | PMID:15380674 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Amlodipine inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:17234320 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Butyric Acid analog inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA] | CTD | PMID:17473824 |
| doxorubicin | multiple interactions | EXP | | 6480464 | 2,3,5,4'-tetrahydroxystilbene-2-O-glucoside inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:19890356 |
| doxorubicin | multiple interactions | ISO | RGD:10226 | 6480464 | [zoledronic acid co-treated with Doxorubicin] results in increased expression of BAX protein | CTD | PMID:19789217 |
| doxorubicin | multiple interactions | ISO | RGD:10226 | 6480464 | pifithrin inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA] | CTD | PMID:14766674 |
| doxorubicin | multiple interactions | ISO | RGD:10226 | 6480464 | Doxycycline inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:17673183 |
| doxorubicin | increases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:12714334 more ... |
| doxorubicin | increases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in increased expression of BAX mRNA | CTD | PMID:15485691 more ... |
| doxorubicin | decreases expression | ISO | RGD:10226 | 6480464 | Doxorubicin results in decreased expression of BAX mRNA | CTD | PMID:16439991 |
| doxorubicin | multiple interactions | ISO | RGD:10226 | 6480464 | [Doxorubicin co-treated with Razoxane] results in increased expression of BAX protein | CTD | PMID:12714334 |
| doxorubicin | multiple interactions | ISO | RGD:10226 | 6480464 | Doxorubicin promotes the reaction [[HSPB1 protein modified form results in increased activity of TRP53 protein] which results in increased expression of BAX protein]; more ... | CTD | PMID:20363884 |
| doxorubicin | multiple interactions | ISO | RGD:10226 | 6480464 | BDKRB1 protein affects the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:18627295 |
| doxorubicin | multiple interactions | ISO | RGD:10226 | 6480464 | bosentan inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:17974986 |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | Tamoxifen promotes the reaction [Doxorubicin results in decreased expression of BAX mRNA] | CTD | PMID:19757172 |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | pluronic block copolymer p85 promotes the reaction [Doxorubicin results in increased expression of BAX mRNA] | CTD | PMID:15939500 |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | IFNA1 protein promotes the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:17959036 |
| doxorubicin | increases expression | ISO | RGD:70373 | 6480464 | Doxorubicin results in increased expression of BAX protein | CTD | PMID:17922852 more ... |
| doxorubicin | increases expression | ISO | RGD:70373 | 6480464 | Doxorubicin results in increased expression of BAX mRNA | CTD | PMID:15939500 |
| doxorubicin | decreases expression | ISO | RGD:70373 | 6480464 | Doxorubicin results in decreased expression of BAX mRNA | CTD | PMID:17404015 more ... |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | [Doxorubicin co-treated with Paclitaxel] results in increased expression of BAX protein; more ... | CTD | PMID:16168113 |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | [Doxorubicin co-treated with Melatonin] results in increased expression of BAX protein | CTD | PMID:20333787 |
| doxorubicin | affects localization | ISO | RGD:70373 | 6480464 | Doxorubicin affects the localization of BAX protein | CTD | PMID:15456408 |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of BAX mRNA; more ... | CTD | PMID:21214929 |
| doxorubicin | affects expression | ISO | RGD:70373 | 6480464 | Doxorubicin affects the expression of BAX mRNA | CTD | PMID:16705698 |
| doxorubicin | affects response to substance | ISO | RGD:70373 | 6480464 | BAX protein affects the susceptibility to Doxorubicin | CTD | PMID:16322301 |
| doxorubicin | affects response to substance | ISO | RGD:70373 | 6480464 | BAX affects the susceptibility to Doxorubicin | CTD | PMID:15492826 |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | [Amifostine co-treated with Doxorubicin] results in increased expression of BAX mRNA | CTD | PMID:15985719 |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of BAX protein]; more ... | CTD | PMID:17542780 |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased expression of and results in increased activity of BAX protein]; more ... | CTD | PMID:20856197 |
| doxorubicin | multiple interactions | ISO | RGD:70373 | 6480464 | 4-amino-1,8-naphthalimide promotes the reaction [Doxorubicin affects the localization of BAX protein] | CTD | PMID:15456408 |
| doxorubicin | multiple interactions | ISO | RGD:10226 | 6480464 | [Doxorubicin co-treated with PI103] results in increased activity of BAX protein | CTD | PMID:23300809 |
| doxycycline | multiple interactions | ISO | RGD:10226 | 6480464 | Doxycycline inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:17673183 |
| elemental selenium | decreases expression | ISO | RGD:10226 | 6480464 | Selenium results in decreased expression of BAX protein | CTD | PMID:17997286 |
| elemental selenium | multiple interactions | ISO | RGD:70373 | 6480464 | Selenium inhibits the reaction [T-2 Toxin results in increased expression of BAX mRNA] | CTD | PMID:16307838 |
| enalapril | decreases expression | EXP | | 6480464 | Enalapril results in decreased expression of BAX protein | CTD | PMID:21153712 |
| endosulfan | multiple interactions | ISO | RGD:10226 | 6480464 | [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in decreased expression of BAX protein | CTD | PMID:22515965 |
| endosulfan | decreases expression | ISO | RGD:10226 | 6480464 | Endosulfan results in decreased expression of BAX protein | CTD | PMID:22515965 |
| erythromycin estolate | decreases expression | EXP | | 6480464 | Erythromycin Estolate results in decreased expression of BAX mRNA | CTD | PMID:12883083 |
| esculetin | multiple interactions | ISO | RGD:70373 | 6480464 | [esculetin co-treated with Paclitaxel] results in increased expression of BAX protein | CTD | PMID:16051289 |
| esculetin | affects localization | ISO | RGD:70373 | 6480464 | esculetin affects the localization of BAX protein | CTD | PMID:19786087 |
| ethanol | affects response to substance | ISO | RGD:10226 | 6480464 | BAX protein affects the susceptibility to Ethanol | CTD | PMID:15977640 |
| ethanol | multiple interactions | ISO | RGD:70373 | 6480464 | ALDH2 protein inhibits the reaction [Ethanol results in increased expression of BAX protein] | CTD | PMID:19429258 |
| ethanol | increases expression | ISO | RGD:10226 | 6480464 | Ethanol results in increased expression of BAX protein | CTD | PMID:19429258 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of BAX mRNA | CTD | PMID:12003908 |
| ethanol | multiple interactions | EXP | | 6480464 | Ethanol affects the reaction [BAX protein binds to BCL2 protein]; more ... | CTD | PMID:16035105 |
| ethanol | affects localization | EXP | | 6480464 | Ethanol affects the localization of BAX protein | CTD | PMID:16035105 |
| ethylbenzene | increases expression | EXP | | 6480464 | ethylbenzene results in increased expression of BAX mRNA; more ... | CTD | PMID:20156836 |
| etoposide | multiple interactions | ISO | RGD:70373 | 6480464 | [ABT-737 co-treated with Etoposide] affects the folding of and results in increased activity of BAX protein; more ... | CTD | PMID:21880625 |
| etoposide | increases expression | ISO | RGD:70373 | 6480464 | Etoposide results in increased expression of BAX protein | CTD | PMID:16120219 |
| etoposide | increases expression | ISO | RGD:70373 | 6480464 | Etoposide results in increased expression of BAX mRNA | CTD | PMID:16120219 PMID:21527772 |
| etoposide | multiple interactions | ISO | RGD:70373 | 6480464 | Etoposide results in increased cleavage of and results in increased expression of BAX protein | CTD | PMID:15131059 |
| etoposide | decreases folding | ISO | RGD:70373 | 6480464 | Etoposide results in decreased folding of BAX protein | CTD | PMID:10620629 |
| etoposide | multiple interactions | ISO | RGD:70373 | 6480464 | Etoposide inhibits the reaction [BAX protein binds to BCL2L1 protein]; more ... | CTD | PMID:10620629 |
| etoposide | affects response to substance | ISO | RGD:10226 | 6480464 | BAX protein affects the susceptibility to Etoposide | CTD | PMID:16077961 |
| etoposide | increases expression | ISO | RGD:70373 | 6480464 | Etoposide results in increased expression of BAX mRNA | CTD | PMID:21527772 |
| etoposide | multiple interactions | ISO | RGD:70373 | 6480464 | Etoposide results in increased activity of and affects the localization of BAX protein; more ... | CTD | PMID:21745461 |
| etoposide | multiple interactions | ISO | RGD:70373 | 6480464 | [Cisplatin co-treated with Etoposide] affects the localization of BAX protein; more ... | CTD | PMID:18676776 |
| eugenol | multiple interactions | ISO | RGD:10226 | 6480464 | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX mRNA]; more ... | CTD | PMID:20434464 |
| eugenol | increases expression | ISO | RGD:10226 | 6480464 | Eugenol results in increased expression of BAX mRNA | CTD | PMID:20537511 |
| ferric oxide | multiple interactions | ISO | RGD:70373 | 6480464 | bromotetrandrine promotes the reaction [[ferric oxide co-treated with ferrous oxide co-treated with Daunorubicin] results in increased expression of BAX protein] | CTD | PMID:19421372 |
| ferrous oxide | multiple interactions | ISO | RGD:70373 | 6480464 | bromotetrandrine promotes the reaction [[ferric oxide co-treated with ferrous oxide co-treated with Daunorubicin] results in increased expression of BAX protein] | CTD | PMID:19421372 |
| flavanone | increases expression | ISO | RGD:70373 | 6480464 | flavanone results in increased expression of BAX protein | CTD | PMID:22056764 |
| fluoranthene | multiple interactions | ISO | RGD:70373 | 6480464 | [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of BAX mRNA | CTD | PMID:17690111 |
| flutamide | increases expression | ISO | RGD:10226 | 6480464 | Flutamide results in increased expression of BAX mRNA | CTD | PMID:17702527 |
| flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of BAX mRNA; more ... | CTD | PMID:20850791 |
| folic acid | affects expression | ISO | RGD:70373 | 6480464 | Folic Acid affects the expression of BAX mRNA | CTD | PMID:16361273 |
| folic acid | multiple interactions | EXP | | 6480464 | [Folic Acid co-treated with Isoflavones] results in decreased expression of BAX protein | CTD | PMID:20060418 |
| folic acid | multiple interactions | EXP | | 6480464 | [Vitamin E co-treated with Folic Acid] affects the expression of BAX protein | CTD | PMID:16933212 |
| folic acid | multiple interactions | ISO | RGD:10226 | 6480464 | PTHLH protein inhibits the reaction [Folic Acid results in increased expression of BAX protein] | CTD | PMID:16672315 |
| formaldehyde | increases expression | ISO | RGD:70373 | 6480464 | Formaldehyde results in increased expression of BAX protein | CTD | PMID:20347000 |
| formaldehyde | multiple interactions | ISO | RGD:70373 | 6480464 | PRDX2 protein inhibits the reaction [Formaldehyde results in increased expression of BAX protein] | CTD | PMID:20347000 |
| fulvestrant | multiple interactions | ISO | RGD:70373 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in decreased expression of BAX protein] | CTD | PMID:15870704 |
| furan | increases expression | EXP | | 6480464 | furan results in increased expression of BAX mRNA | CTD | PMID:20124500 |
| furosemide | affects expression | EXP | | 6480464 | Furosemide affects the expression of BAX mRNA | CTD | PMID:17497460 |
| galactose | multiple interactions | ISO | RGD:70373 | 6480464 | Phycocyanin inhibits the reaction [Galactose results in increased expression of BAX protein] | CTD | PMID:23036742 |
| galactose | increases expression | ISO | RGD:70373 | 6480464 | Galactose results in increased expression of BAX protein | CTD | PMID:23036742 |
| gallic acid | increases expression | ISO | RGD:70373 | 6480464 | Gallic Acid results in increased expression of BAX protein | CTD | PMID:22245431 |
| gamma-hexachlorocyclohexane | increases expression | ISO | RGD:70373 | 6480464 | Lindane results in increased expression of BAX mRNA; more ... | CTD | PMID:14688026 |
| gamma-hexachlorocyclohexane | multiple interactions | ISO | RGD:70373 | 6480464 | Estradiol inhibits the reaction [Lindane results in decreased expression of BAX protein]; more ... | CTD | PMID:18174961 |
| gamma-hexachlorocyclohexane | decreases expression | ISO | RGD:70373 | 6480464 | Lindane results in decreased expression of BAX protein | CTD | PMID:18174961 |
| gamma-hexachlorocyclohexane | decreases expression | EXP | | 6480464 | Lindane results in decreased expression of BAX protein | CTD | PMID:19041923 |
| genistein | multiple interactions | ISO | RGD:70373 | 6480464 | [Calcitriol co-treated with Genistein] results in increased expression of BAX mRNA | CTD | PMID:15955619 |
| genistein | increases expression | ISO | RGD:70373 | 6480464 | Genistein results in increased expression of BAX protein | CTD | PMID:20219070 |
| genistein | multiple interactions | ISO | RGD:70373 | 6480464 | arsenic trioxide promotes the reaction [Genistein results in increased expression of BAX protein]; more ... | CTD | PMID:20219070 |
| genistein | multiple interactions | ISO | RGD:70373 | 6480464 | [Genistein co-treated with TNFSF10 protein] results in increased expression of BAX protein | CTD | PMID:19497411 |
| glutathione | increases expression | ISO | RGD:70373 | 6480464 | Glutathione results in increased expression of BAX protein | CTD | PMID:10897038 |
| glutathione | multiple interactions | ISO | RGD:70373 | 6480464 | [[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of BAX protein | CTD | PMID:21621595 |
| gold atom | multiple interactions | ISO | RGD:70373 | 6480464 | [[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of BAX protein | CTD | PMID:21621595 |
| gold atom | increases expression | ISO | RGD:70373 | 6480464 | Gold results in increased expression of BAX mRNA | CTD | PMID:22178767 |
| gold(0) | multiple interactions | ISO | RGD:70373 | 6480464 | [[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of BAX protein | CTD | PMID:21621595 |
| gold(0) | increases expression | ISO | RGD:70373 | 6480464 | Gold results in increased expression of BAX mRNA | CTD | PMID:22178767 |
| haloperidol | decreases expression | EXP | | 6480464 | Haloperidol results in decreased expression of BAX protein | CTD | PMID:17069804 |
| haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of BAX protein; more ... | CTD | PMID:16462815 |
| heparin | increases expression | ISO | RGD:70373 | 6480464 | Heparin results in increased expression of BAX protein | CTD | PMID:11787776 |
| heptadecafluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of BAX mRNA | CTD | PMID:19646514 |
| hesperetin | affects expression | ISO | RGD:70373 | 6480464 | hesperetin affects the expression of BAX protein | CTD | PMID:15975156 |
| hesperetin | increases expression | ISO | RGD:70373 | 6480464 | hesperetin results in increased expression of BAX protein; more ... | CTD | PMID:22142698 |
| hesperetin | increases expression | EXP | | 6480464 | hesperetin analog results in increased expression of BAX mRNA | CTD | PMID:20564462 |
| hexane | increases expression | EXP | | 6480464 | n-hexane metabolite results in increased expression of BAX protein | CTD | PMID:17492505 |
| hydrogen peroxide | decreases expression | ISO | RGD:70373 | 6480464 | Hydrogen Peroxide results in decreased expression of BAX mRNA | CTD | PMID:12419474 |
| hydrogen peroxide | affects expression | ISO | RGD:70373 | 6480464 | Hydrogen Peroxide affects the expression of BAX mRNA | CTD | PMID:21179406 |
| hydrogen peroxide | increases expression | ISO | RGD:70373 | 6480464 | Hydrogen Peroxide results in increased expression of BAX protein | CTD | PMID:12672908 PMID:22269385 |
| hydrogen peroxide | increases expression | ISO | RGD:70373 | 6480464 | Hydrogen Peroxide results in increased expression of BAX mRNA | CTD | PMID:17395767 PMID:22245672 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of BAX protein | CTD | PMID:12414117 more ... |
| hydrogen peroxide | multiple interactions | ISO | RGD:70373 | 6480464 | [[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of BAX protein | CTD | PMID:21621595 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of BAX protein | CTD | PMID:15683462 more ... |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of BAX protein | CTD | PMID:12414117 more ... |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of BAX protein | CTD | PMID:20041988 more ... |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | calycopterin results in decreased susceptibility to [Hydrogen Peroxide results in increased expression of BAX protein] | CTD | PMID:22081883 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of BAX protein | CTD | PMID:12414117 more ... |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein] | CTD | PMID:20041988 PMID:15683462 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of BAX protein | CTD | PMID:20041988 more ... |
| hydrogen peroxide | affects localization | ISO | RGD:70373 | 6480464 | Hydrogen Peroxide affects the localization of BAX protein | CTD | PMID:21742779 |
| hydrogen peroxide | multiple interactions | ISO | RGD:70373 | 6480464 | Deferoxamine inhibits the reaction [Hydrogen Peroxide affects the localization of BAX protein]; more ... | CTD | PMID:21742779 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Tacrine inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX mRNA]; more ... | CTD | PMID:12414117 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | RLN2 protein affects the reaction [Hydrogen Peroxide affects the expression of BAX mRNA]; more ... | CTD | PMID:17204550 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein] | CTD | PMID:15683462 PMID:20041988 |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of BAX protein; more ... | CTD | PMID:17204550 PMID:17570061 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Hydrogen Peroxide affects the expression of BAX mRNA]; more ... | CTD | PMID:17570061 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of BAX mRNA | CTD | PMID:12414117 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of BAX protein | CTD | PMID:20041988 more ... |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of BAX mRNA; more ... | CTD | PMID:17570061 PMID:17204550 |
| hydrogen peroxide | multiple interactions | ISO | RGD:10226 | 6480464 | Hydrogen Peroxide promotes the reaction [TRP53 protein results in increased expression of BAX] | CTD | PMID:21552291 |
| hydrogen peroxide | multiple interactions | ISO | RGD:70373 | 6480464 | Pergolide inhibits the reaction [[Hydrogen Peroxide results in increased expression of TP53 protein] which results in increased expression of BAX protein]; more ... | CTD | PMID:15081873 |
| hydrogen peroxide | multiple interactions | ISO | RGD:70373 | 6480464 | PIK3C3 protein promotes the reaction [Hydrogen Peroxide results in increased activity of BAX protein] | CTD | PMID:20525898 |
| hydrogen peroxide | increases expression | ISO | RGD:70373 | 6480464 | [Hydrogen Peroxide results in increased expression of TP53 protein] which results in increased expression of BAX protein | CTD | PMID:15081873 |
| hydrogen peroxide | increases expression | ISO | RGD:70373 | 6480464 | Hydrogen Peroxide results in increased expression of BAX mRNA | CTD | PMID:17395767 |
| hydrogen peroxide | increases expression | ISO | RGD:70373 | 6480464 | Hydrogen Peroxide results in increased expression of BAX protein | CTD | PMID:12672908 |
| hydrogen peroxide | increases activity | ISO | RGD:70373 | 6480464 | Hydrogen Peroxide results in increased activity of BAX protein | CTD | PMID:20525898 |
| hydrogen peroxide | multiple interactions | ISO | RGD:70373 | 6480464 | Hydrogen Peroxide promotes the reaction [TP53 protein results in increased expression of BAX] | CTD | PMID:21552291 |
| hydrogen peroxide | multiple interactions | ISO | RGD:70373 | 6480464 | epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein]; more ... | CTD | PMID:12672908 |
| hydroxyurea | increases expression | ISO | RGD:70373 | 6480464 | Hydroxyurea results in increased expression of BAX mRNA | CTD | PMID:16005713 |
| hydroxyurea | increases expression | ISO | RGD:10226 | 6480464 | Hydroxyurea results in increased expression of BAX mRNA | CTD | PMID:16356682 |
| hypoxanthine | multiple interactions | ISO | RGD:70373 | 6480464 | [Mycophenolic Acid co-treated with Hypoxanthine] results in increased expression of BAX protein | CTD | PMID:21396949 |
| indole-3-methanol | increases expression | ISO | RGD:70373 | 6480464 | indole-3-carbinol results in increased expression of BAX | CTD | PMID:16082211 |
| indomethacin | increases expression | ISO | RGD:70373 | 6480464 | Indomethacin results in increased expression of BAX protein | CTD | PMID:11062132 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of BAX mRNA | CTD | PMID:19220725 PMID:22157011 |
| indomethacin | multiple interactions | EXP | | 6480464 | tryptamine analog inhibits the reaction [Indomethacin results in increased expression of BAX mRNA] | CTD | PMID:22157011 |
| indomethacin | increases expression | ISO | RGD:70373 | 6480464 | Indomethacin results in increased expression of BAX protein | CTD | PMID:11005569 more ... |
| indomethacin | increases expression | ISO | RGD:70373 | 6480464 | Indomethacin results in increased expression of BAX protein | CTD | PMID:11005569 more ... |
| indomethacin | increases expression | ISO | RGD:70373 | 6480464 | Indomethacin results in increased expression of BAX protein | CTD | PMID:11062132 more ... |
| indomethacin | increases expression | ISO | RGD:70373 | 6480464 | Indomethacin results in increased expression of BAX protein | CTD | PMID:11532860 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Indomethacin results in increased expression of BAX mRNA]; more ... | CTD | PMID:19220725 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of BAX protein | CTD | PMID:18375387 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of BAX mRNA | CTD | PMID:19220725 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Hydrogen Peroxide affects the expression of BAX mRNA]; more ... | CTD | PMID:17570061 |
| indomethacin | affects localization | EXP | | 6480464 | Indomethacin affects the localization of BAX protein | CTD | PMID:19220725 |
| irbesartan | multiple interactions | EXP | | 6480464 | irbesartan inhibits the reaction [ioversol results in increased expression of BAX mRNA] | CTD | PMID:16828304 |
| isoflurane | decreases expression | EXP | | 6480464 | Isoflurane results in decreased expression of BAX mRNA | CTD | PMID:16978161 |
| isoniazide | multiple interactions | ISO | RGD:10226 | 6480464 | [Isoniazid co-treated with Rifampin] results in increased expression of BAX protein; more ... | CTD | PMID:21419764 |
| isoprenaline | increases expression | ISO | RGD:10226 | 6480464 | Isoproterenol results in increased expression of BAX protein | CTD | PMID:15052282 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of BAX protein | CTD | PMID:16116328 PMID:17961425 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of BAX protein | CTD | PMID:17961425 PMID:16116328 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of BAX mRNA | CTD | PMID:16116328 |
| isotretinoin | increases expression | ISO | RGD:70373 | 6480464 | Isotretinoin results in increased expression of BAX | CTD | PMID:16909596 |
| isotretinoin | increases expression | ISO | RGD:70373 | 6480464 | Isotretinoin results in increased expression of BAX protein | CTD | PMID:16109544 PMID:16135400 |
| isotretinoin | increases expression | ISO | RGD:70373 | 6480464 | Isotretinoin results in increased expression of BAX protein | CTD | PMID:16135400 PMID:16109544 |
| kaempferol | increases expression | ISO | RGD:70373 | 6480464 | kaempferol results in increased expression of BAX protein | CTD | PMID:19028473 |
| kaempferol | multiple interactions | EXP | | 6480464 | kaempferol inhibits the reaction [Doxorubicin promotes the reaction [TP53 protein binds to BAX promoter]]; more ... | CTD | PMID:22155320 |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of BAX mRNA | CTD | PMID:19700661 |
| ketamine | affects localization | ISO | RGD:70373 | 6480464 | Ketamine affects the localization of BAX protein | CTD | PMID:19001360 |
| ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of BAX protein | CTD | PMID:18456338 |
| L-ascorbic acid | multiple interactions | ISO | RGD:70373 | 6480464 | Ascorbic Acid inhibits the reaction [deoxynivalenol results in increased expression of BAX protein] | CTD | PMID:17166419 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Humic Substances results in increased expression of BAX protein] | CTD | PMID:18683188 |
| L-ascorbic acid | multiple interactions | ISO | RGD:70373 | 6480464 | Ascorbic Acid inhibits the reaction [Silicon Dioxide results in increased expression of BAX mRNA]; more ... | CTD | PMID:22245848 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Potassium Dichromate results in increased expression of BAX protein]; more ... | CTD | PMID:21262251 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [lead acetate results in increased expression of BAX protein] | CTD | PMID:17959157 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Streptozocin results in increased expression of BAX protein] | CTD | PMID:18758938 |
| L-methionine | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Methionine results in increased expression of BAX protein] | CTD | PMID:16213988 |
| L-methionine | increases expression | EXP | | 6480464 | Methionine results in increased expression of BAX protein | CTD | PMID:16213988 |
| lansoprazole | increases expression | EXP | | 6480464 | lansoprazole results in increased expression of BAX protein | CTD | PMID:18375387 |
| lead diacetate | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [lead acetate results in increased expression of BAX protein] | CTD | PMID:17959157 |
| lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of BAX mRNA; more ... | CTD | PMID:23146751 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of BAX protein | CTD | PMID:17959157 |
| lead(0) | increases expression | EXP | | 6480464 | Lead results in increased expression of BAX protein | CTD | PMID:22129743 |
| lead(0) | multiple interactions | EXP | | 6480464 | Plant Extracts inhibits the reaction [Lead results in increased expression of BAX protein] | CTD | PMID:22129743 |
| leptomycin B | multiple interactions | ISO | RGD:70373 | 6480464 | leptomycin B inhibits the reaction [Tretinoin results in increased expression of BAX protein] | CTD | PMID:14592536 |
| leukotriene B4 | decreases expression | ISO | RGD:70373 | 6480464 | Leukotriene B4 results in decreased expression of BAX mRNA; more ... | CTD | PMID:15970427 |
| leukotriene B4 | multiple interactions | ISO | RGD:70373 | 6480464 | PD 98059 inhibits the reaction [Leukotriene B4 results in increased expression of BAX protein]; more ... | CTD | PMID:15970427 |
| leuprolide | increases expression | ISO | RGD:70373 | 6480464 | Leuprolide results in increased expression of BAX protein | CTD | PMID:15965100 |
| lipoic acid | multiple interactions | ISO | RGD:70373 | 6480464 | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased localization of BAX protein] | CTD | PMID:15735709 |
| lithium atom | multiple interactions | EXP | | 6480464 | Lithium inhibits the reaction [Methamphetamine results in increased expression of BAX protein] | CTD | PMID:19149911 |
| lithium atom | multiple interactions | ISO | RGD:70373 | 6480464 | Lithium inhibits the reaction [sodium arsenite affects the localization of BAX protein]; more ... | CTD | PMID:17849503 |
| lithium atom | multiple interactions | EXP | | 6480464 | Lithium inhibits the reaction [Cadmium results in increased expression of BAX protein] | CTD | PMID:20455018 |
| lithium atom | multiple interactions | EXP | | 6480464 | Lithium inhibits the reaction [Morphine results in increased expression of BAX mRNA] | CTD | PMID:18976035 |
| lithium atom | decreases expression | ISO | RGD:70373 | 6480464 | Lithium results in decreased expression of BAX mRNA | CTD | PMID:19949822 |
| lithocholic acid | increases expression | EXP | | 6480464 | Lithocholic Acid results in increased expression of BAX mRNA | CTD | PMID:17881359 |
| lithocholic acid | increases expression | ISO | RGD:10226 | 6480464 | Lithocholic Acid results in increased expression of BAX mRNA | CTD | PMID:19433268 |
| lithocholic acid | multiple interactions | ISO | RGD:10226 | 6480464 | [Lithocholic Acid co-treated with 1,4-bis(2-(3,5-dichloropyridyloxy))benzene] results in decreased expression of BAX protein; more ... | CTD | PMID:19433268 |
| lonidamine | affects localization | ISO | RGD:70373 | 6480464 | lonidamine affects the localization of BAX protein | CTD | PMID:20605902 PMID:21889928 |
| lonidamine | multiple interactions | ISO | RGD:70373 | 6480464 | lonidamine promotes the reaction [Curcumin affects the localization of BAX protein]; more ... | CTD | PMID:20605902 |
| losartan | multiple interactions | EXP | | 6480464 | Losartan inhibits the reaction [AGT protein modified form results in increased expression of BAX protein] | CTD | PMID:19298698 |
| losartan | increases expression | EXP | | 6480464 | Losartan results in increased expression of BAX protein | CTD | PMID:17784886 PMID:12623880 |
| losartan | increases expression | EXP | | 6480464 | Losartan results in increased expression of BAX protein | CTD | PMID:12623880 PMID:17784886 |
| losartan | multiple interactions | EXP | | 6480464 | Losartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAX mRNA] | CTD | PMID:15502641 |
| losartan | decreases expression | EXP | | 6480464 | Losartan results in decreased expression of BAX mRNA | CTD | PMID:12845756 |
| lovastatin | increases expression | ISO | RGD:70373 | 6480464 | Lovastatin results in increased expression of BAX protein | CTD | PMID:10473109 |
| lovastatin | affects localization | ISO | RGD:10226 | 6480464 | Lovastatin affects the localization of BAX protein | CTD | PMID:15180944 |
| lutein | increases expression | ISO | RGD:70373 | 6480464 | Lutein results in increased expression of BAX protein | CTD | PMID:17455471 |
| luteolin | increases expression | ISO | RGD:70373 | 6480464 | Luteolin results in increased expression of BAX protein | CTD | PMID:21601631 |
| LY294002 | multiple interactions | ISO | RGD:70373 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ursodeoxycholic Acid inhibits the reaction [Nitroprusside affects the localization of BAX protein]] | CTD | PMID:22178905 |
| LY294002 | multiple interactions | ISO | RGD:70373 | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with TNFSF10 protein] results in increased activity of BAX protein | CTD | PMID:20097879 |
| LY294002 | multiple interactions | ISO | RGD:70373 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Stilbenes analog affects the localization of BAX protein] | CTD | PMID:18449500 |
| LY294002 | multiple interactions | ISO | RGD:70373 | 6480464 | [arsenic trioxide co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased activity of BAX protein | CTD | PMID:15665116 |
| LY294002 | multiple interactions | ISO | RGD:70373 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased expression of and results in increased activity of BAX protein]; more ... | CTD | PMID:20856197 |
| LY294002 | affects localization | ISO | RGD:70373 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the localization of BAX protein | CTD | PMID:15942663 |
| magnesium dichloride | increases expression | ISO | RGD:10226 | 6480464 | Magnesium Chloride results in increased expression of BAX protein | CTD | PMID:17977900 |
| magnesium dichloride | increases expression | EXP | | 6480464 | Magnesium Chloride results in increased expression of BAX protein | CTD | PMID:17977900 |
| maneb | multiple interactions | ISO | RGD:70373 | 6480464 | [Paraquat co-treated with Maneb] results in increased expression of BAX protein | CTD | PMID:15824117 |
| maneb | multiple interactions | ISO | RGD:10226 | 6480464 | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of BAX protein]; more ... | CTD | PMID:20964710 |
| manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of BAX mRNA | CTD | PMID:17623882 |
| mangiferin | multiple interactions | EXP | | 6480464 | mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in increased expression of BAX protein] | CTD | PMID:19201465 |
| mebendazole | multiple interactions | ISO | RGD:70373 | 6480464 | [Mebendazole results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein] | CTD | PMID:18667591 |
| mechlorethamine | multiple interactions | ISO | RGD:70373 | 6480464 | Mechlorethamine results in increased expression of and results in increased activity of BAX protein | CTD | PMID:16738803 |
| medroxyprogesterone acetate | multiple interactions | ISO | RGD:70373 | 6480464 | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BAX protein | CTD | PMID:16709600 |
| meglumine amidotrizoate | increases expression | ISO | RGD:70373 | 6480464 | Diatrizoate Meglumine results in increased expression of BAX protein | CTD | PMID:17173243 |
| melamine | multiple interactions | ISO | RGD:70373 | 6480464 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [melamine results in increased expression of BAX protein]; more ... | CTD | PMID:22915474 |
| melamine | increases expression | ISO | RGD:70373 | 6480464 | melamine results in increased expression of BAX protein | CTD | PMID:22915474 |
| melatonin | increases expression | ISO | RGD:70373 | 6480464 | Melatonin results in increased expression of BAX protein | CTD | PMID:19012662 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Gentamicins results in increased expression of BAX protein] | CTD | PMID:22526374 |
| melatonin | multiple interactions | ISO | RGD:10226 | 6480464 | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of BAX protein] | CTD | PMID:20964710 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein] | CTD | PMID:20041988 PMID:15683462 |
| melatonin | decreases expression | ISO | RGD:70373 | 6480464 | Melatonin results in decreased expression of BAX protein | CTD | PMID:18078454 |
| melatonin | multiple interactions | ISO | RGD:70373 | 6480464 | Melatonin inhibits the reaction [BAX protein binds to BAX protein] | CTD | PMID:18339127 |
| melatonin | multiple interactions | ISO | RGD:70373 | 6480464 | Melatonin promotes the reaction [BID protein binds to BAX protein]; more ... | CTD | PMID:19552762 |
| melatonin | multiple interactions | ISO | RGD:70373 | 6480464 | [Melatonin co-treated with Tretinoin] results in increased expression of BAX protein | CTD | PMID:10965999 |
| melatonin | multiple interactions | ISO | RGD:70373 | 6480464 | [Doxorubicin co-treated with Melatonin] results in increased expression of BAX protein | CTD | PMID:20333787 |
| melatonin | increases expression | EXP | | 6480464 | Melatonin results in increased expression of BAX mRNA | CTD | PMID:16499559 |
| melatonin | decreases expression | EXP | | 6480464 | Melatonin results in decreased expression of BAX protein | CTD | PMID:15964511 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Methionine results in increased expression of BAX protein] | CTD | PMID:16213988 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Indomethacin affects the localization of BAX protein]; more ... | CTD | PMID:19220725 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein] | CTD | PMID:15683462 PMID:20041988 |
| melatonin | increases expression | ISO | RGD:10226 | 6480464 | Melatonin results in increased expression of BAX protein | CTD | PMID:14690559 |
| melatonin | multiple interactions | ISO | RGD:10226 | 6480464 | Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased expression of BAX protein] | CTD | PMID:21138475 |
| melatonin | multiple interactions | ISO | RGD:70373 | 6480464 | [Tretinoin co-treated with Melatonin] results in increased expression of BAX protein | CTD | PMID:9649124 |
| menadione | affects localization | EXP | | 6480464 | Vitamin K 3 affects the localization of BAX protein | CTD | PMID:15961378 |
| mercaptopurine | increases expression | ISO | RGD:10226 | 6480464 | 6-Mercaptopurine results in increased expression of BAX protein | CTD | PMID:9058596 |
| mercury atom | increases expression | EXP | | 6480464 | Mercury results in increased expression of BAX protein | CTD | PMID:21186712 |
| mercury(0) | increases expression | EXP | | 6480464 | Mercury results in increased expression of BAX protein | CTD | PMID:21186712 |
| metformin | multiple interactions | ISO | RGD:70373 | 6480464 | Cisplatin promotes the reaction [Metformin results in increased expression of BAX protein] | CTD | PMID:21388661 |
| metformin | increases expression | ISO | RGD:70373 | 6480464 | Metformin results in increased expression of BAX protein | CTD | PMID:21388661 |
| methadone | affects localization | ISO | RGD:70373 | 6480464 | Methadone affects the localization of BAX protein | CTD | PMID:20691259 |
| methamphetamine | multiple interactions | EXP | | 6480464 | Lithium inhibits the reaction [Methamphetamine results in increased expression of BAX protein]; more ... | CTD | PMID:19149911 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of BAX protein | CTD | PMID:19149911 |
| methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of BAX mRNA | CTD | PMID:17450226 PMID:15890375 |
| methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of BAX mRNA | CTD | PMID:15890375 PMID:17450226 |
| methoxsalen | increases expression | ISO | RGD:70373 | 6480464 | Methoxsalen results in increased expression of BAX protein | CTD | PMID:22796345 |
| methoxychlor | decreases expression | ISO | RGD:10226 | 6480464 | Methoxychlor metabolite results in decreased expression of BAX protein; more ... | CTD | PMID:15525693 |
| methoxychlor | increases expression | ISO | RGD:10226 | 6480464 | Methoxychlor results in increased expression of BAX mRNA | CTD | PMID:16081520 PMID:23000595 |
| methoxychlor | multiple interactions | ISO | RGD:10226 | 6480464 | [ESR1 gene mutant form results in increased susceptibility to Methoxychlor] which results in increased expression of BAX mRNA | CTD | PMID:22306526 |
| methoxychlor | affects response to substance | ISO | RGD:10226 | 6480464 | BAX protein affects the susceptibility to Methoxychlor | CTD | PMID:14973267 |
| methoxychlor | increases expression | ISO | RGD:10226 | 6480464 | Methoxychlor results in increased expression of BAX protein | CTD | PMID:14973267 |
| methoxychlor | increases expression | ISO | RGD:10226 | 6480464 | Methoxychlor results in increased expression of BAX mRNA | CTD | PMID:16081520 |
| methyl methanesulfonate | increases expression | ISO | RGD:70373 | 6480464 | Methyl Methanesulfonate results in increased expression of BAX mRNA | CTD | PMID:21527772 |
| methyltestosterone | multiple interactions | EXP | | 6480464 | [Gossypol co-treated with Methyltestosterone co-treated with Ethinyl Estradiol] results in increased expression of BAX mRNA | CTD | PMID:15451339 |
| microcystin-LR | increases expression | ISO | RGD:10226 | 6480464 | cyanoginosin LR results in increased expression of BAX mRNA | CTD | PMID:17654400 |
| microcystin-LR | increases expression | ISO | RGD:70373 | 6480464 | cyanoginosin LR results in increased expression of BAX protein | CTD | PMID:18214937 |
| mifepristone | affects localization | ISO | RGD:70373 | 6480464 | Mifepristone affects the localization of BAX protein | CTD | PMID:16009178 |
| mifepristone | increases expression | ISO | RGD:70373 | 6480464 | Mifepristone results in increased expression of BAX protein | CTD | PMID:16638347 |
| mifepristone | increases expression | ISO | RGD:70373 | 6480464 | Mifepristone results in increased expression of BAX mRNA | CTD | PMID:16009178 |
| minocycline | multiple interactions | EXP | | 6480464 | Minocycline inhibits the reaction [Sodium Azide affects the localization of BAX protein]; more ... | CTD | PMID:15004018 |
| minocycline | decreases expression | EXP | | 6480464 | Minocycline results in decreased expression of BAX protein | CTD | PMID:15172883 |
| misoprostol | multiple interactions | EXP | | 6480464 | Misoprostol inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein] | CTD | PMID:18602972 |
| mitomycin C | affects localization | ISO | RGD:70373 | 6480464 | Mitomycin affects the localization of BAX protein | CTD | PMID:19834285 |
| mitomycin C | increases expression | ISO | RGD:70373 | 6480464 | Mitomycin results in increased expression of BAX protein | CTD | PMID:11867586 PMID:15120327 |
| mitomycin C | multiple interactions | ISO | RGD:70373 | 6480464 | Tamoxifen promotes the reaction [Mitomycin results in decreased expression of BAX mRNA] | CTD | PMID:19757172 |
| mitomycin C | increases expression | ISO | RGD:70373 | 6480464 | Mitomycin results in increased expression of BAX mRNA | CTD | PMID:18615204 |
| mitomycin C | multiple interactions | ISO | RGD:70373 | 6480464 | silybin inhibits the reaction [Mitomycin affects the localization of BAX protein] | CTD | PMID:19834285 |
| mitomycin C | decreases expression | ISO | RGD:70373 | 6480464 | Mitomycin results in decreased expression of BAX mRNA | CTD | PMID:19757172 |
| mitomycin C | increases expression | ISO | RGD:70373 | 6480464 | Mitomycin results in increased expression of BAX protein | CTD | PMID:15120327 PMID:11867586 |
| mono(2-ethylhexyl) phthalate | increases expression | ISO | RGD:70373 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of BAX mRNA | CTD | PMID:12927354 |
| monocrotaline | multiple interactions | ISO | RGD:10226 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BAX mRNA | CTD | PMID:21224054 |
| monocrotophos | increases expression | EXP | | 6480464 | Monocrotophos results in increased expression of BAX mRNA | CTD | PMID:20957986 |
| monocrotophos | increases expression | EXP | | 6480464 | Monocrotophos results in increased expression of BAX mRNA | CTD | PMID:20957986 PMID:21445290 |
| monocrotophos | increases expression | EXP | | 6480464 | Monocrotophos results in increased expression of BAX protein | CTD | PMID:21445290 |
| monocrotophos | multiple interactions | EXP | | 6480464 | Monocrotophos results in increased expression of and affects the localization of BAX protein | CTD | PMID:20957986 |
| morphine | multiple interactions | ISO | RGD:70373 | 6480464 | Morphine inhibits the reaction [Dactinomycin results in increased expression of BAX protein]; more ... | CTD | PMID:12927789 |
| morphine | multiple interactions | ISO | RGD:70373 | 6480464 | PDGFB protein inhibits the reaction [Morphine results in increased expression of BAX protein] | CTD | PMID:21483469 |
| morphine | increases expression | ISO | RGD:70373 | 6480464 | Morphine results in increased expression of BAX protein | CTD | PMID:10534122 more ... |
| morphine | increases expression | ISO | RGD:70373 | 6480464 | Morphine results in increased expression of BAX protein | CTD | PMID:10534122 PMID:19070643 |
| morphine | increases expression | EXP | | 6480464 | Morphine results in increased expression of BAX protein | CTD | PMID:12196588 |
| morphine | increases expression | EXP | | 6480464 | Morphine results in increased expression of BAX mRNA | CTD | PMID:18976035 |
| morphine | decreases expression | EXP | | 6480464 | Morphine results in decreased expression of BAX mRNA | CTD | PMID:15183518 |
| morphine | multiple interactions | EXP | | 6480464 | Lithium inhibits the reaction [Morphine results in increased expression of BAX mRNA] | CTD | PMID:18976035 |
| morphine | multiple interactions | ISO | RGD:10226 | 6480464 | TGFB1 protein affects the reaction [Morphine results in increased expression of BAX protein] | CTD | PMID:10809959 |
| morphine | increases expression | ISO | RGD:10226 | 6480464 | Morphine results in increased expression of BAX protein | CTD | PMID:10809959 |
| morphine | multiple interactions | ISO | RGD:70373 | 6480464 | [Morphine results in increased phosphorylation of and results in increased stability of TP53 protein] which results in increased expression of BAX protein | CTD | PMID:12702572 |
| morphine | multiple interactions | ISO | RGD:70373 | 6480464 | [[Morphine results in increased expression of BAX protein] co-treated with [Morphine results in decreased expression of BCL2 protein]] results in increased activity of CASP3 protein | CTD | PMID:10534122 |
| morphine | increases expression | ISO | RGD:70373 | 6480464 | Morphine results in increased expression of BAX protein | CTD | PMID:19070643 PMID:10534122 |
| morphine | multiple interactions | ISO | RGD:70373 | 6480464 | Morphine inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:17542780 |
| mycophenolic acid | multiple interactions | ISO | RGD:70373 | 6480464 | [Mycophenolic Acid co-treated with Hypoxanthine] results in increased expression of BAX protein | CTD | PMID:21396949 |
| myricetin | decreases expression | ISO | RGD:70373 | 6480464 | myricetin results in decreased expression of BAX protein | CTD | PMID:15748703 |
| myricetin | multiple interactions | ISO | RGD:70373 | 6480464 | Tetradecanoylphorbol Acetate inhibits the reaction [myricetin results in decreased expression of BAX protein] | CTD | PMID:15748703 |
| N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of BAX protein | CTD | PMID:12587291 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Buthionine Sulfoximine] results in decreased expression of BAX protein] | CTD | PMID:11341981 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester) affects the expression of BAX protein] | CTD | PMID:22704995 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide affects the localization of BAX protein] | CTD | PMID:18412143 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAX mRNA]; more ... | CTD | PMID:22085843 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:10226 | 6480464 | Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of BAX mRNA] | CTD | PMID:21549813 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [cordycepin results in increased expression of BAX protein] | CTD | PMID:21310227 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [nickel acetate results in increased expression of BAX protein] | CTD | PMID:22245127 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased expression of BAX protein] | CTD | PMID:20674558 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [surfactin peptide results in increased expression of BAX protein] | CTD | PMID:19954742 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased localization of BAX protein] | CTD | PMID:17237268 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of BAX protein] | CTD | PMID:15496615 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased localization of BAX protein] | CTD | PMID:15735709 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of and results in increased activity of BAX protein] | CTD | PMID:17574045 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:17542780 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:10226 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of BAX mRNA] | CTD | PMID:21533816 |
| N-acetyl-L-cysteine | increases expression | ISO | RGD:70373 | 6480464 | Acetylcysteine results in increased expression of BAX protein | CTD | PMID:11166918 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:10226 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased expression of BAX protein]; more ... | CTD | PMID:21616140 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [perfosfamide affects the folding of BAX protein]; more ... | CTD | PMID:18034189 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [cadmium acetate results in increased cleavage of BAX protein] | CTD | PMID:16169029 |
| N-acetyl-L-cysteine | decreases expression | ISO | RGD:70373 | 6480464 | Acetylcysteine results in decreased expression of BAX protein | CTD | PMID:19376147 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [chromium tripicolinate results in increased expression of BAX protein] | CTD | PMID:19376147 |
| N-ethyl-N-nitrosourea | increases expression | ISO | RGD:10226 | 6480464 | Ethylnitrosourea results in increased expression of BAX mRNA | CTD | PMID:19100860 |
| N-ethyl-N-nitrosourea | affects expression | ISO | RGD:10226 | 6480464 | Ethylnitrosourea affects the expression of BAX mRNA | CTD | PMID:11356909 |
| N-ethyl-N-nitrosourea | increases expression | EXP | | 6480464 | Ethylnitrosourea results in increased expression of BAX mRNA | CTD | PMID:15954086 |
| N-formyl-L-methionyl-L-leucyl-L-phenylalanine | increases activity | ISO | RGD:70373 | 6480464 | N-Formylmethionine Leucyl-Phenylalanine results in increased activity of BAX protein | CTD | PMID:20130848 |
| N-methyl-4-phenylpyridinium | increases expression | ISO | RGD:10226 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of BAX protein | CTD | PMID:12880480 |
| N-methyl-4-phenylpyridinium | increases expression | ISO | RGD:70373 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of BAX protein | CTD | PMID:19646423 PMID:21295016 |
| N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of BAX protein | CTD | PMID:18602972 more ... |
| N-methyl-4-phenylpyridinium | multiple interactions | ISO | RGD:70373 | 6480464 | SNCA mRNA affects the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein] | CTD | PMID:19646423 |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | Drugs, Chinese Herbal inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA]; more ... | CTD | PMID:19524685 |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | [1-Methyl-4-phenylpyridinium results in increased activity of CAPN1 protein] which results in increased localization of BAX protein | CTD | PMID:18496573 |
| N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA | CTD | PMID:19466539 PMID:19524685 |
| N-methyl-4-phenylpyridinium | increases expression | ISO | RGD:70373 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of BAX protein | CTD | PMID:21295016 |
| N-methyl-4-phenylpyridinium | multiple interactions | ISO | RGD:70373 | 6480464 | Quercetin inhibits the reaction [squamosamide inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein]] | CTD | PMID:21295016 |
| N-methyl-4-phenylpyridinium | increases expression | ISO | RGD:70373 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA | CTD | PMID:17266988 PMID:20686228 |
| N-methyl-4-phenylpyridinium | multiple interactions | ISO | RGD:70373 | 6480464 | salvianolic acid B inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA] | CTD | PMID:20686228 |
| N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of BAX protein | CTD | PMID:19135049 PMID:18602972 |
| N-methyl-4-phenylpyridinium | multiple interactions | ISO | RGD:70373 | 6480464 | rosiglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA] | CTD | PMID:17266988 |
| N-methyl-4-phenylpyridinium | increases expression | ISO | RGD:70373 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA | CTD | PMID:17266988 |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA]; more ... | CTD | PMID:19466539 |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | Misoprostol inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein] | CTD | PMID:18602972 |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | Amitriptyline inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein]; more ... | CTD | PMID:19135049 |
| N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of BAX protein | CTD | PMID:18602972 PMID:19135049 |
| N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA | CTD | PMID:19466539 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BAX protein | CTD | PMID:16030430 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases expression | ISO | RGD:10226 | 6480464 | Methylnitronitrosoguanidine results in decreased expression of BAX protein; more ... | CTD | PMID:20434464 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:10226 | 6480464 | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX mRNA]; more ... | CTD | PMID:20434464 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to [Methylnitronitrosoguanidine co-treated with 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide] | CTD | PMID:18376143 |
| N-methyl-N-nitrosurea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of BAX protein | CTD | PMID:16168987 more ... |
| N-methyl-N-nitrosurea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of BAX protein | CTD | PMID:16011256 more ... |
| N-methyl-N-nitrosurea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of BAX protein | CTD | PMID:16168987 more ... |
| N-methyl-N-nitrosurea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of BAX protein | CTD | PMID:16047940 more ... |
| N-methyl-N-nitrosurea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of BAX protein | CTD | PMID:16011256 more ... |
| N-methyl-N-nitrosurea | multiple interactions | EXP | | 6480464 | Niacinamide inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein] | CTD | PMID:16168987 |
| N-methyl-N-nitrosurea | multiple interactions | EXP | | 6480464 | FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein] | CTD | PMID:16011256 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:10226 | 6480464 | Diethylnitrosamine results in increased expression of BAX mRNA | CTD | PMID:19100860 PMID:18056438 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:10226 | 6480464 | Diethylnitrosamine results in increased expression of BAX mRNA | CTD | PMID:18056438 more ... |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | morin inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX protein] | CTD | PMID:19931519 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of BAX protein | CTD | PMID:21167192 PMID:19073162 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of BAX protein | CTD | PMID:19931519 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [5,7-dimethoxyflavone co-treated with Diethylnitrosamine] results in increased expression of BAX protein | CTD | PMID:21554863 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:10226 | 6480464 | Diethylnitrosamine results in increased expression of BAX mRNA | CTD | PMID:18056438 PMID:19100860 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [Diethylnitrosamine results in increased expression of BAX protein] | CTD | PMID:19073162 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of BAX protein | CTD | PMID:19073162 PMID:21167192 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Cyclohexanols] results in decreased expression of BAX protein | CTD | PMID:17393424 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BAX protein; more ... | CTD | PMID:11915028 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BAX protein; more ... | CTD | PMID:20452335 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:10226 | 6480464 | CYP2E1 protein promotes the reaction [Diethylnitrosamine results in increased expression of BAX mRNA] | CTD | PMID:18056438 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | chrysin promotes the reaction [Diethylnitrosamine results in increased expression of BAX protein] | CTD | PMID:21167192 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of BAX mRNA | CTD | PMID:15890375 PMID:14600272 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of BAX mRNA | CTD | PMID:14600272 PMID:15890375 |
| NAD zwitterion | decreases expression | ISO | RGD:70373 | 6480464 | NAD results in decreased expression of BAX protein | CTD | PMID:12390773 |
| NAD(+) | decreases expression | ISO | RGD:70373 | 6480464 | NAD results in decreased expression of BAX protein | CTD | PMID:12390773 |
| naloxone | multiple interactions | ISO | RGD:70373 | 6480464 | Naloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in increased expression of BAX protein]] | CTD | PMID:12927789 |
| naringin | increases expression | ISO | RGD:70373 | 6480464 | naringin results in increased expression of BAX mRNA | CTD | PMID:22847135 |
| nickel atom | multiple interactions | EXP | | 6480464 | Grape Seed Proanthocyanidins inhibits the reaction [Nickel results in increased expression of BAX protein] | CTD | PMID:21417627 |
| nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of BAX protein | CTD | PMID:21417627 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of BAX protein | CTD | PMID:20391133 |
| nicotinamide | multiple interactions | EXP | | 6480464 | Niacinamide inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein] | CTD | PMID:16168987 |
| nicotinamide | multiple interactions | EXP | | 6480464 | Niacinamide inhibits the reaction [Thiotepa results in increased expression of BAX mRNA]; more ... | CTD | PMID:22164206 |
| nicotinamide | increases expression | ISO | RGD:70373 | 6480464 | Niacinamide results in increased expression of BAX mRNA | CTD | PMID:16998810 |
| nifedipine | multiple interactions | EXP | | 6480464 | Nifedipine inhibits the reaction [Gentamicins results in increased expression of BAX protein] | CTD | PMID:19698708 |
| nimesulide | multiple interactions | ISO | RGD:70373 | 6480464 | nimesulide inhibits the reaction [Etoposide results in increased activity of and affects the localization of BAX protein] | CTD | PMID:21745461 |
| nimodipine | increases expression | ISO | RGD:70373 | 6480464 | Nimodipine results in increased expression of BAX protein | CTD | PMID:17490525 |
| nitric oxide | affects localization | ISO | RGD:10226 | 6480464 | Nitric Oxide affects the localization of BAX protein | CTD | PMID:14634119 |
| nitric oxide | decreases expression | ISO | RGD:10226 | 6480464 | Nitric Oxide results in decreased expression of BAX protein | CTD | PMID:14634119 |
| nitric oxide | multiple interactions | ISO | RGD:70373 | 6480464 | [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased expression of BAX protein | CTD | PMID:10828028 |
| nitroprusside | multiple interactions | EXP | | 6480464 | FGF2 protein inhibits the reaction [Nitroprusside results in increased expression of BAX protein]; more ... | CTD | PMID:10203697 |
| nitroprusside | increases expression | ISO | RGD:70373 | 6480464 | Nitroprusside results in increased expression of BAX protein | CTD | PMID:22178905 |
| nitroprusside | multiple interactions | ISO | RGD:70373 | 6480464 | Nitroprusside results in increased expression of and affects the localization of BAX protein; more ... | CTD | PMID:22178905 |
| nitroprusside | affects localization | EXP | | 6480464 | Nitroprusside affects the localization of BAX protein | CTD | PMID:15961378 |
| nitroprusside | increases expression | EXP | | 6480464 | Nitroprusside results in increased expression of BAX protein | CTD | PMID:10203697 |
| o-cresol | increases expression | EXP | | 6480464 | 2-cresol results in increased expression of BAX mRNA | CTD | PMID:21705299 |
| o-cresol | multiple interactions | EXP | | 6480464 | Sodium Selenite inhibits the reaction [2-cresol results in increased expression of BAX mRNA] | CTD | PMID:21705299 |
| ochratoxin A | decreases expression | ISO | RGD:70373 | 6480464 | ochratoxin A results in decreased expression of BAX protein | CTD | PMID:19367635 |
| ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of BAX mRNA | CTD | PMID:23208426 |
| ochratoxin A | affects localization | ISO | RGD:70373 | 6480464 | ochratoxin A affects the localization of BAX protein | CTD | PMID:20549612 |
| ochratoxin A | increases expression | ISO | RGD:70373 | 6480464 | ochratoxin A results in increased expression of BAX protein | CTD | PMID:20549612 |
| ochratoxin A | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to ochratoxin A | CTD | PMID:20549612 |
| okadaic acid | affects localization | ISO | RGD:70373 | 6480464 | Okadaic Acid affects the localization of BAX protein | CTD | PMID:19084044 |
| okadaic acid | decreases expression | ISO | RGD:70373 | 6480464 | Okadaic Acid results in decreased expression of BAX protein | CTD | PMID:18937299 |
| okadaic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Okadaic Acid results in increased expression of BAX protein] | CTD | PMID:10510466 |
| okadaic acid | increases expression | EXP | | 6480464 | Okadaic Acid results in increased expression of BAX protein | CTD | PMID:10510466 |
| okadaic acid | multiple interactions | ISO | RGD:70373 | 6480464 | Okadaic Acid results in increased cleavage of and results in increased activity of BAX protein | CTD | PMID:19084044 |
| olanzapine | increases expression | EXP | | 6480464 | olanzapine results in increased expression of BAX protein | CTD | PMID:16462815 |
| ouabain | affects localization | ISO | RGD:70373 | 6480464 | Ouabain affects the localization of BAX protein | CTD | PMID:18247327 |
| ouabain | increases expression | ISO | RGD:70373 | 6480464 | Ouabain results in increased expression of BAX protein | CTD | PMID:17096883 |
| ouabain | multiple interactions | ISO | RGD:70373 | 6480464 | Ouabain inhibits the reaction [HSPD1 protein binds to BAX protein] | CTD | PMID:18247327 |
| oxaliplatin | increases expression | ISO | RGD:70373 | 6480464 | oxaliplatin results in increased expression of BAX protein | CTD | PMID:16227409 |
| oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of BAX protein | CTD | PMID:19428505 |
| oxaliplatin | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [oxaliplatin results in increased expression of BAX protein]; more ... | CTD | PMID:19428505 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of BAX mRNA | CTD | PMID:18636392 |
| paclitaxel | multiple interactions | ISO | RGD:70373 | 6480464 | [esculetin co-treated with Paclitaxel] results in increased expression of BAX protein | CTD | PMID:16051289 |
| paclitaxel | increases expression | ISO | RGD:70373 | 6480464 | Paclitaxel results in increased expression of BAX protein | CTD | PMID:10516758 more ... |
| paclitaxel | increases expression | ISO | RGD:70373 | 6480464 | Paclitaxel results in increased expression of BAX protein | CTD | PMID:12632493 more ... |
| paclitaxel | increases expression | ISO | RGD:70373 | 6480464 | Paclitaxel results in increased expression of BAX protein | CTD | PMID:10822281 more ... |
| paclitaxel | increases expression | ISO | RGD:70373 | 6480464 | Paclitaxel results in increased expression of BAX protein | CTD | PMID:12632493 more ... |
| paclitaxel | increases expression | ISO | RGD:70373 | 6480464 | Paclitaxel results in increased expression of BAX protein | CTD | PMID:10516758 more ... |
| paclitaxel | multiple interactions | ISO | RGD:70373 | 6480464 | [Doxorubicin co-treated with Paclitaxel] results in increased expression of BAX protein; more ... | CTD | PMID:16168113 |
| paclitaxel | increases expression | ISO | RGD:10226 | 6480464 | Paclitaxel results in increased expression of BAX mRNA | CTD | PMID:17449502 |
| paclitaxel | affects response to substance | ISO | RGD:10226 | 6480464 | BAX protein affects the susceptibility to Paclitaxel | CTD | PMID:17652622 |
| paclitaxel | multiple interactions | ISO | RGD:10226 | 6480464 | [BAK1 protein mutant form co-treated with BAX protein mutant form] inhibits the reaction [Paclitaxel results in increased activity of and results in increased cleavage of CASP3 protein] | CTD | PMID:17652622 |
| paclitaxel | multiple interactions | ISO | RGD:70373 | 6480464 | [Paclitaxel results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein] | CTD | PMID:11726273 |
| paclitaxel | increases expression | ISO | RGD:70373 | 6480464 | Paclitaxel results in increased expression of BAX protein | CTD | PMID:10822281 more ... |
| paclitaxel | increases expression | ISO | RGD:70373 | 6480464 | [Paclitaxel results in increased expression of TP53 protein] which results in increased expression of BAX mRNA | CTD | PMID:9041188 |
| paclitaxel | increases expression | ISO | RGD:70373 | 6480464 | Paclitaxel results in increased expression of BAX mRNA | CTD | PMID:10822281 |
| palmitic acid | increases expression | ISO | RGD:70373 | 6480464 | Palmitic Acid results in increased expression of BAX | CTD | PMID:15945276 |
| palmitic acid | increases expression | EXP | | 6480464 | Palmitic Acid results in increased expression of BAX | CTD | PMID:15945276 |
| paracetamol | affects localization | ISO | RGD:10226 | 6480464 | Acetaminophen affects the localization of BAX protein | CTD | PMID:21572097 PMID:17906064 |
| paracetamol | multiple interactions | ISO | RGD:10226 | 6480464 | dioscin inhibits the reaction [Acetaminophen results in increased expression of BAX protein] | CTD | PMID:22939915 |
| paracetamol | increases expression | ISO | RGD:10226 | 6480464 | Acetaminophen results in increased expression of BAX protein | CTD | PMID:12540782 more ... |
| paracetamol | increases expression | ISO | RGD:70373 | 6480464 | Acetaminophen results in increased expression of BAX mRNA | CTD | PMID:22230336 |
| paracetamol | affects localization | ISO | RGD:10226 | 6480464 | Acetaminophen affects the localization of BAX protein | CTD | PMID:17906064 more ... |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of BAX mRNA | CTD | PMID:20732408 |
| paracetamol | multiple interactions | ISO | RGD:10226 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Acetaminophen affects the localization of BAX protein] | CTD | PMID:20423716 |
| paracetamol | affects expression | ISO | RGD:70373 | 6480464 | Acetaminophen affects the expression of BAX mRNA | CTD | PMID:20732408 |
| paracetamol | affects localization | ISO | RGD:10226 | 6480464 | Acetaminophen affects the localization of BAX protein | CTD | PMID:17906064 PMID:21572097 |
| paracetamol | increases expression | ISO | RGD:10226 | 6480464 | Acetaminophen results in increased expression of BAX protein | CTD | PMID:20355050 PMID:12540782 |
| paracetamol | multiple interactions | ISO | RGD:10226 | 6480464 | Plant Extracts inhibits the reaction [Acetaminophen results in increased expression of BAX protein] | CTD | PMID:20355050 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of BAX protein | CTD | PMID:11562448 |
| paracetamol | affects response to substance | ISO | RGD:10226 | 6480464 | BAX protein affects the susceptibility to Acetaminophen | CTD | PMID:17906064 |
| paracetamol | multiple interactions | ISO | RGD:10226 | 6480464 | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of BAX mRNA] | CTD | PMID:12540782 |
| paracetamol | increases expression | ISO | RGD:10226 | 6480464 | Acetaminophen results in increased expression of BAX protein | CTD | PMID:12540782 PMID:20355050 |
| paracetamol | increases expression | ISO | RGD:10226 | 6480464 | Acetaminophen results in increased expression of BAX mRNA | CTD | PMID:12540782 |
| paracetamol | affects expression | ISO | RGD:10226 | 6480464 | Acetaminophen affects the expression of BAX mRNA | CTD | PMID:17562736 |
| paraquat | multiple interactions | ISO | RGD:70373 | 6480464 | [Paraquat co-treated with Maneb] results in increased expression of BAX protein | CTD | PMID:15824117 |
| paraquat | increases expression | ISO | RGD:70373 | 6480464 | Paraquat results in increased expression of BAX protein | CTD | PMID:18253895 |
| paraquat | decreases expression | ISO | RGD:70373 | 6480464 | Paraquat results in decreased expression of BAX mRNA | CTD | PMID:18836921 |
| paraquat | multiple interactions | EXP | | 6480464 | [Paraquat co-treated with decitabine] results in increased expression of BAX protein | CTD | PMID:22796470 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of BAX mRNA | CTD | PMID:22678742 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of BAX protein | CTD | PMID:12714668 PMID:22678742 |
| paraquat | multiple interactions | EXP | | 6480464 | NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of BAX mRNA] | CTD | PMID:22678742 |
| paraquat | multiple interactions | ISO | RGD:10226 | 6480464 | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of BAX protein]; more ... | CTD | PMID:20964710 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of BAX protein | CTD | PMID:12714668 |
| paraquat | affects expression | EXP | | 6480464 | Paraquat affects the expression of BAX mRNA | CTD | PMID:15206577 |
| paraquat | multiple interactions | EXP | | 6480464 | Docosahexaenoic Acids inhibits the reaction [Paraquat results in increased expression of BAX protein] | CTD | PMID:12714668 |
| paraquat | multiple interactions | ISO | RGD:10226 | 6480464 | GPX1 protein affects the reaction [Paraquat affects the expression of BAX mRNA] | CTD | PMID:12654481 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:10226 | 6480464 | perfluorooctane sulfonic acid results in increased expression of BAX mRNA | CTD | PMID:21115943 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of BAX mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of BAX mRNA | CTD | PMID:19162173 PMID:21318169 |
| pergolide | multiple interactions | ISO | RGD:70373 | 6480464 | Pergolide inhibits the reaction [[Hydrogen Peroxide results in increased expression of TP53 protein] which results in increased expression of BAX protein] | CTD | PMID:15081873 |
| pergolide | multiple interactions | ISO | RGD:10226 | 6480464 | Pergolide inhibits the reaction [Levodopa results in increased expression of BAX protein] | CTD | PMID:15672541 |
| perillyl alcohol | multiple interactions | ISO | RGD:10226 | 6480464 | perilla alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of BAX protein] | CTD | PMID:19161993 |
| permethrin | multiple interactions | EXP | | 6480464 | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of BAX protein | CTD | PMID:12587291 |
| peroxynitrous acid | increases expression | EXP | | 6480464 | Peroxynitrous Acid results in increased expression of BAX mRNA; more ... | CTD | PMID:20869986 |
| peroxynitrous acid | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Peroxynitrous Acid results in increased expression of BAX mRNA]; more ... | CTD | PMID:20869986 |
| phenethyl isothiocyanate | multiple interactions | ISO | RGD:70373 | 6480464 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [phenethyl isothiocyanate results in increased expression of BAX protein]; more ... | CTD | PMID:16054126 |
| phenethyl isothiocyanate | increases expression | ISO | RGD:70373 | 6480464 | phenethyl isothiocyanate results in increased expression of BAX protein | CTD | PMID:16054126 |
| phenobarbital | decreases expression | ISO | RGD:10226 | 6480464 | Phenobarbital results in decreased expression of BAX protein | CTD | PMID:10426811 |
| phenobarbital | multiple interactions | ISO | RGD:10226 | 6480464 | [Lithocholic Acid co-treated with Phenobarbital] results in decreased expression of BAX protein; more ... | CTD | PMID:19433268 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of BAX protein | CTD | PMID:17456340 |
| phenobarbital | multiple interactions | ISO | RGD:10226 | 6480464 | Phenobarbital inhibits the reaction [MYC protein results in increased expression of BAX protein] | CTD | PMID:10449034 |
| phenobarbital | increases expression | ISO | RGD:10226 | 6480464 | Phenobarbital results in increased expression of BAX mRNA | CTD | PMID:19270015 |
| phenobarbital | multiple interactions | ISO | RGD:10226 | 6480464 | [Phenobarbital co-treated with MYC protein] results in increased expression of BAX protein | CTD | PMID:9230198 |
| phenylephrine | decreases expression | EXP | | 6480464 | Phenylephrine results in decreased expression of BAX protein | CTD | PMID:19910689 |
| phenylephrine | multiple interactions | EXP | | 6480464 | PTHLH protein affects the reaction [Phenylephrine results in decreased expression of BAX protein] | CTD | PMID:19910689 |
| phenytoin | multiple interactions | ISO | RGD:10226 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BAX mRNA | CTD | PMID:21224054 |
| phloroglucinol | increases expression | ISO | RGD:70373 | 6480464 | Phloroglucinol metabolite results in increased expression of BAX protein | CTD | PMID:22796323 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:70373 | 6480464 | Tetradecanoylphorbol Acetate inhibits the reaction [myricetin results in decreased expression of BAX protein] | CTD | PMID:15748703 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10226 | 6480464 | perilla alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of BAX protein] | CTD | PMID:19161993 |
| phorbol 13-acetate 12-myristate | decreases expression | ISO | RGD:10226 | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of BAX protein | CTD | PMID:19161993 |
| physcion | increases expression | ISO | RGD:70373 | 6480464 | physcione results in increased expression of BAX protein | CTD | PMID:22285236 |
| physcion | decreases expression | ISO | RGD:70373 | 6480464 | physcione results in decreased expression of BAX protein | CTD | PMID:22285236 |
| phytosphingosine | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased localization of BAX protein]; more ... | CTD | PMID:17237268 |
| phytosphingosine | affects localization | ISO | RGD:70373 | 6480464 | phytosphingosine affects the localization of BAX protein | CTD | PMID:15486061 |
| picolinic acid | multiple interactions | EXP | | 6480464 | picolinic acid inhibits the reaction [Cisplatin results in increased expression of BAX protein] | CTD | PMID:20817559 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of BAX mRNA | CTD | PMID:15890375 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of BAX mRNA | CTD | PMID:15890375 PMID:19162173 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of BAX mRNA | CTD | PMID:15890375 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of BAX mRNA | CTD | PMID:15890375 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of BAX mRNA | CTD | PMID:21318169 more ... |
| potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of BAX protein | CTD | PMID:21262251 |
| potassium dichromate | increases expression | ISO | RGD:10226 | 6480464 | Potassium Dichromate results in increased expression of BAX protein | CTD | PMID:19219935 |
| potassium dichromate | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Potassium Dichromate affects the localization of BAX protein]; more ... | CTD | PMID:21262251 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:10226 | 6480464 | [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of BAX protein | CTD | PMID:19433268 |
| progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of BAX mRNA | CTD | PMID:15941375 |
| propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of BAX mRNA | CTD | PMID:16643972 |
| propofol | multiple interactions | EXP | | 6480464 | Propofol inhibits the reaction [Doxorubicin results in increased expression of BAX protein] | CTD | PMID:22015447 |
| propofol | increases expression | ISO | RGD:10226 | 6480464 | Propofol results in increased expression of BAX protein | CTD | PMID:21786383 |
| propranolol | decreases expression | EXP | | 6480464 | Propranolol results in decreased expression of BAX mRNA | CTD | PMID:11218852 |
| prostaglandin E2 | multiple interactions | ISO | RGD:70373 | 6480464 | [BAX binds to Dinoprostone] which results in increased localization of BAX | CTD | PMID:17369862 |
| prostaglandin E2 | multiple interactions | EXP | | 6480464 | Dinoprostone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of BAX protein] | CTD | PMID:16396944 |
| pterostilbene | affects response to substance | ISO | RGD:70373 | 6480464 | BAX protein affects the susceptibility to pterostilbene | CTD | PMID:22572619 |
| pterostilbene | increases expression | ISO | RGD:70373 | 6480464 | pterostilbene results in increased expression of BAX protein | CTD | PMID:20152895 more ... |
| pterostilbene | increases expression | ISO | RGD:10226 | 6480464 | pterostilbene results in increased expression of BAX protein | CTD | PMID:20681671 |
| pterostilbene | increases expression | ISO | RGD:70373 | 6480464 | pterostilbene results in increased expression of BAX mRNA | CTD | PMID:20152895 |
| pterostilbene | increases expression | ISO | RGD:70373 | 6480464 | pterostilbene results in increased expression of BAX protein | CTD | PMID:20152895 PMID:22572619 |
| pterostilbene | increases expression | ISO | RGD:70373 | 6480464 | pterostilbene results in increased expression of BAX protein | CTD | PMID:22572619 |
| purine-6-thiol | increases expression | ISO | RGD:10226 | 6480464 | 6-Mercaptopurine results in increased expression of BAX protein | CTD | PMID:9058596 |
| puromycin | affects localization | ISO | RGD:70373 | 6480464 | Puromycin affects the localization of BAX protein | CTD | PMID:18339127 |
| quercetin | affects expression | ISO | RGD:70373 | 6480464 | Quercetin affects the expression of BAX protein | CTD | PMID:15975156 |
| quercetin | multiple interactions | ISO | RGD:70373 | 6480464 | Quercetin inhibits the reaction [squamosamide inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein]] | CTD | PMID:21295016 |
| quercetin | multiple interactions | ISO | RGD:70373 | 6480464 | MCL1 protein inhibits the reaction [Quercetin results in increased localization of and results in increased activity of BAX protein] | CTD | PMID:21138867 |
| quercetin | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to Quercetin | CTD | PMID:21138867 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of BAX mRNA | CTD | PMID:23281070 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of BAX protein] | CTD | PMID:23281070 |
| quercetin | increases activity | ISO | RGD:70373 | 6480464 | Quercetin results in increased activity of BAX protein | CTD | PMID:18359480 |
| quercetin | multiple interactions | ISO | RGD:70373 | 6480464 | arsenic trioxide promotes the reaction [Quercetin results in increased activity of BAX protein]; more ... | CTD | PMID:18359480 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Thioacetamide affects the expression of BAX protein modified form] | CTD | PMID:21885874 |
| quercetin | increases expression | ISO | RGD:70373 | 6480464 | Quercetin results in increased expression of BAX protein | CTD | PMID:16049707 PMID:22222411 |
| quercetin | increases expression | ISO | RGD:70373 | 6480464 | Quercetin results in increased expression of BAX mRNA | CTD | PMID:17652743 PMID:21632981 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA] | CTD | PMID:19466539 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin analog inhibits the reaction [AGT protein results in increased expression of BAX protein] | CTD | PMID:19794523 |
| quercetin | increases expression | ISO | RGD:10226 | 6480464 | Quercetin results in increased expression of BAX protein | CTD | PMID:17039455 |
| quercetin | multiple interactions | ISO | RGD:70373 | 6480464 | [Quercetin results in increased susceptibility to Cisplatin] which results in increased expression of BAX protein | CTD | PMID:16619537 |
| quercetin | increases expression | ISO | RGD:70373 | 6480464 | Quercetin results in increased expression of BAX protein | CTD | PMID:16049707 |
| quercetin | increases expression | ISO | RGD:70373 | 6480464 | Quercetin results in increased expression of BAX mRNA | CTD | PMID:17652743 |
| quercetin | increases expression | ISO | RGD:70373 | 6480464 | Quercetin results in increased expression of BAX | CTD | PMID:16059641 |
| quercetin | multiple interactions | ISO | RGD:70373 | 6480464 | Quercetin promotes the reaction [TNFSF10 protein affects the localization of BAX protein] | CTD | PMID:17876056 |
| quercetin | increases expression | ISO | RGD:70373 | 6480464 | Quercetin metabolite results in increased expression of BAX protein | CTD | PMID:16280456 |
| quercetin | multiple interactions | ISO | RGD:70373 | 6480464 | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein] | CTD | PMID:12672908 |
| quercetin | multiple interactions | ISO | RGD:70373 | 6480464 | Quercetin inhibits the reaction [Dimethyl Sulfoxide results in increased expression of BAX mRNA] | CTD | PMID:17652743 |
| quinacrine | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to Quinacrine | CTD | PMID:16177561 |
| raloxifene | affects expression | ISO | RGD:70373 | 6480464 | Raloxifene affects the expression of BAX protein | CTD | PMID:16009171 |
| ramipril | affects expression | EXP | | 6480464 | Ramipril affects the expression of BAX protein | CTD | PMID:10728395 |
| ranitidine | multiple interactions | ISO | RGD:70373 | 6480464 | Ranitidine inhibits the reaction [Rotenone results in increased expression of BAX protein] | CTD | PMID:19723537 |
| razoxane | multiple interactions | ISO | RGD:10226 | 6480464 | [Doxorubicin co-treated with Razoxane] results in increased expression of BAX protein | CTD | PMID:12714334 |
| razoxane | increases expression | ISO | RGD:10226 | 6480464 | Razoxane results in increased expression of BAX protein | CTD | PMID:12714334 |
| reserpine | multiple interactions | EXP | | 6480464 | IAPP protein inhibits the reaction [Reserpine results in increased expression of BAX protein] | CTD | PMID:19463876 |
| reserpine | increases expression | EXP | | 6480464 | Reserpine results in increased expression of BAX protein | CTD | PMID:19463876 |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAX protein]; more ... | CTD | PMID:12902349 |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:12632486 more ... |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of BAX protein | CTD | PMID:21111721 |
| resveratrol | decreases expression | ISO | RGD:10226 | 6480464 | resveratrol results in decreased expression of BAX protein | CTD | PMID:23090186 |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | [resveratrol co-treated with TNFSF10 protein] results in increased activity of BAX protein | CTD | PMID:20097879 |
| resveratrol | affects localization | ISO | RGD:70373 | 6480464 | resveratrol affects the localization of BAX protein | CTD | PMID:15827328 PMID:16617056 |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | [allyl sulfide co-treated with resveratrol] results in increased expression of BAX mRNA | CTD | PMID:18512326 |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | [resveratrol results in increased phosphorylation of TP53 protein] which results in increased expression of BAX protein | CTD | PMID:18222423 |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:15633232 more ... |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX mRNA | CTD | PMID:15633232 |
| resveratrol | increases expression | ISO | RGD:10226 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:18201729 |
| resveratrol | affects localization | ISO | RGD:10226 | 6480464 | resveratrol affects the localization of BAX protein | CTD | PMID:20940732 |
| resveratrol | multiple interactions | ISO | RGD:10226 | 6480464 | resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein] | CTD | PMID:18791811 |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:12632486 more ... |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | [resveratrol results in increased acetylation of and results in increased activity of TP53 protein] promotes the reaction [TP53 protein binds to BAX promoter]; more ... | CTD | PMID:19810103 |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:16731767 more ... |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:17823925 more ... |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:17164350 more ... |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | TP53 affects the reaction [resveratrol results in increased expression of BAX protein] | CTD | PMID:19846903 |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:16731767 more ... |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:16731767 more ... |
| resveratrol | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to resveratrol | CTD | PMID:16550006 PMID:16518869 |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:17164350 more ... |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of and affects the localization of BAX protein | CTD | PMID:17116725 PMID:17636462 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [Diethylnitrosamine results in increased expression of BAX protein] | CTD | PMID:19073162 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA] | CTD | PMID:19466539 |
| resveratrol | increases expression | ISO | RGD:10226 | 6480464 | resveratrol results in increased expression of BAX mRNA | CTD | PMID:15637762 |
| resveratrol | multiple interactions | ISO | RGD:10226 | 6480464 | resveratrol inhibits the reaction [Cisplatin affects the localization of BAX protein]; more ... | CTD | PMID:21593185 |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:17049120 more ... |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX | CTD | PMID:21743969 |
| resveratrol | decreases expression | ISO | RGD:70373 | 6480464 | resveratrol results in decreased expression of BAX mRNA | CTD | PMID:16998810 |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of and affects the localization of BAX protein | CTD | PMID:17636462 PMID:17116725 |
| resveratrol | decreases expression | ISO | RGD:70373 | 6480464 | resveratrol results in decreased expression of BAX protein | CTD | PMID:14749477 |
| resveratrol | affects localization | ISO | RGD:70373 | 6480464 | resveratrol affects the localization of BAX protein | CTD | PMID:16617056 |
| resveratrol | affects folding | ISO | RGD:70373 | 6480464 | resveratrol affects the folding of BAX protein | CTD | PMID:16617056 |
| resveratrol | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to resveratrol | CTD | PMID:16518869 PMID:16550006 |
| resveratrol | affects expression | ISO | RGD:70373 | 6480464 | resveratrol affects the expression of BAX mRNA | CTD | PMID:16624241 |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | MRK 003 affects the reaction [resveratrol results in increased expression of BAX] | CTD | PMID:21743969 |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | CTSD protein affects the reaction [resveratrol promotes the reaction [BAX protein binds to BAX protein]] | CTD | PMID:17116725 |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | CASP2 protein affects the reaction [resveratrol affects the folding of BAX protein] | CTD | PMID:16617056 |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | BAX protein promotes the reaction [resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein]] | CTD | PMID:16518869 |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX mRNA | CTD | PMID:15633232 PMID:19796711 |
| resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:12632486 more ... |
| resveratrol | decreases expression | ISO | RGD:10226 | 6480464 | resveratrol results in decreased expression of BAX mRNA | CTD | PMID:18819863 |
| resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | resveratrol inhibits the reaction [MFGE8 protein results in increased expression of BAX protein] | CTD | PMID:21505870 |
| resveratrol | increases localization | ISO | RGD:70373 | 6480464 | resveratrol results in increased localization of BAX protein | CTD | PMID:19423619 |
| resveratrol | decreases expression | ISO | RGD:70373 | 6480464 | resveratrol results in decreased expression of BAX protein | CTD | PMID:14749477 PMID:21505870 |
| riboflavin | increases expression | ISO | RGD:70373 | 6480464 | Riboflavin results in increased expression of BAX protein | CTD | PMID:12654180 |
| rifampicin | multiple interactions | ISO | RGD:10226 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BAX mRNA | CTD | PMID:21224054 |
| rifampicin | multiple interactions | ISO | RGD:10226 | 6480464 | [Isoniazid co-treated with Rifampin] results in increased expression of BAX protein; more ... | CTD | PMID:21419764 |
| rifampicin | decreases expression | ISO | RGD:70373 | 6480464 | Rifampin results in decreased expression of BAX protein | CTD | PMID:12645856 PMID:11958592 |
| rifampicin | decreases expression | ISO | RGD:70373 | 6480464 | Rifampin results in decreased expression of BAX protein | CTD | PMID:11958592 PMID:12645856 |
| rosiglitazone | multiple interactions | ISO | RGD:70373 | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with rosiglitazone] results in increased expression of BAX mRNA; more ... | CTD | PMID:19056168 |
| rosiglitazone | increases expression | ISO | RGD:70373 | 6480464 | rosiglitazone results in increased expression of BAX protein | CTD | PMID:17461445 more ... |
| rosiglitazone | increases expression | ISO | RGD:70373 | 6480464 | rosiglitazone results in increased expression of BAX protein | CTD | PMID:19056168 more ... |
| rosiglitazone | increases expression | ISO | RGD:70373 | 6480464 | rosiglitazone results in increased expression of BAX protein | CTD | PMID:17461445 more ... |
| rosiglitazone | increases expression | ISO | RGD:70373 | 6480464 | rosiglitazone results in increased expression of BAX mRNA | CTD | PMID:17639046 PMID:19056168 |
| rosiglitazone | multiple interactions | ISO | RGD:70373 | 6480464 | rosiglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA] | CTD | PMID:17266988 |
| rosiglitazone | increases expression | ISO | RGD:70373 | 6480464 | rosiglitazone results in increased expression of BAX protein | CTD | PMID:17461445 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of BAX mRNA | CTD | PMID:20623750 |
| rosiglitazone | multiple interactions | ISO | RGD:70373 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glycosylation End Products, Advanced results in increased expression of BAX mRNA]]; more ... | CTD | PMID:21765445 |
| rosiglitazone | increases expression | ISO | RGD:70373 | 6480464 | rosiglitazone results in increased expression of BAX mRNA | CTD | PMID:19056168 |
| rosiglitazone | increases expression | ISO | RGD:70373 | 6480464 | rosiglitazone results in increased expression of BAX protein | CTD | PMID:20210794 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:70373 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of BAX protein] | CTD | PMID:17461445 |
| rotenone | increases expression | ISO | RGD:70373 | 6480464 | Rotenone results in increased expression of BAX protein | CTD | PMID:19777565 |
| rotenone | multiple interactions | EXP | | 6480464 | Antiparkinson Agents inhibits the reaction [Rotenone results in decreased expression of BAX mRNA] | CTD | PMID:21807080 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of BAX mRNA | CTD | PMID:21807080 |
| rotenone | multiple interactions | ISO | RGD:70373 | 6480464 | Ranitidine inhibits the reaction [Rotenone results in increased expression of BAX protein] | CTD | PMID:19723537 |
| rotenone | increases expression | ISO | RGD:70373 | 6480464 | Rotenone results in increased expression of BAX protein | CTD | PMID:19539006 more ... |
| rotenone | multiple interactions | ISO | RGD:70373 | 6480464 | Tranexamic Acid inhibits the reaction [Rotenone results in increased expression of BAX protein] | CTD | PMID:19539006 |
| rotenone | increases expression | ISO | RGD:70373 | 6480464 | Rotenone results in increased expression of BAX protein | CTD | PMID:19539006 PMID:19777565 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of BAX protein | CTD | PMID:18082360 |
| rotenone | increases expression | ISO | RGD:10226 | 6480464 | Rotenone results in increased expression of BAX mRNA | CTD | PMID:17702527 |
| rutin | affects expression | ISO | RGD:70373 | 6480464 | Rutin affects the expression of BAX protein | CTD | PMID:15975156 |
| S-(1,2-dichlorovinyl)-L-cysteine | increases expression | ISO | RGD:70373 | 6480464 | S-(1,2-dichlorovinyl)cysteine results in increased expression of BAX protein | CTD | PMID:15967204 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | RGD:10226 | 6480464 | Buthionine Sulfoximine results in increased expression of BAX protein | CTD | PMID:18552690 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:70373 | 6480464 | [Cadmium Chloride co-treated with Buthionine Sulfoximine] results in decreased expression of BAX protein; more ... | CTD | PMID:11341981 |
| S-nitrosoglutathione | multiple interactions | ISO | RGD:70373 | 6480464 | [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased expression of BAX protein | CTD | PMID:10828028 |
| sanguinarine | increases expression | ISO | RGD:70373 | 6480464 | sanguinarine results in increased expression of BAX protein | CTD | PMID:22215411 |
| sappanchalcone | increases expression | ISO | RGD:70373 | 6480464 | sappanchalcone results in increased expression of BAX protein | CTD | PMID:21963806 |
| scopolamine | increases expression | ISO | RGD:10226 | 6480464 | Scopolamine Hydrobromide results in increased expression of BAX protein | CTD | PMID:17120751 |
| selenium atom | decreases expression | ISO | RGD:10226 | 6480464 | Selenium results in decreased expression of BAX protein | CTD | PMID:17997286 |
| selenium atom | multiple interactions | ISO | RGD:70373 | 6480464 | Selenium inhibits the reaction [T-2 Toxin results in increased expression of BAX mRNA] | CTD | PMID:16307838 |
| sildenafil | multiple interactions | EXP | | 6480464 | sildenafil inhibits the reaction [Streptozocin results in increased expression of BAX mRNA]; more ... | CTD | PMID:20574430 |
| sildenafil | multiple interactions | EXP | | 6480464 | sildenafil inhibits the reaction [Cisplatin results in increased expression of BAX protein] | CTD | PMID:19152827 |
| silibinin | multiple interactions | ISO | RGD:70373 | 6480464 | silybin inhibits the reaction [Mitomycin affects the localization of BAX protein] | CTD | PMID:19834285 |
| silicon dioxide | increases expression | ISO | RGD:70373 | 6480464 | Silicon Dioxide results in increased expression of BAX protein | CTD | PMID:20060462 |
| silicon dioxide | increases expression | ISO | RGD:70373 | 6480464 | Silicon Dioxide results in increased expression of BAX protein | CTD | PMID:20060462 PMID:22245848 |
| silicon dioxide | increases expression | ISO | RGD:70373 | 6480464 | Silicon Dioxide results in increased expression of BAX mRNA | CTD | PMID:22245848 |
| silicon dioxide | multiple interactions | ISO | RGD:70373 | 6480464 | Ascorbic Acid inhibits the reaction [Silicon Dioxide results in increased expression of BAX mRNA]; more ... | CTD | PMID:22245848 |
| silver atom | increases expression | ISO | RGD:70373 | 6480464 | Silver results in increased expression of BAX mRNA | CTD | PMID:21611810 |
| silver(0) | increases expression | ISO | RGD:70373 | 6480464 | Silver results in increased expression of BAX mRNA | CTD | PMID:21611810 |
| simvastatin | affects localization | ISO | RGD:70373 | 6480464 | Simvastatin affects the localization of BAX protein | CTD | PMID:20045437 |
| simvastatin | increases expression | ISO | RGD:70373 | 6480464 | Simvastatin results in increased expression of BAX protein | CTD | PMID:17901590 PMID:20045437 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of BAX protein | CTD | PMID:12557325 |
| simvastatin | increases expression | ISO | RGD:70373 | 6480464 | Simvastatin results in increased expression of BAX protein | CTD | PMID:20045437 PMID:17901590 |
| simvastatin | increases expression | ISO | RGD:70373 | 6480464 | Simvastatin results in increased expression of BAX mRNA | CTD | PMID:17901590 |
| simvastatin | increases expression | ISO | RGD:70373 | 6480464 | Simvastatin results in increased expression of BAX protein | CTD | PMID:20045437 |
| sirolimus | affects localization | ISO | RGD:70373 | 6480464 | Sirolimus affects the localization of BAX protein | CTD | PMID:11602639 |
| sirolimus | increases expression | ISO | RGD:10226 | 6480464 | Sirolimus results in increased expression of BAX protein; more ... | CTD | PMID:19922502 |
| sirolimus | multiple interactions | ISO | RGD:10226 | 6480464 | [Sirolimus results in decreased activity of RPS6KB1 protein] which results in increased expression of BAX mRNA; more ... | CTD | PMID:19922502 |
| sirolimus | increases expression | ISO | RGD:70373 | 6480464 | Sirolimus results in increased expression of BAX protein | CTD | PMID:15782132 |
| sirolimus | multiple interactions | ISO | RGD:70373 | 6480464 | [Curcumin co-treated with Sirolimus] results in increased expression of BAX | CTD | PMID:19373661 |
| sodium azide | multiple interactions | EXP | | 6480464 | Minocycline inhibits the reaction [Sodium Azide affects the localization of BAX protein] | CTD | PMID:15004018 |
| sodium azide | affects localization | EXP | | 6480464 | Sodium Azide affects the localization of BAX protein | CTD | PMID:15004018 |
| sodium chloride | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BAX protein | CTD | PMID:16030430 |
| sodium chloride | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of BAX protein]; more ... | CTD | PMID:22431579 |
| sodium fluoride | increases expression | EXP | | 6480464 | Sodium Fluoride results in increased expression of BAX protein | CTD | PMID:18696052 |
| staurosporine | multiple interactions | ISO | RGD:70373 | 6480464 | Staurosporine promotes the reaction [BID protein binds to BAX protein]; more ... | CTD | PMID:19552762 |
| staurosporine | affects localization | EXP | | 6480464 | Staurosporine affects the localization of BAX protein | CTD | PMID:15961378 |
| staurosporine | affects expression | EXP | | 6480464 | Staurosporine affects the expression of BAX mRNA | CTD | PMID:11296547 |
| staurosporine | multiple interactions | ISO | RGD:10226 | 6480464 | Tacrine inhibits the reaction [Staurosporine results in increased expression of BAX protein] | CTD | PMID:12579951 |
| staurosporine | increases expression | ISO | RGD:10226 | 6480464 | Staurosporine results in increased expression of BAX protein | CTD | PMID:12579951 |
| staurosporine | multiple interactions | ISO | RGD:70373 | 6480464 | Staurosporine affects the folding of and results in increased activity of BAX protein | CTD | PMID:16007140 |
| streptozocin | multiple interactions | ISO | RGD:10226 | 6480464 | IGF1 protein inhibits the reaction [Streptozocin results in increased expression of BAX protein] | CTD | PMID:11375343 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of BAX mRNA | CTD | PMID:19931367 more ... |
| streptozocin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Streptozocin results in increased expression of BAX mRNA]; more ... | CTD | PMID:23267840 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of BAX protein | CTD | PMID:18758938 more ... |
| streptozocin | multiple interactions | EXP | | 6480464 | Angiotensin-Converting Enzyme Inhibitors inhibits the reaction [Streptozocin results in increased expression of BAX protein]; more ... | CTD | PMID:22429817 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of BAX protein | CTD | PMID:18758938 more ... |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of BAX mRNA | CTD | PMID:19931367 PMID:20574430 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of BAX protein | CTD | PMID:20650802 PMID:18758938 |
| streptozocin | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Streptozocin results in increased expression of BAX protein] | CTD | PMID:18758938 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of BAX protein | CTD | PMID:20650802 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of BAX mRNA | CTD | PMID:20574430 |
| streptozocin | multiple interactions | EXP | | 6480464 | sildenafil inhibits the reaction [Streptozocin results in increased expression of BAX mRNA]; more ... | CTD | PMID:20574430 |
| streptozocin | multiple interactions | EXP | | 6480464 | Diazoxide inhibits the reaction [Streptozocin results in increased expression of BAX protein] | CTD | PMID:20650802 |
| streptozocin | increases expression | ISO | RGD:10226 | 6480464 | Streptozocin results in increased expression of BAX protein | CTD | PMID:11375343 |
| styrene | decreases expression | ISO | RGD:70373 | 6480464 | Styrene results in decreased expression of BAX protein | CTD | PMID:15212811 |
| styrene oxide | affects expression | ISO | RGD:70373 | 6480464 | styrene oxide affects the expression of BAX mRNA | CTD | PMID:11230554 |
| styrene oxide | increases expression | EXP | | 6480464 | styrene oxide results in increased expression of BAX protein | CTD | PMID:12663515 |
| sulfasalazine | affects localization | ISO | RGD:70373 | 6480464 | Sulfasalazine affects the localization of BAX protein | CTD | PMID:12381674 |
| sulforaphane | increases expression | ISO | RGD:70373 | 6480464 | sulforafan results in increased expression of BAX protein | CTD | PMID:16033772 |
| sulforaphane | increases expression | ISO | RGD:10226 | 6480464 | sulforafan results in increased expression of BAX protein | CTD | PMID:17942926 |
| sulindac | multiple interactions | ISO | RGD:70373 | 6480464 | SB 203580 inhibits the reaction [Sulindac affects the localization of BAX protein] | CTD | PMID:17136320 |
| sulindac | increases expression | ISO | RGD:70373 | 6480464 | Sulindac results in increased expression of BAX protein | CTD | PMID:11062132 |
| sulindac | affects localization | ISO | RGD:70373 | 6480464 | Sulindac affects the localization of BAX protein | CTD | PMID:17136320 |
| sulindac | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to Sulindac | CTD | PMID:11062132 |
| surfactin | multiple interactions | ISO | RGD:70373 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [surfactin peptide results in increased expression of BAX protein]; more ... | CTD | PMID:19954742 |
| surfactin | increases expression | ISO | RGD:70373 | 6480464 | surfactin peptide results in increased expression of BAX protein | CTD | PMID:19954742 |
| surfactin C | multiple interactions | ISO | RGD:70373 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [surfactin peptide results in increased expression of BAX protein]; more ... | CTD | PMID:19954742 |
| surfactin C | increases expression | ISO | RGD:70373 | 6480464 | surfactin peptide results in increased expression of BAX protein | CTD | PMID:19954742 |
| tacrine | multiple interactions | ISO | RGD:10226 | 6480464 | Tacrine inhibits the reaction [Staurosporine results in increased expression of BAX protein] | CTD | PMID:12579951 |
| tacrine | multiple interactions | EXP | | 6480464 | Tacrine inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX mRNA]; more ... | CTD | PMID:12414117 |
| tacrolimus hydrate | multiple interactions | ISO | RGD:10226 | 6480464 | Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BAX protein] | CTD | PMID:10205001 |
| tacrolimus hydrate | multiple interactions | EXP | | 6480464 | [Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BAX protein | CTD | PMID:15571979 |
| tamoxifen | affects expression | ISO | RGD:10226 | 6480464 | Tamoxifen affects the expression of BAX mRNA | CTD | PMID:17555576 |
| tamoxifen | multiple interactions | ISO | RGD:70373 | 6480464 | Tamoxifen promotes the reaction [Mitomycin results in decreased expression of BAX mRNA]; more ... | CTD | PMID:19757172 |
| tamoxifen | multiple interactions | ISO | RGD:70373 | 6480464 | [Tamoxifen co-treated with TNFSF10 protein] results in increased expression of BAX protein | CTD | PMID:17767197 |
| tamoxifen | multiple interactions | ISO | RGD:70373 | 6480464 | [Tamoxifen co-treated with AG 1879] affects the localization of BAX protein | CTD | PMID:17186241 |
| taurine | multiple interactions | EXP | | 6480464 | Taurine inhibits the reaction [sodium arsenite results in increased expression of BAX protein] | CTD | PMID:19616567 |
| taurine | multiple interactions | EXP | | 6480464 | Taurine inhibits the reaction [sodium arsenite results in increased expression of BAX protein] | CTD | PMID:19616567 PMID:20830294 |
| taurine | multiple interactions | EXP | | 6480464 | Taurine inhibits the reaction [sodium arsenite results in increased expression of BAX mRNA] | CTD | PMID:20830294 |
| taurine | multiple interactions | EXP | | 6480464 | Taurine inhibits the reaction [Alloxan results in increased expression of BAX protein] | CTD | PMID:22138235 |
| tazarotene | increases expression | ISO | RGD:70373 | 6480464 | tazarotene results in increased expression of BAX protein | CTD | PMID:16109552 PMID:16196285 |
| tazarotene | increases expression | ISO | RGD:70373 | 6480464 | tazarotene results in increased expression of BAX protein | CTD | PMID:16196285 PMID:16109552 |
| temozolomide | increases expression | ISO | RGD:70373 | 6480464 | temozolomide analog results in increased expression of BAX protein | CTD | PMID:19363609 |
| temozolomide | multiple interactions | ISO | RGD:10226 | 6480464 | TRP53 protein affects the reaction [[temozolomide co-treated with O(6)-benzylguanine] results in increased expression of BAX protein] | CTD | PMID:20980775 |
| terazosin | increases expression | ISO | RGD:70373 | 6480464 | Terazosin results in increased expression of BAX protein | CTD | PMID:12883741 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:70373 | 6480464 | hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of BAX protein] | CTD | PMID:18552516 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:10226 | 6480464 | tert-Butylhydroperoxide results in increased expression of BAX protein | CTD | PMID:20510348 |
| tert-butyl hydroperoxide | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein] | CTD | PMID:15569404 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of BAX protein | CTD | PMID:15569404 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:70373 | 6480464 | tert-Butylhydroperoxide results in increased expression of BAX protein | CTD | PMID:17419000 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:70373 | 6480464 | tert-Butylhydroperoxide results in decreased expression of BAX mRNA | CTD | PMID:12419474 |
| tert-butyl hydroperoxide | affects localization | ISO | RGD:70373 | 6480464 | tert-Butylhydroperoxide affects the localization of BAX protein | CTD | PMID:18552516 |
| testosterone | multiple interactions | ISO | RGD:70373 | 6480464 | gingerol inhibits the reaction [Testosterone results in decreased expression of BAX protein] | CTD | PMID:18030663 |
| testosterone | multiple interactions | EXP | | 6480464 | Testosterone promotes the reaction [sildenafil inhibits the reaction [Streptozocin results in increased expression of BAX mRNA]]; more ... | CTD | PMID:20574430 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone deficiency results in increased expression of BAX mRNA; more ... | CTD | PMID:20850791 |
| testosterone | decreases expression | ISO | RGD:10226 | 6480464 | Testosterone results in decreased expression of BAX protein | CTD | PMID:18030663 |
| testosterone | multiple interactions | EXP | | 6480464 | Dihydrotestosterone inhibits the reaction [Testosterone deficiency results in increased expression of BAX mRNA]; more ... | CTD | PMID:20850791 |
| testosterone | multiple interactions | ISO | RGD:10226 | 6480464 | gingerol inhibits the reaction [Testosterone results in decreased expression of BAX protein] | CTD | PMID:18030663 |
| testosterone | decreases expression | ISO | RGD:70373 | 6480464 | Testosterone results in decreased expression of BAX protein | CTD | PMID:18030663 |
| testosterone | decreases expression | ISO | RGD:70373 | 6480464 | Testosterone results in decreased expression of BAX mRNA | CTD | PMID:21592394 |
| testosterone | multiple interactions | ISO | RGD:70373 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of BAX mRNA | CTD | PMID:21592394 |
| tetrachloroethene | affects expression | ISO | RGD:70373 | 6480464 | Tetrachloroethylene affects the expression of BAX protein | CTD | PMID:16010555 |
| tetrachloroethene | increases expression | ISO | RGD:70373 | 6480464 | Tetrachloroethylene results in increased expression of BAX protein | CTD | PMID:12160929 |
| tetrachloroethene | increases activity | ISO | RGD:70373 | 6480464 | Tetrachloroethylene results in increased activity of BAX protein | CTD | PMID:12160929 |
| tetrachloromethane | multiple interactions | ISO | RGD:10226 | 6480464 | PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of BAX mRNA] | CTD | PMID:18038451 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | [Carbon Tetrachloride co-treated with TM4SF4 protein] results in increased expression of BAX mRNA | CTD | PMID:17069928 |
| thalidomide | increases expression | EXP | | 6480464 | Thalidomide results in increased expression of BAX mRNA | CTD | PMID:18291259 |
| thapsigargin | increases activity | ISO | RGD:70373 | 6480464 | Thapsigargin results in increased activity of BAX protein | CTD | PMID:20130848 |
| thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of BAX mRNA | CTD | PMID:17292413 |
| thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of BAX protein | CTD | PMID:21885874 |
| thioacetamide | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Thioacetamide affects the expression of BAX protein modified form] | CTD | PMID:21885874 |
| thioacetamide | multiple interactions | ISO | RGD:10226 | 6480464 | TXNIP gene mutant form inhibits the reaction [Thioacetamide results in increased expression of BAX protein] | CTD | PMID:20713078 |
| thioacetamide | increases expression | ISO | RGD:10226 | 6480464 | Thioacetamide results in increased expression of BAX protein | CTD | PMID:20713078 |
| thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of BAX protein | CTD | PMID:16937528 |
| thymidine | multiple interactions | ISO | RGD:70373 | 6480464 | Thymidine inhibits the reaction [Adenosine results in increased localization of BAX protein] | CTD | PMID:11570579 |
| thymol | increases expression | ISO | RGD:70373 | 6480464 | Thymol results in increased expression of BAX protein | CTD | PMID:21640085 |
| titanium dioxide | increases expression | ISO | RGD:70373 | 6480464 | titanium dioxide results in increased expression of BAX protein | CTD | PMID:20362650 |
| titanium dioxide | increases expression | ISO | RGD:10226 | 6480464 | titanium dioxide results in increased expression of BAX mRNA; more ... | CTD | PMID:20381595 |
| titanium dioxide | increases expression | ISO | RGD:70373 | 6480464 | titanium dioxide results in increased expression of BAX mRNA | CTD | PMID:19486931 |
| tocopherol | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to Tocopherols | CTD | PMID:16001965 |
| tranexamic acid | multiple interactions | ISO | RGD:70373 | 6480464 | Tranexamic Acid inhibits the reaction [Rotenone results in increased expression of BAX protein] | CTD | PMID:19539006 |
| trans-resveratrol | decreases expression | ISO | RGD:70373 | 6480464 | resveratrol results in decreased expression of BAX protein | CTD | PMID:14749477 PMID:21505870 |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:12632486 more ... |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of BAX protein | CTD | PMID:21111721 |
| trans-resveratrol | decreases expression | ISO | RGD:10226 | 6480464 | resveratrol results in decreased expression of BAX protein | CTD | PMID:23090186 |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | [resveratrol co-treated with TNFSF10 protein] results in increased activity of BAX protein | CTD | PMID:20097879 |
| trans-resveratrol | affects localization | ISO | RGD:70373 | 6480464 | resveratrol affects the localization of BAX protein | CTD | PMID:15827328 PMID:16617056 |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | [allyl sulfide co-treated with resveratrol] results in increased expression of BAX mRNA | CTD | PMID:18512326 |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | [resveratrol results in increased phosphorylation of TP53 protein] which results in increased expression of BAX protein | CTD | PMID:18222423 |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:15633232 more ... |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX mRNA | CTD | PMID:15633232 |
| trans-resveratrol | increases expression | ISO | RGD:10226 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:18201729 |
| trans-resveratrol | affects localization | ISO | RGD:10226 | 6480464 | resveratrol affects the localization of BAX protein | CTD | PMID:20940732 |
| trans-resveratrol | multiple interactions | ISO | RGD:10226 | 6480464 | resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein] | CTD | PMID:18791811 |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:12632486 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | [resveratrol results in increased acetylation of and results in increased activity of TP53 protein] promotes the reaction [TP53 protein binds to BAX promoter]; more ... | CTD | PMID:19810103 |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:16731767 more ... |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:17823925 more ... |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:17164350 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | TP53 affects the reaction [resveratrol results in increased expression of BAX protein] | CTD | PMID:19846903 |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:16731767 more ... |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:16731767 more ... |
| trans-resveratrol | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to resveratrol | CTD | PMID:16550006 PMID:16518869 |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:17164350 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of and affects the localization of BAX protein | CTD | PMID:17116725 PMID:17636462 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [Diethylnitrosamine results in increased expression of BAX protein] | CTD | PMID:19073162 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA] | CTD | PMID:19466539 |
| trans-resveratrol | increases expression | ISO | RGD:10226 | 6480464 | resveratrol results in increased expression of BAX mRNA | CTD | PMID:15637762 |
| trans-resveratrol | multiple interactions | ISO | RGD:10226 | 6480464 | resveratrol inhibits the reaction [Cisplatin affects the localization of BAX protein]; more ... | CTD | PMID:21593185 |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:17049120 more ... |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX | CTD | PMID:21743969 |
| trans-resveratrol | decreases expression | ISO | RGD:70373 | 6480464 | resveratrol results in decreased expression of BAX mRNA | CTD | PMID:16998810 |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of and affects the localization of BAX protein | CTD | PMID:17636462 PMID:17116725 |
| trans-resveratrol | decreases expression | ISO | RGD:70373 | 6480464 | resveratrol results in decreased expression of BAX protein | CTD | PMID:14749477 |
| trans-resveratrol | affects localization | ISO | RGD:70373 | 6480464 | resveratrol affects the localization of BAX protein | CTD | PMID:16617056 |
| trans-resveratrol | affects folding | ISO | RGD:70373 | 6480464 | resveratrol affects the folding of BAX protein | CTD | PMID:16617056 |
| trans-resveratrol | increases response to substance | ISO | RGD:70373 | 6480464 | BAX protein results in increased susceptibility to resveratrol | CTD | PMID:16518869 PMID:16550006 |
| trans-resveratrol | affects expression | ISO | RGD:70373 | 6480464 | resveratrol affects the expression of BAX mRNA | CTD | PMID:16624241 |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | MRK 003 affects the reaction [resveratrol results in increased expression of BAX] | CTD | PMID:21743969 |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | CTSD protein affects the reaction [resveratrol promotes the reaction [BAX protein binds to BAX protein]] | CTD | PMID:17116725 |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | CASP2 protein affects the reaction [resveratrol affects the folding of BAX protein] | CTD | PMID:16617056 |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | BAX protein promotes the reaction [resveratrol promotes the reaction [CASP6 protein results in increased cleavage of LMNA protein]] | CTD | PMID:16518869 |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX protein | CTD | PMID:12632486 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAX protein]; more ... | CTD | PMID:12902349 |
| trans-resveratrol | increases expression | ISO | RGD:70373 | 6480464 | resveratrol results in increased expression of BAX mRNA | CTD | PMID:15633232 PMID:19796711 |
| trans-resveratrol | increases localization | ISO | RGD:70373 | 6480464 | resveratrol results in increased localization of BAX protein | CTD | PMID:19423619 |
| trans-resveratrol | multiple interactions | ISO | RGD:70373 | 6480464 | resveratrol inhibits the reaction [MFGE8 protein results in increased expression of BAX protein] | CTD | PMID:21505870 |
| trans-resveratrol | decreases expression | ISO | RGD:10226 | 6480464 | resveratrol results in decreased expression of BAX mRNA | CTD | PMID:18819863 |
| triamcinolone acetonide | increases expression | EXP | | 6480464 | Triamcinolone Acetonide results in increased expression of BAX protein | CTD | PMID:15987869 |
| trichloroethene | affects expression | ISO | RGD:10226 | 6480464 | Trichloroethylene affects the expression of BAX mRNA | CTD | PMID:21135412 |
| trichloroethene | increases expression | ISO | RGD:70373 | 6480464 | Trichloroethylene results in increased expression of BAX protein | CTD | PMID:12160929 |
| trichostatin A | multiple interactions | ISO | RGD:70373 | 6480464 | [D 21266 co-treated with trichostatin A] results in increased activity of BAX protein; more ... | CTD | PMID:15781658 |
| trichostatin A | multiple interactions | ISO | RGD:70373 | 6480464 | SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]; more ... | CTD | PMID:19887557 |
| trichostatin A | increases expression | ISO | RGD:70373 | 6480464 | trichostatin A results in increased expression of BAX protein | CTD | PMID:16010430 PMID:19887557 |
| trichostatin A | increases expression | ISO | RGD:70373 | 6480464 | trichostatin A results in increased expression of BAX protein | CTD | PMID:16010430 |
| triciribine | multiple interactions | ISO | RGD:70373 | 6480464 | triciribine inhibits the reaction [Ursodeoxycholic Acid inhibits the reaction [Nitroprusside affects the localization of BAX protein]] | CTD | PMID:22178905 |
| trifluoperazine | increases expression | ISO | RGD:70373 | 6480464 | Trifluoperazine results in increased expression of BAX protein | CTD | PMID:21475906 |
| tris(picolinato)chromium | multiple interactions | ISO | RGD:70373 | 6480464 | Acetylcysteine inhibits the reaction [chromium tripicolinate results in increased expression of BAX protein] | CTD | PMID:19376147 |
| tris(picolinato)chromium | increases expression | ISO | RGD:70373 | 6480464 | chromium tripicolinate results in increased expression of BAX protein | CTD | PMID:19376147 |
| troglitazone | increases expression | ISO | RGD:70373 | 6480464 | troglitazone results in increased expression of BAX mRNA | CTD | PMID:17143939 |
| troglitazone | increases expression | ISO | RGD:70373 | 6480464 | troglitazone results in increased expression of BAX protein | CTD | PMID:20540935 more ... |
| troglitazone | increases expression | ISO | RGD:70373 | 6480464 | troglitazone results in increased expression of BAX protein | CTD | PMID:20540935 more ... |
| troglitazone | increases expression | ISO | RGD:70373 | 6480464 | troglitazone results in increased expression of BAX protein | CTD | PMID:15100737 more ... |
| troglitazone | increases expression | ISO | RGD:70373 | 6480464 | troglitazone results in increased expression of BAX protein | CTD | PMID:15100737 more ... |
| troglitazone | multiple interactions | ISO | RGD:70373 | 6480464 | GSK3B protein affects the susceptibility to [troglitazone results in increased expression of BAX protein]; more ... | CTD | PMID:20540935 |
| troglitazone | increases expression | ISO | RGD:70373 | 6480464 | troglitazone results in increased expression of BAX protein | CTD | PMID:15100737 PMID:17143939 |
| tryptamine | multiple interactions | EXP | | 6480464 | tryptamine analog inhibits the reaction [Indomethacin results in increased expression of BAX mRNA] | CTD | PMID:22157011 |
| tunicamycin | increases activity | ISO | RGD:70373 | 6480464 | Tunicamycin results in increased activity of BAX protein | CTD | PMID:17553788 |
| umbelliferone | increases expression | ISO | RGD:70373 | 6480464 | 7-hydroxycoumarin results in increased expression of BAX protein | CTD | PMID:15964220 |
| urethane | decreases expression | ISO | RGD:10226 | 6480464 | Urethane results in decreased expression of BAX mRNA | CTD | PMID:12400877 |
| ursodeoxycholic acid | increases expression | ISO | RGD:70373 | 6480464 | Ursodeoxycholic Acid results in increased expression of BAX | CTD | PMID:17461466 |
| ursodeoxycholic acid | multiple interactions | ISO | RGD:70373 | 6480464 | triciribine inhibits the reaction [Ursodeoxycholic Acid inhibits the reaction [Nitroprusside affects the localization of BAX protein]]; more ... | CTD | PMID:22178905 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of BAX protein] | CTD | PMID:10510466 more ... |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [TP53 protein results in increased expression of BAX protein] | CTD | PMID:14514686 PMID:17881359 |
| ursodeoxycholic acid | multiple interactions | ISO | RGD:10226 | 6480464 | Ursodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in increased expression of BAX protein] | CTD | PMID:21419764 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of BAX protein] | CTD | PMID:9562975 more ... |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [TGFB1 protein results in increased expression of BAX protein] | CTD | PMID:10510466 PMID:14514686 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of BAX protein] | CTD | PMID:9562975 more ... |
| ursodeoxycholic acid | decreases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in decreased expression of BAX protein | CTD | PMID:15970352 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [TP53 protein results in increased expression of BAX protein] | CTD | PMID:17881359 PMID:14514686 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [TP53 protein results in increased expression of and results in increased localization of BAX protein]; more ... | CTD | PMID:17881359 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [TGFB1 protein results in increased expression of BAX protein] | CTD | PMID:14514686 PMID:10510466 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Okadaic Acid results in increased expression of BAX protein] | CTD | PMID:10510466 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [E2F1 protein results in increased expression of BAX protein]; more ... | CTD | PMID:14514686 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of BAX protein] | CTD | PMID:20137712 more ... |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of BAX mRNA] | CTD | PMID:20137712 |
| ursolic acid | increases expression | ISO | RGD:70373 | 6480464 | ursolic acid results in increased expression of BAX protein | CTD | PMID:16012738 |
| usnic acid | decreases expression | ISO | RGD:70373 | 6480464 | usnic acid results in decreased expression of BAX protein | CTD | PMID:22285236 |
| valproic acid | increases expression | ISO | RGD:70373 | 6480464 | Valproic Acid results in increased expression of BAX protein | CTD | PMID:19006566 |
| valproic acid | multiple interactions | ISO | RGD:70373 | 6480464 | [Valproic Acid co-treated with decitabine co-treated with TNFSF10 protein] results in increased activity of BAX protein | CTD | PMID:21771726 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of BAX mRNA | CTD | PMID:21318169 |
| valproic acid | multiple interactions | EXP | | 6480464 | Valproic Acid inhibits the reaction [Methamphetamine results in increased expression of BAX protein] | CTD | PMID:19149911 |
| vincristine | decreases expression | ISO | RGD:70373 | 6480464 | Vincristine results in decreased expression of BAX mRNA | CTD | PMID:16001973 |
| vincristine | multiple interactions | ISO | RGD:70373 | 6480464 | Vincristine results in increased cleavage of and results in increased expression of BAX protein | CTD | PMID:15131059 |
| vincristine | affects response to substance | ISO | RGD:70373 | 6480464 | BAX protein affects the susceptibility to Vincristine | CTD | PMID:22178383 |
| vindesine | multiple interactions | ISO | RGD:70373 | 6480464 | Tamoxifen promotes the reaction [Vindesine results in decreased expression of BAX mRNA] | CTD | PMID:19757172 |
| vindesine | decreases expression | ISO | RGD:70373 | 6480464 | Vindesine results in decreased expression of BAX mRNA | CTD | PMID:19757172 |
| wogonin | multiple interactions | ISO | RGD:70373 | 6480464 | [wogonin co-treated with Fluorouracil] results in increased expression of BAX protein | CTD | PMID:20570612 |
| wogonin | increases expression | ISO | RGD:70373 | 6480464 | wogonin results in increased expression of BAX protein | CTD | PMID:20570612 PMID:21457722 |
| wortmannin | multiple interactions | ISO | RGD:70373 | 6480464 | wortmannin inhibits the reaction [Leukotriene B4 results in increased expression of BAX protein] | CTD | PMID:15970427 |
| ytterbium | increases expression | ISO | RGD:70373 | 6480464 | Ytterbium analog results in increased expression of BAX protein | CTD | PMID:19632212 |
| zearalenone | affects localization | ISO | RGD:70373 | 6480464 | Zearalenone affects the localization of BAX protein | CTD | PMID:19541794 |
| zearalenone | increases expression | ISO | RGD:10226 | 6480464 | Zearalenone results in increased expression of BAX protein | CTD | PMID:21767629 |
| zebularine | affects cleavage | ISO | RGD:70373 | 6480464 | pyrimidin-2-one beta-ribofuranoside affects the cleavage of BAX protein | CTD | PMID:19459041 |
| zerumbone | multiple interactions | EXP | | 6480464 | zerumbone promotes the reaction [[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BAX protein] | CTD | PMID:20452335 |
| zinc atom | increases expression | ISO | RGD:70373 | 6480464 | Zinc results in increased expression of BAX protein | CTD | PMID:15880691 |
| zinc atom | multiple interactions | ISO | RGD:70373 | 6480464 | Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]] | CTD | PMID:19887557 |
| zinc atom | increases expression | ISO | RGD:10226 | 6480464 | Zinc deficiency results in increased expression of BAX protein | CTD | PMID:20101602 |
| zinc atom | increases expression | ISO | RGD:70373 | 6480464 | Zinc results in increased expression of BAX mRNA | CTD | PMID:12107073 |
| zinc dichloride | multiple interactions | ISO | RGD:70373 | 6480464 | [Citric Acid co-treated with zinc chloride] results in increased expression of BAX protein | CTD | PMID:16624386 |
| zinc dichloride | multiple interactions | ISO | RGD:10226 | 6480464 | zinc chloride promotes the reaction [Doxorubicin results in increased expression of BAX mRNA] | CTD | PMID:19714248 |
| zinc pyrithione | increases expression | ISO | RGD:70373 | 6480464 | zinc pyrithione results in increased expression of BAX mRNA | CTD | PMID:21424779 |
| zinc(0) | increases expression | ISO | RGD:70373 | 6480464 | Zinc results in increased expression of BAX protein | CTD | PMID:15880691 |
| zinc(0) | multiple interactions | ISO | RGD:70373 | 6480464 | Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]] | CTD | PMID:19887557 |
| zinc(0) | increases expression | ISO | RGD:10226 | 6480464 | Zinc deficiency results in increased expression of BAX protein | CTD | PMID:20101602 |
| zinc(0) | increases expression | ISO | RGD:70373 | 6480464 | Zinc results in increased expression of BAX mRNA | CTD | PMID:12107073 |
| zoledronic acid | multiple interactions | ISO | RGD:10226 | 6480464 | [zoledronic acid co-treated with Doxorubicin] results in increased expression of BAX protein | CTD | PMID:19789217 |
| zoledronic acid | multiple interactions | ISO | RGD:70373 | 6480464 | [Tretinoin co-treated with zoledronic acid] results in increased expression of BAX protein | CTD | PMID:20349282 |
| zoledronic acid | decreases expression | ISO | RGD:70373 | 6480464 | zoledronic acid results in decreased expression of BAX mRNA | CTD | PMID:19036117 |